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Protein-ligand interaction is one of process that plays key role in all biological 
processes that occur in body and thus it underpins the whole biological science. Thus 
the detailed knowledge of such interactions is of immense importance to understand 
the physiology and helpful in the discovery of new medicines to benefit human health. 
To understand the protein-ligand interactions, an-depth knowledge of biophysical 
behavior of protein and ligand that includes degree of complementarity of the binding 
site of the protein and the ligand, binding site location, affinity, binding energies, and 
entropy and enthalpy changes accompanied is pre-requirement There are various 
examples of biologically relevant protein ligand interaction, where studying binding 
mechanism, forces involved, "and themiodynamics is helpful either in understanding 
physiology or in designing new medicines. Examples which immediately stand out 
from the many includes interaction of exogenous and endogenous compounds with 
carrier protein, human seruig'^  albumin (HSA), interaction of detergent, sodium 
dodecyl sulphate, which mimics membrane, with glycoprotein and interaction of 
small molecules with amyloidogenic proteins. Keeping in mind the significance of 
these protein ligand interactions, in this thesis following important protein ligand 
systems have been investigated with the help of various biophysical techniques: 
1. Interaction of hippuric acid (HA), a uremic toxin, with carrier protein, human 
serum albumin (HSA) to determine plausible reason behind its impaired elimination. 
2. Interaction of furosemide (FUR), a diuretic drug, with human serum albumin 
(HSA) to know FUR binding mechanism and its binding sites on HSA. Binding 
mechanism obtained help in detennination of the reason of FUR impaired binding to 
HSA in uremia. 
3. Interaction of sodium dodecyl sulphate (SDS) that mimics membrane, to bovine 
serum fetuin (BSF) (a model glycoprotein) at pH 2 and 7.4 to know modes of SDS 
interaction with BSF under different solution condition. 
4. The effect of n-acetylneuraminic acid (Neu5Ac), a monosaccharide that occur 
naturally at the end of sugar chains attached to the surfaces of cells and soluble 
proteins, on the amyloid fibrillization of hen egg white lysozyme (HEWL), a model 
protein, to determine potency of NeuSAc as inhibitor of amyloid fibrillization. 
Chapter 1 
As the introduction part of the thesis, overview of basic models of protein Hgand 
interaction, forces involved, changes in thennodynamic parameters and techniques to 
study protein ligand interaction has been reviewed. Physiologically significant 
examples of protein ligand interaction related to the work earned out in this thesis 
were also discussed. 
Chapter 2 
Binding of hippuric acid (HA), a uremic toxin, with human serum albumin (HSA) 
has been examined by isothennal titration calorimetry (ITC), differential scanning 
calorimetry (DSC), molecular docking, circular dichroism (CD) and fluorescence 
spectroscopy to understand the reason that govern its impaired elimination from 
biological system. ITC results shows that the HA binds with HSA at high (^b -lO'*) 
and low affinity (K\, -10 ) sites whereas spectroscopic results predict binding at a 
single site (A^b-lO )^. The HA forni complex with HSA that involves electrostatic, 
hydrogen and hydrophobic binding forces as illustrated by calculated thennodynamic 
parameters. Molecular docking and displacement studies collectively revealed that 
HA bound to both site I and site II; however, relatively strongly to the later. Esterase-
Hke activity of HSA confirms the involvement of Arg410 and Tyr411 of Sudlow site 
II in binding of HA. CD results show slight conformational changes occurs in the 
protein upon ligation that may be responsible for the discrepancy in van't Hoff and 
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calorimetric enthalpy change. Furthemiore, an increase in 7j^ ^ and 7j^ is observed 
from DSC results that indicate increase in stability of HSA upon binding to HA. The 
combined results provide that HA binds to HSA at both of its binding site with 
different affinity and thus its elimination is hindered. 
Chapter 3 
Exogenous substances like drugs, when absorbed, enter into the circulatory system 
and bind reversibly and extensively to human serum albumin (HSA). But transport of 
various dmgs like a diuretic, furosemide (FUR), via albumin in uremia is seriously 
compromised due to accumulation of uremic toxins. The reason behind it is explored 
by investigating the binding mechanism of FUR to HSA. Isothennal titration 
calorimetry results show that FUR binds with HSA at high (Kb-lO"*) and low affinity 
(Kb~10 ) sites while spectroscopic results predicts binding at single site (Kb~10 ). 
Thennodynamic analysis shows that the HSA-FUR complex fomiation occurs via 
hydrogen bonds, hydrophobic interactions and undergoes slight structural changes as 
evident by FTIR, far-UV CD. Further, the fluorescence lifetime of HSA decreases 
only marginally and thus magnitude of energy transfer efficiency is small as obtained 
by time resolved measurements. Displacement experiment predicts that the FUR 
binds mainly to site I but a new site having lower affinity was also observed which 
shares some residues with site II which is supported by molecular docking results. 
Results revealed that in uremia, FUR indirectly competes for Arg410, Lys414 and 
Ser489 with site II bound uremic toxins while directly compete for site I with site I 
bound uremic toxins. 
Chapter 4 
Protein-sodium dodecyl sulphate (SDS) interaction has wide range of applications 
from food industry to cosmetics and the drug industry. Moreover, SDS mimics the 
native hydrophobic milieu of the phospholipids bilayer in vivo and thus study of 
protein surfactant interaction serves as model for membrane proteins and lipids 
interaction. Thus the mode of interaction of SDS with a glycoprotein, bovine serum 
fetuin (BSF) is studied in sub- critical micellar concentration at pH above (pH 7.4) 
and below (pH 2) pi to know the effect of solution condition on mode of interacfion of 
SDS to glycoprotein. It has been observed that at pH 2, SDS interacts with BSF 
through its negatively charged head groups and thus the hydrophobic tails of SDS on 
protein-SDS complex become free, that increases surface hydrophobicity of protein-
SDS complex. As a result, the protein-SDS complex interacts with each other, not the 
water, and cause protein to undergo aggregation. The nature of aggregates is amyloid 
due to enhance ThT binding and p-sheet fomiation. The formation of amyloid fibrils, 
however, decreases in presence of SDS above 0.75 mM due to repulsion between the 
protein-SDS complexes. However, at pH 7.4, SDS interacts with BSF at two sites, 
high affinity (Ki- 10 )^ and low affinity (^i~ 10^). Binding of SDS to BSF occurs with 
the posifive entropy change that is originafing from the hydrophobic interaction that 
results in disruption of highly dynamic hydrogen bonds between molecules of water 
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by the SDS molecules. Moreover, due to hydrophobic environment generated by alkyl 
chain of SDS molecules around tryptophan, induction of a-helical structure in BSF 
occurs. This increase in a-helical content on increasing SDS concentrations constrain 
environment around tryptophan. As a consequence, the interconversion of confonners 
decreases and resulted in decrement of fluorescence ifetime for BSF. These findings 
demonstrate that the mode of interaction of SDS to protein is different under different 
solution condition. 
Chapter 5 
There is a great interest in developing small inhibitors of amyloid aggregation of 
proteins which is related to growing pathologic states known as neurodegenerative 
disorders, hi the present study, the effect of n-acetylneuraminic acid (NeuSAc), a non 
reducing, monosaccharide that occur naturally at the end of sugar chains attached to 
the surfaces of cells and soluble proteins, on the amyloid fibrillization of hen egg 
white lysozyme (HEWL) are reported. When HEWL incubated at 65''C for 168 hours 
then the amyloid fonnation occurs as evident from the increase in ThT binding, 
increased hydrophobicity of solvent-exposed surfaces, transition of a-helix to P-sheet. 
These amyloid fibrils of HEWL generated under studied condition are cytotoxic to the 
human neuronal glioblastoma. However this fibrillization process is inhibited by 
NeuSAc as it decrease ThT binding, hydrophobicity of solvent-exposed surfaces, and 
transition of a-helical structure to P-sheet. Furthermore, NeuSAc also protect cells 
against cytotoxic nature of HEWL amyloid fibrils. The NeuSAc attenuates the heat 
induced amyloid fonnafion in HEWL by the stabilizadon of the native state of HEWL 
according to the effect of preferenfial hydration rather than direct interaction with 
protein, hi preferential hydration mechanism, a NeuSAc molecule get excluded from 
the environment around the protein and are replaced by water and thus nonspecifically 
inhibits the heat induced amyloid formafion in HEWL. Thus NeuSAc may be a 
potential therapeutic candidate for inhibition of amyloid fibril formation. 
The present work is the first report on the above mentioned protein ligand interactions 
with the above illustrated objectives. Thus this work may enable researcher's to 
understand the physiology and may helpful in the discovery of new medicines to 
benefit human health. 
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ABSTRACT 
ABSTRACT 
Protein-ligand interaction is one of process that plays key role m all biological 
processes that occur in body and thus it underpins the whole biological science. Thus 
the detailed knowledge of such interactions is of immense importance to understand 
the physiology and helpful in the discovery of new medicines to benefit human health. 
To understand the protem-ligand interactions, an-depth knowledge of biophysical 
behavior of protein and ligand that includes degree of complementarity of the binding 
site of the protein and the ligand, binding site location, affinity, bmdmg energies, and 
entropy and enthalpy changes accompanied is pre-requirement There are various 
examples of biologically relevant protein ligand interaction, where studying binding 
mechanism, forces involved, and themiodynamics is helpful either in understanding 
physiology or in designing new medicines. Examples which immediately stand out 
from the many includes interaction of exogenous and endogenous compounds with 
earner protein, human serum albumin (HSA), interaction of detergent, sodium 
dodecyl sulphate, which mimics membrane, with glycoprotein and interaction of 
small molecules with amyloidogenic proteins. Keeping in mind the significance of 
these protein ligand interactions, in this thesis following important protein ligand 
systems have been investigated with the help of various biophysical techniques: 
1. Interaction of hippuric acid (HA), a uremic toxin, with carrier protein, human 
serum albumin (HSA) to determine plausible reason behind its impaired elimination. 
2. Interaction of furosemide (FUR), a diuretic drug, with human serum albumin 
(HSA) to know FUR binding mechanism and its binding sites on HSA. Binding 
mechanism obtained help in determination of the reason of FUR impaired binding to 
HSA in uremia. 
3. Interaction of sodium doc.ecyl sulphate (SDS) that mimics membrane, to bovine 
serum fetuin (BSF) (a model glycoprotein) at pH 2 and 7.4 to know modes of SDS 
interaction with BSF under different solution condition. 
4. The effect of n-acetylneuraminic acid (Neu5Ac), a monosaccharide that occur 
naturally at the end of sugar chains attached to the surfaces of cells and soluble 
protems, on the amyloid fibrilHzation of hen egg white lysozyme (HEWL), a model 
protein, to determine potency of Neu5Ac as inhibitor of amyloid fibnllization. 
Chapter 1 
As the introduction part of the thesis, overview of basic models of protein ligand 
interaction, forces involved, changes in theiTOodynamic parameters and techniques to 
study protein ligand interaction has been reviewed. Physiologically significant 
examples of protein ligand interaction related to the work earned out in this thesis 
were also discussed. 
Chapter 2 
Binding of hippuric acid (HA), a uremic toxin, with human serum albumin (HSA) 
has been examined by isotheraial titration calorimetiy (ITC), differential scanning 
calorimetry (DSC), molecular docking, circular dichroism (CD) and fluorescence 
spectroscopy to understand the reason that govern its impaired elimination from 
biological system. ITC results shows that the HA binds with HSA at high {Kb -10 ) 
and low affinity (^b ~10^) sites whereas spectroscopic results predict binding at a 
single site (Kb~10^). The HA fonn complex with HSA that involves electrostatic, 
hydrogen and hydrophobic binding forces as illustrated by calculated thermodynamic 
parameters. Molecular docking and displacement studies collectively revealed that 
HA bound to both site 1 and site II; however, relatively strongly to the later. Esterase-
like activity of HSA confirms the involvement of Arg410 and Tyr411 of Sudlow site 
II in binding of HA. CD results show slight conforaiafional changes occurs in the 
protein upon ligation that may be responsible for the discrepancy in van't Hoff and 
calorimetric enthalpy change. Furthemiore, an increase in 7^^^  and T,^ , is observed 
from DSC results that indicate increase in stability of HSA upon binding to HA. The 
combined results provide that HA binds to HSA at both of its binding site with 
different affinity and thus its elimination is hindered. 
Chapter 3 
Exogenous substances like drugs, when absorbed, enter into the circulatory system 
and bind reversibly and extensively to human serum albumin (HSA). But transport of 
various drugs like a diuretic, furosemide (FUR), via albumin in uremia is seriously 
compromised due to accumulation of uremic toxins. The reason behind it is explored 
by investigating the binding mechanism of FUR to HSA. Isotheniial titration 
,4x 
calorimetry results show that FUR binds with HSA at high (Kb~10 ) and low affinity 
(Kb~10^) sites while spectroscopic results predicts binding at single site (Kb~10 ). 
Thermodynamic analysis shows that the HSA-FUR complex fomiation occurs via 
hydrogen bonds, hydrophobic interactions and undergoes slight structural changes as 
evident by FTIR, far-UV CD. Further, the fluorescence lifetime of HSA decreases 
only marginally and thus magnitude of energy transfer efficiency is small as obtained 
by time resolved measurements. Displacement experiment predicts that the FUR 
binds mainly to site I but a new site having lower affinity was also observed which 
shares some residues with site II which is supported by molecular docking results. 
Results revealed that in uremia, FUR indirectly competes for Arg410, Lys414 and 
Ser489 with site II bound uremic toxins while directly compete for site I with site I 
bound uremic toxins. 
Chapter 4 
Protein-sodium dodecyl sulphate (SDS) interaction has wide range of applications 
from food industry to cosmetics and the drug industry. Moreover, SDS mimics the 
native hydrophobic milieu of the phospholipids bilayer in vivo and thus study of 
protein surfactant interaction serves as model for membrane proteins and lipids 
interaction. Thus the mode of interaction of SDS with a glycoprotein, bovine seiaim 
fetuin (BSF) is studied in sub- critical micellar concentration at pH above (pH 7.4) 
and below (pH 2) pi to know the effect of solution condition on mode of interaction of 
SDS to glycoprotein. It has been observed that at pH 2, SDS interacts with BSF 
through its negatively charged head groups and thus the hydrophobic tails of SDS on 
protein-SDS complex become free, that increases surface hydrophobicity of protein-
SDS complex. As a result, the protein-SDS complex interacts with each other, not the 
water, and cause protein to undergo aggregation. The nature of aggregates is amyloid 
due to enhance ThT binding and P-sheet formation. The formation of amyloid fibrils, 
however, decreases in presence of SDS above 0.75 mM due to repulsion between the 
protein-SDS complexes. However, at pH 7.4, SDS interacts with BSF at two sites, 
high affinity (^i^ 10 )^ and low affinity (^|~ 10^). Binding of SDS to BSF occurs with 
the positive entropy change that is originating from the hydrophobic interaction that 
results in disruption of highly dynamic hydrogen bonds between molecules of water 
by the SDS molecules. Moreover, due to hydrophobic environment generated by alky! 
chain of SDS molecules around tryptophan, induction of a-helical stmcture in BSF 
occurs. This increase in a-helical content on increasing SDS concentrations constrain 
environment around tryptophan. As a consequence, the interconversion of conformers 
decreases and resulted in decrement of fluorescence ifetime for BSF. These findings 
demonstrate that the mode of interaction of SDS to protein is different under different 
solution condition. 
Chapter 5 
There is a great interest in developing small inhibitors of amyloid aggregation of 
proteins which is related to growing pathologic states known as neurodegenerative 
disorders. In the present study, the effect of n-acetylneuraminic acid (NeuSAc), a non 
reducing, monosaccharide that occur naturally at the end of sugar chains attached to 
the surfaces of cells and soluble proteins, on the amyloid fibrillization of hen egg 
white lysozyme (HEWL) are reported. When HEWL incubated at 65"C for 168 hours 
then the amyloid formation occurs as evident from the increase in ThT binding, 
increased hydrophobicity of solvent-exposed surfaces, transition of a-helix to P-sheet. 
These amyloid fibrils of HEWL generated under studied condition are cytotoxic to the 
human neuronal glioblastoma. However this fibrillization process is inhibited by 
Neu5Ac as it decrease ThT binding, hydrophobicity of solvent-exposed surfaces, and 
transition of a-helical structure to P-sheet. Furthermore, NeuSAc also protect cells 
against cytotoxic nature of HEWL amyloid fibrils. The NeuSAc attenuates the heat 
induced amyloid fonnation in HEWL by the stabilization of the nafive state of HEWL 
according to the effect of preferenfial hydrafion rather than direct interacfion with 
protein. In preferenfial hydration mechanism, a NeuSAc molecule get excluded from 
the environment around the protein and are replaced by water and thus nonspecifically 
inhibits the heat induced amyloid formation in HEWL. Thus NeuSAc may be a 
^potential therapeutic candidate for inhibition of amyloid fibril foimation. 
The present work is the first report on the above mentioned protein ligand interacfions 
with the above illustrated objecfives. Thus this work may enable researcher's to 
understand the physiology and may helpful in the discovery of new medicines to 
benefit human health. 
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1.1. Protein-ligand interaction and associated 
conformational changes-an overview 
I j 
1.1.1. Introduction 
All biological processes that occur in body are directly or indirectly based on the 
fundamental principle of highly regulated intermolecular interaction and recognition. 
Amongst many types of such interaction, process-one is protein-ligand interactions 
[Peroz^o et al., 2004]. In particular, proteins perfonn their function through 
interaction with molecules of low molecular weight called as ligands [Ahmad et al., 
2012]. However, in biological systems, the term 'ligand' has many different 
meanings. In broadest sense, it is used to mean any molecule which interacts with a 
given macromolecule. The tenn ligand, thus includes other macromolecules 
(peptides/proteins/nucleic acids/lipids/carbohydrates or mixed molecular species) as 
well as, molecules of small molecular mass (arbitrary < ~ 1-2 kDa). So it can be said 
that, ligand therefore cover a very large and structurally diverse group of molecules 
which, unsurprisingly also display a wide variety of physico-chemical characteristics. 
According to Harding and Chowdhry [Harding and Chowdhry, 2001], ligands are 
those molecules which interact in (potentially) reversible, non-covalent manner with 
a given molecule and thereby moderate biological role in a controllable manner. 
Consequently, protein ligand interaction can be described as interaction of ligand to a 
protein molecule in reversible, non-covalent manner without the requirement to make 
or break covalent bonds. In light of this scenario, different aspects related to protein 
ligand interaction, ranging from, the mechanism of interaction, the confomiational 
changes associated, forces involved, themiodynamics, techniques available for their 
study to importance of physiological significant protein ligand interactions are 
discussed. 
1.1.2. JMechanism involve in protein-ligand interaction 
The protein-ligand binding mechanisms have evolved from the early "lock-and-key" 
[Fischer, 1894] to the "induced fit" [Koshland, 1958] and to the now popular 
"confonnational selection" models [Frauenfelder et al., 1991; Ma et al., 1999; Tsai et 
al., 1999]. 
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1.1.2.1. Lock and key model. The lock-and-key model was first proposed by Fischer, 
1894 [Fischer, 1894] to explain binding of a single substrate (ligand) to the enzyme 
(protein). According to this model, an analogy that explains enzyme as the lock and 
substrate as the key was given. The prerequisite of this model is that the enzyme and 
substrate are both rigid and their surfaces should be complementary, and therefore 
only the correctly sized key (substrate) fits into the key hole (active site) of the lock 
(enzyme). Besides, the keys with incorrectly positioned teeth (incorrectly shaped or 
sized substrate molecules) do not fit into the lock (enzyme) because both the key and 
the lock cannot change their shape and size as shown in Figure 1.1.1 A. However, at 
that time nothing was known about the active site and thus in 1958, a biochemist, 
Daniel Koshland, [Koshland, 1958] thought that the 'lock and key' model required 
some modificafions as the existed did not explain discrepancies such as the lack of 
hydrolytic activity of kinases, noncompetitive inhibition. Therefore, a modification 
called the 'induced fit' model was proposed to compensate for the rigid, structurally 
invariable protein and ligand. 
1.1.2.2. Induced fit model. In 1958, a biochemist, Daniel Koshland, proposed the 
induced fit model (Figure 1.1.IB) in the following terms "a) the precise orientafion of 
catalytic groups is required for enzyme action, b) the substrate causes an appreciable 
change in the three-dimensional relationship of the amino acids at the active site, and 
c) the changes in the protein structure caused by the substrate will bring the catalytic 
groups into the proper alignment, whereas a non-substrate will not." Briefly, 
according to it, the ligand binding induces a conformafional change in the protein. 
However, it seems that this model holds for the proteins showing minor or moderate 
conformational change after the ligand binding. Bosshard [Bosshard, 2001] suggested 
that "induced fit is possible only if the match between the interacting sites is strong 
enough to provide the initial complex enough strength and longevity so that induced 
fit takes place within a reasonable time". Therefore, the induced fit mechanism alone 
cannot explain well the association between ligand and proteins undergoing large 
conformational changes after ligand binding [Tobi and Bahar, 2005]. Thus, the 
concept of conformational selection model has emerged as an alternative for induced 
fit and is becoming prevalent. 
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Figure 1.1.1. Different models for mechanism of protein ligand binding. (A) lock 
and key (B) induced fit (C) conformational selection model. 
1.11.2.3. Conformational selection model. Recently, an alternative model, 
conformational selection (also termed as preexisting equilibrium, population 
selection, fluctuation fit, or selected fit), for induced fit has emerged and becoming 
established. Fundamentally, it is extension of folding fiinnel model, postulated that, 
among the conformations of the dynamically fluctuating protein the ligand selects the 
one that is compatible with binding, and shifts the conformational ensemble towards 
the most compatible state as shown in Figure l.l.lC. Generally, the conformational 
changes in this model are beyond local side chains rearrangements near the binding 
site, but rather display large concerted motions or entire domain movements. Straub 
and Szabolcsi [Straub and Szabolcsi, 1964], was first to suggest tlie selective binding 
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of ligand to a single protein conformation in the ensemble, initial experimental 
evidence for the hypothesis came from Zavodszky et al in 1966 [Zavodszky et al., 
1966]. However, later, Frauenfelder, et al described the energy landscape of proteins 
[Frauenfelder et al., 1991], which in 1999 led to the generalized concept of 
'conformational selection and population shift' [Ma et al, 1999; Tsai et al., 1999]. 
I 
1.1.3. Conformational changes on interaction of ligand to protein 
Protein conformation is of principal importance in understanding bimolecular 
intefactions. In the simplest scenario, two molecules may interact with no change in 
their conformation, as in the key-and-lock model. Molecular interactions that involve 
confonnational changes in the interacting molecules are more versatile and best 
explained by conformational selection model as explained earlier. Conformational 
changes may also take place away from the binding interface. This is often the 
prerequisite for functional activity. Binding of ligand in membrane receptor protein 
occiirs at the extracellular region but causes changes at the cytoplasmic region, so that 
an 'Extracellular signal is allowed to alter intracellular activity e.g. norepinephrine-
induced helical rotational orientation changes in the transmembrane helices of 132 
adrenergic receptor, a G-protein coupled receptors and induced conformational 
changes that alter intracellular activity. Conformational changes in proteins are made 
possible by their intrinsic flexibility. These changes may occur with only relatively 
small expenditure of energy [Bhattacharya et al., 2008]. At the molecular structural 
levdl, conformational changes in single polypeptides are the result of changes in main 
cha^n torsional angles and side chain orientations. The overall effect of such changes 
may be localised with reorientations of a few residues and small torsional changes in 
the regional main chain. On the other hand torsional changes localised at very few 
critically placed residues may lead to large changes in tertiary structure. The later type 
of confonnational changes is described as domain motions. 
1.1.3.1. Domain motions. Domain motions have two basic components. Hinge 
motions may occur within strands, beta-sheets and alpha-helices not constrained by 
tertiary packing forces. On hinge-opening the motion is perpendicular to the plane of 
the interface, which is lost after opening as shown in Figure 1.1.2A. 
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Figure 1.1.2. Mechanism of domain movement. (A) Ligand-induced hinge motion (B) 
Ligand-induced shear motion. 
Thel closed conformation is usually stabilised by a bound ligand. It occurs in the 
context of secondary stnictiire interactions. Hinge motion at extended strand involves 
a few large changes in main chain torsion angles at the hinge connecting two 
domains, constrained only by the Ramachandran allowance of torsional angles. Shear 
motions occur parallel to the interface between closely packed segments of 
polypeptides as shown in Figure 1.1.2B. This type of motion is more severely 
coristraincd with additional packing contacts due to interdigitating side chains. It 
occurs in the context of tertiar}- structure interactions. Large shear movement that 
makes the interdigitating lock from one state to another is not observed in domain 
mcjtions. as in subunit interface of allosteric proteins [Gerstein et al., 1994]. 
I.L3.2. Allosteric transitions. Multimeric proteins have an extra dimensionality to 
conformational transitions due to their quarternary structure. Conformational changes 
diie to allosteric transitions are found in all G-protein binding receptors [Wang and 
L^wis, 2013], haemoglobin etc [Edelstein, 2013; Kukic and Nielsen, 2010]. Since, 
haemoglobin is the classic protot}pe of allosteric proteins with cooperative behaviour, 
th^s the binding of small molecules (oxygen) at a region of the protein affects its 
binding affinity with other molecules at a distant region as shown in Figiirel. 1.3. 
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Figure 1.1.3.Allosteric behavior of hemoglobin on oxygen binding. 
1.1.4. Forces involved in protein-Iigand interaction 
Protein ligand interaction can be described as interaction of ligand to a protein 
molecule in reversible, non-covalent manner without the requirement to make or 
break covalent bonds. The interacting molecules in each type of forces that held 
protein and ligand together are shown in Figure 1.1.4. 
The main forces are discussed below: 
I 
1.1.4.1. Electrostatic interactions. These interactions play a prominent role in 
steering charged ligands into the protein binding site and thus are among the most 
important forces to be considered when analyzing the protein ligand binding 
interaction [Kukic and Nielsen, 2010]. The strength of these bonds may vary from 30-
12(^  kcal/mol. The bond length is around 0.25 nm. There are three types of 
electrostatic interaction found: 
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1.1.4.1.1. Charge-charge interactions. These are found between oppositely charged 
atoms, ligand functional groups, or protein side chains, such as positively charged 
(amine or imine groups, lysine, arginine, histidine) and negatively charged (carboxyl 
group, phosphate groups, glutamatc side chain). This tj'pc of electrostatic interaction 
has be^n observed in number of protein ligand systems in biological and non-
biologi(;:al systems [Sharp and Honig, 1990]. Since many drugs like virstatin, 
lomefloxacin etc contain acid or amine functional groups which gets ionized and thus 
interacts via ionic bonds formation with the positively charged carrier protein, human 
serum albumin at physiological pH [Chamani et al., 2011; Chatterjee et al., 2012]. 
Another protein ligand system where these forces predominate is interaction of 
sodium dodecyl sulphte (SDS) with protein at acidic pH. The headgroups of the 
surfactants bind to groups of opposite charge on the protein. A change in pH will 
cause a change in the net-charge of the protein and consequently in the binding as 
observed in soybean peroxidase [Zhang et al., 2009]. 
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Figure 1.1.4. Diagrammatic representation of forces involved in protein ligand interaction. 
Furthermore the chaiacterstic featui-es like bond length, bond strengtli along witli the 
cxainplcs of each type of force are summarized in Tabic 1.11. 
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1.1.4.1.2. Charge-dipole interactions. These are found between ionized amino acid 
side chains and the dipole of the Hgand moiety or water molecule. An important 
contribution to the enthalpy change associated with a binding event arises from it. The 
dipole moments of the polar side chains of amino acid also affect their interaction 
with ligands [Sharp and Honig, 1990]. 
Factors. The electrostatic interaction depends upon the many factors: 
• Dielectric constant of the medium. The strength of electrostatic interaction is 
inversely propotional to the dielectric constant of the medium. For water, that has 
highest dielectric constant, have lowest value of binding strength whereas in vacuum, 
the binding strength is maximum as shown in Table 1.1.1. 
• pH. Change in pH majorly affects the electrostatic interaction between protein and 
ligands. As the pH drops, H^bind to the carboxyl groups (COO") ofaspartic 
acid (Asp) and glutamic acid (Glu), neutralizing their negative charge, and H^ bind to 
the unoccupied pair of electrons on the N atom of the amino (NH2) groups 
of lysine (Lys) and arginine (Arg) giving them a positive charge. It change the net 
charge on the molecule (becomes more positive) and thus affects electrostatic 
interaction. However, with increase in the pH, H^ are removed from the COOH 
groups of Asp and Glu, giving them a negative charge (COO'), and from the 
NHs^ groups of Lys and Arg removing their positive charge. It changes the net charge 
on the molecule (becomes more negative) and thus affects electrostatic interaction. 
• Ionic strength. Increasing salt concentration reduces the strength of ionic binding 
by providing competing ions for the charged residues. 
1.1.4.2. Hydrogen bonding. These bonds are foraied between hydrogen covalently 
bonded to some electronegative group ("donor"), and another electronegative atom, 
such as oxygen or nitrogen ("acceptor"). The hydrogen bond is specific, directional 
due to their orientations, lengths, and angular preferences. Proteins contain abundant 
hydrogen bond donors and acceptors in their backbone as well as in the side chains. 
These hydrogen bond donors and acceptors present in proteins interact with proton 
donors and acceptors (water molecule or any other ligand) present in the environment. 
Hydrogen bonding, therefore, occurs not only between ligand and protein and within 
I 
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the protein itself, but also with the surrounding medium. These bonds are fairly 
weaker than ionic bond but are stronger than other non covalent bonds with strength 
between m 0.4-35 kcal/mol [Emsley, 1980]. As these bonds are weak, so can be 
formed and broken rapidly during binding event, confonnational changes, or protein 
folding. It has been observed in certain cases even simple thermal fluctuations in 
biological systems may switched on or off hydrogen bonding [Tuckerman et al., 
2002]. Due to these properties, the role of hydrogen bonds in governing specific 
interactions in biological recognition processes is absolutely crucial. Based on the 
location of donor/acceptor, hydrogen bonding is of two types, intra-and inter-
molecular. 
1.1.4.2.1. Intramolecular interaction involves the formation of non covalent bond 
between hydrogen (covalently bonded to electronegative group) with the 
electronegative atom of same molecule. The formation of a-helical structure 
secondary of protein is a typical example where intramolecular hydrogen bonding 
exists. 
1.1.4.2.2. Intermolecular interaction involves the formation of non covalent bond 
between hydrogen (covalently bonded to electronegative group) with the 
electronegative atom of other molecule. There are ample of examples where 
intermolecular hydrogen bonding is found, for instance, interaction of human serum 
albumin (HSA) with drugs like tamoxifen, flirosemide and many more [Bourassa et 
al., 2011; Zaidietal., 2013a]. 
Both types of hydrogen bonding are partly responsible for the secondary, tertiary, and 
quaternary structures of proteins. They play a pivotal role in molecular recognition 
events, and thus influence the binding specificity of protein towards ligand. These 
interactions, despite of their weakness, play an important role in stabilising 
appropriate conformations of ligand-protein complexes, for instance among the 
complexes between protein kinases and their inhibitors [Bissantz et al., 2010], HSA 
and drug [Bourassa et al., 2011]. 
Factors. There are some factors which affects hydrogen bonding, including the 
10 
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• Nature of hydrogen donors and acceptors. Particularly, in the nature of hydrogen-
bond donors and acceptors, the resonance of electrons between donors and acceptors 
plays an important role in affecting the strength of hydrogen bonding. This resonance 
effect can redistribute the electron density on the hydrogen donors and acceptors by 
the driving force that having the conformation of structure to reach a most stable state. 
In addition, it can affect the basicity of the acceptors that further influence the 
strength of hydrogen bonding. 
• Solvent. The type of solvent also affects the hydrogen bonding extent because of 
different level of intermolecular attractions. Some solvents involve in hydrogen 
bonding and thus interfere with the non covalent bonding of protein and ligand. Water 
is a very common example of interacting solvent and thus the binding strength of 
ligand to protein is found to be low in water as compare to vacuum as shown in Table 
1.1.1. 
1.1.4.3. van der Waals. These interactions are very important for the structure and 
interactions of biological molecules. There are both attractive and repulsive van der 
Waals interactions that control the binding events. Attractive van der Waals 
interactions involve two induced dipoles that arise from fluctuations in the charge 
densities that occur between adjacent uncharged atoms, which are not covalently 
bound. The attraction between molecules is greatest at a distance called the van der 
Waals radius. If molecules approach each other more closely repulsive forces 
develops. Repulsive van der Waals interactions occur when the distance between two 
involved atoms becomes very small, but no dipoles are induced. In the latter case, the 
repulsion is a result of the electron-electron repulsion that occurs in two partly-
overlapping electron clouds [Ninham and Parsegian, 1970]. 
van der Waals interactions are very weak (0.1-4 kcal/mol) compared to other non 
covalent bonds. The magnitude of these forces depends on how easily an atom is 
polarized. There are three types of van der Waals forces 
1.1.4.3.1. Dipole-dipole interaction. These forces, which occur between molecules 
cxDntaining electronegative atoms cause molecules to orient themselves so that the 
positive end of one molecule is directed toward the negative end of another. 
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1.1.4.3.2. Dipole-induced dipole interaction. A pennanent dipole induces a transient 
dipole in an nearby molecule by distorting its electron distribution. 
1.1.4.3.3. Induced dipole-induced dipole interaction. The motion of electrons in 
nearby nonpolar molecules results in transient charge imbalance in adjacent 
molecules. A transient dipole in one molecule results polarizes the electron in 
neighbouring molecule. This attractive interaction, often called London dispersion 
forces, is extremely weak. 
Other than hydrogen-bond and disulfide bonds, van der Waals interaction is the 
another important bonding type that helps stabilizing the protein structure. In the 
coiled-coil protein and leucine zipper, there are heptad repeat which form by the side 
chain interaction between each alpha helix; heptad-repeat is repeated at every seventh 
residues [Landschulz et al., 1988]. If these repeating residues are hydrophobic, such 
as leucine, van der Waals interaction will be formed to stabilize this protein structure. 
These interactions were also observed in the binding of 2-methoxy-3-isobutylpyrazine 
to the mouse major urinary protein [Barratt et al., 2005]. 
1.1.4.4. Hydrophobic interaction. Hydrophobic interactions, believed to be 
important determinants of the stability of many protein stmctures, multisubunit 
protein complexes, and protein/ligand complexes, may be considered to be the result 
of two component interaction processes: the removal of nonpolar groups from water 
(hydration) and the packing of these groups within proteins or protein complexes. The 
interactions between ligands and the hydrophobic side chains of proteins contribute 
significandy to the binding free energy. When a ligand interacts with the protein 
hydrophobically, the first thing come in mind is that the clustering of their 
hydrophobic groups occurs. But it results in a negative contribution to the change in 
entropy of the system because the clustering corresponds to a decrease in the disorder 
of the system. Further, the role of the solvent should not be ignored which should be 
considered whenever a tendency for an event to occur is calculated. Thus, nonpolar 
ligand molecules/groups do dissolve slightly in water, but strong interactions of these 
molecules with water is not possible. Thus, introduction of such a non-hydrogen 
bonding surface into water causes disruption of the hydrogen bonding network 
between water molecules. The hydrogen bonds are reoriented tangentially to such 
12 
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surface to minimize disruption of the hydrogen bonded 3D network of water 
molecules and thus leads to a structured water "cage" around the nonpolar surface. 
Thus, the hydrophobic interaction is mostly an entropic effect originating from the 
disruption of highly dynamic hydrogen bonds between molecules of liquid water by 
the nonpolar solute [Scatena et al., 2001]. Hydrophobic interaction involves in 
binding of most of the drugs like etoricoxib [Seedher and Bhatia, 2006], zonisamide 
[Shahabadi et al., 2013], due to hydrophobic nature of binding pockets of HSA. It 
also play role in inhibition of human protein kinase CK2a by tetrabromobenzotriazole 
and some C5-substituted analogues [Wasik et al., 2010]. 
Factors. The hydrophobic interactions are influenced by many factors, including 
• Temperature. With increase in temperature, hydrophobic interaction increases. 
However at very high temperature, denaturation of protein occurs. 
• Carbon chain length. With increase in length of carbon chain in ligand, generally 
hydrophobic interaction increases as observed in binding of butyl and octyl group 
containing ligand to trypsinogen [Lina et al., 2000]. 
• Shape of hydrophobes. Ligands having aliphatic groups, without branches on 
carbon chain have more chances of interaction via hydrophobic interaction than of 
aromatic groups and branched molecules because of steric hinderance in interacting 
with the other molecule. 
1.1.4.5. Interactions mediated by aromatic rings. Noncovalent interactions 
involving aromatic rings such as p-stacking and cation/p are central in understanding 
many protein ligand complexes. It involves interaction between ligands and rings of 
aromatic amino acid (Phe, Trp, and Tyr) side chains in protein. The unique steric and 
electronic properties of these side chains give rise to large polarizabilities and 
quadrupole moments that result in interaction of aromatic rings of ligand and protein 
with preferred geometries. These interactions can be considered under electrostatic 
interaction [Salonen et al., 2011]. For interactions between two aromatic systems, 
there are two predominant geometries; parallel (two aromatic rings are parallel to each 
other) and perpendicular (two aromatic rings are perpendicular i.e. edge-to-face 
arrangement). The preference to perpendicular interactions increases when the acidity 
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of the interacting "side" atoms increases; this happens upon introduction of a strongly 
electron-withdrawing substituent in either ortho- or para-position.There are three 
types of interactions involving aromatic rings: 
1.1.4.5.1. Cation-TT interaction. This is a strong non-covalent force where the side 
chains (TT components of aromatic amino acids) provide a surface of the negative 
electrostatic potential to bind with a range of cations and cationic amino acids through 
electrostatic interaction up to an average interatomic distance of 3.6 A. In a protein, 
over 25% of all Trp are involved in cation-Ti interactions as Trp265-Lys248 in 
aldehyde oxidoreductase (-8.8 kcal/mol); Tip58-Lys76 in transaldolase B (-4.4 
kcal/mol); Trp211-Arg77 in oligopeptide-binding protein (OppA) (-8.4 kcal/mol); 
Trpll75-Argll36 in the tyrosine kinase domain of the insulin receptor (-6.8 
kcal/mol) [Gallivan and Dougherty, 1999]. Protein-ligand or receptor-drug 
interactions such as binding of epinephrine, dopamine to G protein coupled receptors 
[ToiTice et al, 2009], Cys-loop receptors (ligand-gated ion channels) with 
acetylcholine [Nys et al., 2013], tetrodotoxin to Na'^  channels [Santarelli et al, 2007] 
etc are remarkable examples having cation-7t interaction. 
1.1.4.5.2. ;r-stacJ<ing. This class of interaction involves direct attraction between 
•& 
arene rings. The n electrons in the aromatic rings of aromatic amino acids residues are 
localized above and below the face of the ring. This excess of electrons gives the face 
of the ring a small net negative charge, whereas the hydrogen atoms on its edge have 
a coiTCsponding positive net charge. The electrostatic interaction between these partial 
charges dominates the interactions between aromatic rings. Such rings preferentially 
interact with the positively charged edge of one ring pointing at the negatively 
charged face of another, or with their rings parallel but offset so that the edge of one 
ring is interacting with the face of the other. The commonly held impression that 
aromatic rings interact favorably by stacking their rings one above the other is 
incorrect. This type of interaction is responsible for the self-assembly mechanism of 
amyloid formation and thus a lot of inhibitors having chances of 7i-stacking due to 
aromatic rings are proposed e.g. polyphenols [Hudson et al, 2009; Porat et al., 2006]. 
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1.1.5. Thermodynamics of protein-ligand interaction 
Detemiination of thermodynamic parameters is necessary for complete understanding 
of protein ligand interaction. Three important thennodynamic parameters are crucial 
to consider, change in Gibbs free energy (AG), enthalpy (AH), entropy (AS). These 
thennodynamic data contain information crucial not only for elucidating the binding 
mechanism but also for rational drug design through relating the thennodynamic data 
to the structural data, which alone cannot fully describe the driving forces for binding 
or predict accurately the binding affinity. The three ftindamental parameters AG, AH, 
AS are discussed further in details. 
1.1.5.1. Gibbs free energy (AG). It is the most important thennodynamic parameter 
because it detennines the direction of the bimolecular equilibrium. The negative sign 
means that the binding reaction or conformational transition will proceed 
spontaneously to an extent governed by the magnitude of AG; the positive sign means 
that the energy is needed to drive the reaction to fonn a product, with the magnitude 
of AG specifying the amount of the required energy. Free energy changes are a 
function of states, i.e., their values are defined merely by the initial and final 
thermodynamic states, regardless of the pathway connecting them. Furthermore, it is a 
balance between enthalpy and entropy, e.g., the observed AG can be the same with 
completely opposing contribution by enthalpy and entropy (equation 1.1.1): 
AG =AH -TAS (1.1.1) 
A protein ligand interaction with positive AH and AS (binding dominated by 
hydrophobic effect) can give the same value of AG as a interaction of another set of 
protein ligand with negative AH and AS (when specific interacfions dominate). This is 
due to a common phenomenon observed in protein ligand interaction. This makes the 
binding free energy relatively insensifive to change in molecular details of the 
interaction process, and thus the consideration of the AH and AS are crucial for a 
detailed understanding of the free energy of binding [Ferozzo et al., 2004]. 
Enthalpy-entropy compensation. If ligand interacts with protein by forces other 
than hydrophobic interaction than the AH is negative due to bonding but it occur at 
the expense of increased order, leading to more negative AS. However, if a ligand 
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interacts hydrophobically, the hydrophobic effect could become much more 
significant than the loss of entropy (confonnational entropy, rotational and 
translational entropy) or decrease in order. The consequences of the enthalpy-entropy 
compensation are i) that it does not bring out dramatic change in the binding free 
energy and as such leads to only small changes in binding affinity over a range of 
temperatures; ii) that it makes it difficult to distinguish between the entropy-driven or 
enthalpy-driven binding processes and, therefore, cautions are required to explain the 
experimental data, design drug, or plan engineering experiments. This phenomenon of 
enthalpy-entropy compensation has been widely observed in biological systems by 
using the thermodynamic methods [Chodera and Mobley, 2013; Eftink et al., 1983; 
Perozzoetal, 2004]. 
1.1.5.2. Enthalpy (AH). It is a measure of the total energy of a themiodynamic 
system. It includes the internal energy, energy required to make room for it by 
displacing its enviromnent and establishing its volume and pressure. The total 
enthalpy, H, of a system cannot be measured directly and, as such, the change in 
enthalpy, AH, is a more usefiil quantity than its absolute value, which is equal to the 
sum of non-mechanical work done on it and the heat supplied to it. The AH is positive 
or negative in endothermic or exothermic process, respectively. In the protein-solvent 
system, the enthalpy change reflects the amount of heat energy required to achieve a 
particular state. For binding reactions, negative enthalpy values are common (but not 
omnipresent), reflecting a tendency for the system to fall to lower energy levels by 
bond formation. The binding enthalpy in its strict sense is considered as the 
noncovalent bond formation at binding interface. However, the heat effect of a 
binding reaction is a global property of the entire system, including contribution from 
solvent and protons [Cooper and Johnson, 1994]. Therefore, the change in enthalpy of 
binding must be the result of the fomiation and breaking of many individual bonds, 
including the loss of protein-solvent and ligand-solvent hydrogen bonds, electrostatic 
and van der Waals interactions, the fomiation of noncovalent bonds between the 
protein and ligand, and the solvent reorganization near the protein surfaces. These 
individual components may make either favorable or unfavorable contributions, and 
the result is a combination of these contributions, with specific interactions 
dominafing the binding enthalpy. 
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1.1.5.3. Entropy (AS). It is a measure of the tendency of a process, such as a 
chemical reaction, to be entropically favored, or to proceed in a particular direction. 
Further the entropy can be seen as an expression of the disorder or randomness. The 
total entropy change (AStot) of protein-ligand binding can be expressed as the sum of 
the three entropic tenns: the solvent entropy (ASsoiv), confomiational entropy (ASconf) 
and the rotation and translation entropy (AS,/t) as shown in equation: 
AS .^. = AS , +AS . +AS . (1.1.2) 
tot solv conf r/t ^ '' 
where the ASsoiv describes the change in entropy resulting from solvent release upon 
binding; the ASconf is a configurationally terni reflecting the reduction in rotational 
degrees of freedom around torsion angles of protein and ligand; and the AS,/t 
represents the loss in translational and rotational degrees of freedom of the acceptor 
and ligand upon complex fonnation. The most important contribution to the AStot 
arises from the solvation term ASsoiv, primarily due to the release of well-bound water 
molecules on the surfaces of the protein and ligand, and the accompanying burial of 
the hydrophobic surface area. Since the entropy of hydration of polar and apolar 
groups is large, the burial of solvent accessible surface area and the solvent release 
upon binding often make a large, favorable contribution to the entropy increase. The 
ASconf and AS,/t make unfavorable contributions to total entropy, i.e., causing entropy 
reduction. Although the positive entropy changes resulting from a natural tendency 
for disruption of order and exclusion of water molecules are common for binding 
reactions [Chodera and Mobley, 2013], all binding reactions would have to overcome 
the inescapable entropic penalties [Amzel, 2000] (i.e., the negative AS,/t and ASconf 
upon complex formation) through large solvent entropy gain (positive ASsoiv) or 
favorable protein-ligand interactions (negative AH) if binding is to occur. Based on 
the above details, [Ross and Subramanian, 1981] predicted the forces involved in the 
binding of protein to ligand by the sign and magnitude of thermodynamic parameters 
AH and AS are summarized in Table 1.1.2. 
1.1.5.4. Heat capacity (ACp). It characterizes the amount of heat required to change a 
substance's temperature by a given amount. In protein ligand interaction, when ligand 
binds to protein, there occurs removal of water molecules from protein surface area 
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that often results in a large negative ACp. Therefore, the heat capacity provides a link 
between thermodynamic data and structural information of macromolecules through 
the correlation of ACp and burial of surface area [Rajarathnam and Rosgen, 2013]. It 
is detennine from the value of AH by following equation: 
^ ^ ; ' - ^ (1.1.3) 
Table 1.1.2. Expected signs of thermodynamic parameters (AH and AS) in different 
types of interaction as adapted from [Ross and Subramanian, 1981]. 
Types of interaction 
Electrostatic 
Hydrogen bonding 
(at low dielectric 
medium) 
van der Waal 
Hydrophobic 
Enthalpy change (AH) 
Slight positive/negative 
negative 
negative 
positive 
Entropy change (AS) 
positive 
negative 
negative 
positive 
1.1.6. Techniques used to study protein-ligand interaction 
Figure 1.1.5 enlists all techniques that give information directly or indirectly about the 
binding of ligand to protein. The basis of detection, infonnation obtained, 
concentration of protein used and limitations of the following discussed techniques 
are presented in Table! .1.3. 
1.1.6.1. Spectroscopic techniques 
1.1.6.1.1. Fluorescence spectroscopy. It is widely used method for studying protein 
conformational changes and protein ligand interaction. This is because of the presence 
of intrinsic fluorophores (tryptophan, tyrosine and phenylalanine) in almost all 
proteins. In addition, certain extrinsic fluorophores (like l-anilino,8-naphthalene 
sulphate, Thioflavin T) have been developed that can be used for specific probing of 
the function and stmcture of proteins [Biancalana and Koide, 2010; Gasymov and 
Glasgow, 2007]. To study ligand binding to protein, change in quantum yield of 
ligand fluorescence, intrinsic protein fluorescence, or fluorescence of a covalenfly or 
noncovalenfly bound fluorescent probe whichever is sensitive is determined. It can be 
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used indirectly to calculate the binding constants and stoichiometry of particular 
protein-ligand interactions from the dependence of the observed fluorescence of a 
protein ligand mixture upon total ligand concentration. The relevant theory, approach, 
and possible pitfalls associated with the fluorescent measurement of interactions is 
presented with respect to both perturbation of ligand fluorescence on binding, along 
with the perturbation of the intrinsic fluorescence of acceptor on interacting with 
ligand. Furthermore, fluorescence spectroscopy can also be used to trace the 
formation of amyloid by using external fluorophore which specifically binds to 
amyloid fibrils. It is very sensitive techniques (picogram quantities of protein can be 
detected). However, it reported the microenvironment of the fluorophores and its data 
analysis is also not easy. Fluorescence measurements can be broadly classified into 
two types of measurements: 
• Steady-state measurements. The most common type, are those performed with 
constant illumination and observation. The sample is illuminated with a continuous 
beam of light, and the intensity or emission spectrum is recorded. Because of the 
nanosecond timescale of fluorescence, most measurements are steady-state 
measurements. When the sample is first exposed to light, steady state is reached 
almost immediately. 
• Time-resolved measurements. It is used for measuring intensity decays or 
anisotropy decays. For these measurements the sample is exposed to a pulse of light, 
where the pulse width is typically shorter than the decay time of the sample. This 
intensity decay is recorded with a high-speed detection system that permits the 
intensity or anisotropy to be measured on the nanosecond timescale. It provides 
information not available from the steady-state data. It is important to understand the 
relationship between steady-state and time-resolved measurements. One can 
distinguish static and dynamic quenching using lifetime measurements in protein 
ligand interaction studies. Fonnation of static ground-state complexes do not decrease 
the decay time of the uncomplexed fluorophores because only the unquenched 
fluorophores are observed. Dynamic quenching is a rate process acting on the entire 
excited-state population, and thus decreases the mean decay time of the entire excited-
state population. Resonance energy transfer is also best studied using time-resolved 
measurements [Alcala et al., 1987; Lakowicz, 2006]. 
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1.1.6.1.2. Circular dichroism spectroscopy (CD). It is used to study structural 
changes of proteins. Changes in conformation upon changing pH, temperature, 
presence and absence of ligand can be studied by CD measurements. For 
determination of structure of protein by CD, it is not necessary to know the amino 
acids sequence. Further it also take small amount of sample (0.1-1 mg/ml) and 
consume less time as compare to NMR and X-ray. For protein ligand interaction 
study, stop flow mode is particularly useful. However, certain compounds have low 
signal to noise ratio and thus samples should be UV transparent that limits the use of 
certain buffers, salts and solvents [Kelly and Price, 2000]. 
1.1.6.1.3. Fourier transform infrared spectroscopy (FTIR). FTIR spectroscopy 
provides information about the secondary structure content of proteins, like CD and 
unlike X-ray crystallography and NMR spectroscopy which provide information 
about the tertiary structure [Barth, 2007]. Characteristic bands found in the infrared 
spectra region of proteins and polypeptides include the Amide I (1700-1600 cm"^ ) and 
Amide II (1600-1500 cm"'). These arise from the amide bonds that link the amino 
acids. The absorption associated with the Amide I band leads to stretching vibrations 
of the C=0 bond of the amide, absorption associated with the Amide II band leads 
primarily to bending vibrations of the N—H bond . Because both the C=0 and the 
N—H bonds are involved in the hydrogen bonding that takes place between the 
different elements of secondary structure, the locations of both the Amide I and 
Amide II bands are sensitive to the secondary structure content of a protein. It can 
also be used in amyloid protein and/or peptide studies. The multiple advantages 
provided by it allow an almost continuous structural view of protein/peptide 
conversion during the aggregation process. Moreover, it is now well-established 
that infrared can differentiate oligomers from fibrils simply on their spectral features. 
Thus it is certainly the fastest and easiest method to obtain this information. It has 
limitation that it requires higher protein concentration thus there are possible chances 
of aggregation in the samples [Sarroukh et al., 2013]. 
1.1.6.2. Calorimetric methods. 
1.1.6.2.1. Isothermal titration calorimetry (ITC). ITC measures the heat evolved 
during macromolecular association events. In an ITC experiment, one binding partner 
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(ligand) is titrated into a solution containing another binding partner (protein), and the 
extent of binding is determined by direct measurement of heat exchange (whether heat 
is being generated or absorbed upon the binding. It helps in understanding the binding 
mode, binding affinity, stoichiometry, AH, AS and AG. This is the direct method for 
determination of thermodynamic parameters of protein ligand interaction and the 
experiments can be perfonned in a physiologically relevant buffer, no surface effects 
have to be taken into account, and the interacting species do not require 
immobilisafion or labelling. But the use of higher concentration of protein is the 
limitation. It is a major limitation as in the case of relatively weak energefic of 
protein-ligand interactions [Falconer and Collins, 2011] where solubility of protein 
and ligand is a major issue. Further at higher concentration, molecular crowding, 
where molecular interactions were also involved, is not ignorable [Ward and 
Holdgate, 2001]. Besides, the obtained binding constant should be in narrow range 
(lO^'-lO'^M"'). 
1.1,6.2.2. Differential scanning calorimetry (DSC). It measures the heat capacity of 
the system as a function of temperature under isobaric condition. It has become a 
popular method in biophysical chemistry for evaluating protein confonnational 
stability as well as protein-ligand and protein-protein interactions. As it involves 
model-based assumptions. More recently, the application of theory to DSC has been 
proved to be useful for estimating very high binding constants, as well as for 
characterizing the energetics of binding and unfolding. In this context, it is useful to 
simulate the signal obtained by DSC in order to: 
• Understand the themiodynamic basis underlying the observed changes in protein 
stability when the macromolecule binds to a specific ligand, 
• Identify the chemical equilibria and modifications that give rise to the observed 
output signal from the calorimeter, and 
• Interpret the experimental data by comparing the real and theoretical process, thus 
confimiing or eliminating the assumed model. It also helps to elucidate the 
redistribution among the different species (native, unfolded, and liganded protein) 
involved in the global unfolding process by using the species distribution profile. 
However, like ITC it also requires the higher concentration of protein. But, in DSC, 
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the temperature range under which thennal denaturation can be studied has a hmit due 
to generation of vapour pressure in sealed chambers as a consequence of gas 
evolution on the denaturation of proteins that may lead to over pressurization and 
mpture which limits the effective temperature range of experimentations. Furthennore 
the dimensional changes in the protein should be measured over any time but the heat 
exchange during a process from DSC cannot be detemiined over long times or at slow 
heating or cooling rates since the finite quantity of heat exchanges will be dispersed 
over too long a time to be detected. Baseline curvature limits the sensitivity of DSC 
for detecting weak transitions. As other sensitive instruments, the purity of the sample 
is a prerequisite to the DSC. For DSC measurements of heteromeric proteins 
(multimeric), the subunits seem to be polymorphic species which are sensed as an 
impure sample. The major issue is that DSC can measure heat capacity for reversible 
process. Further, themial aggregation of proteins may cause severe hann to the 
instrument as well as the quality of data because heterogeneous (solid and liquid) 
systems are difficult to examine [Johnson, 2013]. 
1.1.6.3. X-ray crystallography. K is well established technique that gives 
comprehensive atomic level infomiation. It detemiines the structures of large 
molecules and assemblies along with the proper surface water molecules positions. It 
produces a single structural model that is easy to visualize and interpret. However, a 
crystal is a stationary assemblage procured from an extremely non physiological-
concentrated solution. This intense environment may itself cause confomiational 
alterations in the protein molecule to induce an altered mode of ligand interaction 
which ultimately results in erratic interaction induced conformational changes from its 
original one. Moreover, the crystal stjuctures of protein bound with the ligand are 
generally acquired by co-crystallization but the milieu of crystallization conditions for 
apo-protein are not essentially identical for this co-crystallization [Brylinski and 
Skolnick, 2008]. Hence, ligand-induced confomiational transitions in a protein-ligand 
complex offer a dispute for the accurate stmctural determinations. In some cases, even 
crystal production can be difficult and often impossible. When the protein is large and 
flexible, then crystals structure fonnafion is problematic and the final structural model 
represents a time averaged structure, where details of molecular mobility remain 
unresolved. 
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1.1.6.4. Nuclear magnetic resonance (NMR). It gives comprehensive atomic level 
infoimation of proteins or protein ligand complex under solution conditions which are 
closer to biological condition and also free from artifacts resulting from crystallization 
as that of X-ray crystallography. It also provides about the infoimation on dynamics 
and thus increasingly used to monitor confonnational changes on ligand binding to 
proteins/ fragments [Stark and Powers, 2012]. However, it requires concentrated 
solution and thus presents chances of aggregation. Further it is limited to 
detemiination of structure of small proteins (< 20 kDa). 
1.1.6.5. Surface plasmon resonance (SPR). It is a rapidly developing technique for 
the study of ligand binding interactions with membrane proteins, which are the major 
molecular targets for validated drugs and for current and foreseeable drug discovery. 
SPR is label-free and capable of measuring real-time quantitative binding affinities 
and kinetics for membrane proteins interacting with ligand molecules using relatively 
small quantities of materials and has potential to be medium-throughput. However 
this is insensitive to the contaminants problem from surface coupling [Patching, 
2013]. 
1.1.6.6. Molecular docking. These methods are used for determination of ligand 
binding sites on the protein along with binding energies. However, docking is still 
constrained by their restricted consideration of protein flexibility issues. The degree of 
flexibility is limited to either side chain motions or small variations of the backbone. 
However, certain degree of flexibility is allowed by modeling side-chain variations in 
Autodock4, Gold, FlexX, Rosetta Ligand and small variations of the backbone in 
Glide, Rosetta Ligand [Ahmad et al., 2012] 
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1.1.7. Examples of protein-ligand interaction 
1.1.7.1. Ligands interaction to human serum albumin (HSA). The HSA is the most 
abundant serum protein that serves as a transporter for several endogenous and 
exogenous compounds [Varshney et al., 2010]. It binds ligands generally on two sites 
which are present in subdomain II A and subdomain III A [Sudlow et al., 1975], It 
transports biologically active ligands like fatty acids, hemin, bilirubin as well as drugs 
in the body to their target sites. Binding of drugs to HSA plays a major role in drug 
therapy as it affects phamiacokinetics and phamiacodynamics of drugs. Among 
pharmacokinetic parameters, distribution plays a key role in detemiining the ability of 
drug effectiveness. The unbound or free drug fraction determines the actual volume of 
distribution and the drug concentration at the target site. However, the free fraction of 
a drug is significantly reduced when the drug affinity to the HSA is high. Thus, high 
affinity for HSA may consequently be a benefit or a drawback for efficacy depending 
on the drug and the target. For instance, HSA binding is particularly usefirl for 
lipophilic drugs (P-blockers) and metabolites, because this binding improves their 
solubility and somefimes decreases their toxicity. Significant changes of the free drug 
concentration can occur because of the interaction of the administered drug with other 
therapeutics or endogenous compounds for their binding to the carrier. Illness status 
can also determine a changing of the unbound drug fraction because of significant 
alterations of the semm earner concentration [Lin and Lu, 1997]. For instance, HSA 
interacts with certain hamiful compounds which are synthesized inside the body or 
accumulated in diseased condition e.g. uremic toxins. It includes variety of 
compounds including hippuric acid (HA), indoxyl sulfate (IS), and 3-carboxy-4-
methyl-5-propyl-2-furanpropionic acid (CMPF), indole-3-acetic acid (lAA), 
creatinine, p-cresol [Duranton et al., 2012]. These compounds retained in the blood 
during kidney related diseases and interact negatively with the nonnal biological 
funcfions of the body. These uremic toxins interfere with the binding of drugs to HSA 
and thus disturb the drug disposidon and phannacological actions. One of the 
examples is of furosemide, one of the most potent diurefic drugs commercially 
available. The changes in its phamiacokinetics and phamiacodynamics are frequently 
seen in patients of renal problem. Even when concentrafion of HSA is within the 
reference range, a decrease in serum binding of furosemide is frequently observed 
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[Takamura et al., 1997]. It is believed to be due to the competition between uremic 
toxins and drug for the binding site on HSA as shown in Figure 1.1.6. Another 
example is the concurrent administration of warfarin, anticoagulant drug, with 
phenylbutazone, which is known to bind to the same high-affinity binding site on 
HSAi resuhs in an enhanced risk of hemorrhage in patients because of the higher 
concentration of the free anticoagulant drug being displaced from the shared binding 
site on the carrier. Thus it is necessary to understand the binding mechanism, location 
i 
of binding sites, binding energetics to HSA as well as pharmacokinetics and 
pharmacodynamics of drug in the body. 
a 
'TT- t^^p^s-^-^sffi::^ 
Blood 
Normal condition 
r f 
Blood 
Uremic condition 
• 
'— 
hd 
Human serum albumin 
Drug 1 (site 1 specific) 
Drug 2 (site 11 specific) 
Site 1 bound uremic toxin 
Site 11 bound uremic toxin j 
Figure 1.1.6. Schematic representation of mechanism of drug interaction in uremic condition. 
1.1. 12. SDS-protein interaction. Sodium dodecyl sulphate (SDS) is amphiphilic 
molecule that preferentially absorbed at interfaces [Tanford, 1973]. It is an anionic 
surfactant with a 12-carbon hydrophobic tail and a negatively charged sulfate 
hydrophilic head group. It is known to interact with globular proteins, and in general, 
causes denaturation almost 1000 times lower concentration that is generally needed 
for other chemical denaturants such as urea [Chamani et al., 2006; Lee et al., 2011; 
Moosavi-Movahedi et al., 2005; Nielsen et al., 2007; Tanford, 1968]. However, it also 
cause refolding of proteins like DNA binding protein having leucine zipper [Lanckriet 
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and Middelberg, 2004; Moriyama et al., 2003]. The mode of SDS binding to proteins 
distinguished according to the concentration. At the sub-critical micellar 
concentrations (sub-CMC), SDS monomers bind to proteins by predominantly 
hydrophobic interactions causing unfolding of the tertiary structure, and at 
concentrations higher than CMC, the micelles nucleate on the hydrophobic patches of 
the protein chain driving it to expand [Bhuyan, 2010]. However, the mode of 
interiction changes with the change in pH as in the case of soyabean peroxidase 
[Zhang et al., 2009]. Protein-SDS interaction has wide range of applications from 
food industry to cosmetics and the drug industry [Li et al, 1995; Moore et al., 2003; 
Murray et al, 1969; Rangel-Yagui et al., 2005; Wang, 1999]. SDS mimics the native 
hydrophobic milieu of the phospholipids bilayer in vivo and thus study of protein 
surfactant interaction serves as model for membrane proteins and lipids interaction 
[Gangabadage et al, 2008; Ulmer and Bax, 2005]. It is obsei-ved that in sub-CMC 
of SDS the peptide from human complement receptor 1 is initially alpha-helical but 
converts rapidly to a beta-sheet structure and large quantities of fibrils forms. 
Howejver, above the CMC, peptide adopts a stable alpha-helical structure and no 
fibrils' are observed. These findings demonstrate the sensitivity of fibril fonnation to 
solution conditions and suggest a possible role for membrane components in amyloid 
fibril formation in living systems [Pertinhez et al., 2002]. Thus increased knowledge 
in this area may also play role in understanding the membrane protein-lipid 
interaction under neurodegenerative disorders. 
1.1.7.3. Small molecules interact with proteins and inhibit/induce aggregation. 
Proteins have native functional states but can fonn amyloid fibrils under certain 
diseased condition. In the amyloid state, proteins aggregated with f!-sheet-rich 
structures. Accumulation of amyloids can result in protein amyloidosis, which has 
attracted much attention. Amyloidosis is associated with many serious 
neurodegenerative diseases, such as Alzheimer's disease [Sipe, 1992], prion disease, 
[Safar and Prusiner, 1998]. Consequently, it is important to clarify the mechanism of 
amyloidosis, so that it can be inhibited or controlled. There has been much interest in 
the past decade in explaining and characterizing small molecules that interacts with 
amyloids and can either act as labels and allow imaging techniques to detect deposited 
amyloid structures (e.g. thioflavin T and congo red dye etc) or may have potential to 
act as future de novo inhibitors' (therapeutic agents) for the treatment of amyloid-
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associated diseases (e.g. polyphenols, acridines, osmolytes etc). However, the mode 
Osmolytes Polyphenols 
(sugars, proline etc) (EGCG, curcumin etc) 
» % 
,-• \ 
> " 
Native Partially unfolded Proto-filament Amyloid fibril 
of interaction is different for different type of molecules as shown in Figure 1.1.7. 
Figure 1.1.7. Schematic representation of mechanism of interaction of small molecules 
(osmolytes, polyphenols) with the protein amyloids. 
For iiistance it is believed that, polyphenols inhibits amyloid formation by weak 
forces between inhibitor and peptide chains, including hydrogen bonding, 
hydrophobic and aromatic interactions have been suggested to be the driving forces in 
the ahti-amyloidogenic role of polyphenols [Porat et al., 2006]. Furthermore, 
antioxidant capacities are also thought to be involved in the anti-amyloidogenic 
activity of polyphenols [Conte et al., 2003]. Studies on inhibition of the amyloid 
formation in lysozyme by glycoacridines suggest that planarity of the acridine core 
ring is important but not the sole parameter affecting the inhibitory activity of the 
compounds [Seedher and Bhatia, 2006]. Another group of inhibitor is osmolytes 
which inhibits amyloid formation of lysozyme also induce refolding of misfolded 
proteins and stabilizing proteins [Kar and Kishore, 2007]. Mechanisms of protein 
osmolyte interactions, the effect of osmolytes on protein stability, and how osmolytes 
correct protein misfolding defects and remove protein aggregation have been widely 
investigated. It has been demonstrated that the unfavourable interaction between the 
peptide backbone and the osmolytes leading to the preferential hydration of the 
protein domain is the driving force of protein stabilization or folding. It was also 
observed that certain molecules like inorganic phosphate (Pi) that is also a part of 
normal metabolism binds specifically to the active site of acylphosphatases from 
Sulfolobus solfataricus and Drosophila melanogaster and inhibits the formation of 
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amyloid-like aggregates [Soldi et al., 2006]. Furthennore, amyloidosis occurs at the 
cell surface, the interaction between the protein and cell interface is also important. 
Thus the molecules on the cell surfaces are of interest as additives to control 
amyloidosis. Glycosaminoglycans (heparin sulpate) interacts with Amyloid beta (AP) 
(Alzheimer's disease) [Leveugle et al., 1994], P2-microglobulin (dialysis related 
amyloidosis) [Corlin et al, 2010], and prion protein [Gonzalez-Iglesias et al., 2002], 
human muscle acylphosphatase [Motamedi-Shad et al., 2012] and induce protein 
amyloidosis. Thus the interaction between protein amyloids and small molecules are 
of inimense importance for discovery of future de novo therapeutic agents against 
amyloid-associated diseases. 
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1.2. Introduction of proteins used in study 
BeloW, a brief introduction of proteins structure and function is given that are used in 
this thesis. 
1.2.1. Human serum albumin (HSA) 
It is a multifunctional and non-glycosylated, single-chain protein synthesized in liver 
cells. Jt has 585 amino acids and a molecular weight of 66.5 kDa [Varshney et al, 
2010]j. Due to a large number of acidic (98 Glu + Asp) and basic (83 Lys + Arg) 
residues, the protein are highly soluble in aqueous media (>20% w/w). The three-
dimensional structure has been detennined crystallographically in several 
laboratories, and now the structure is known at a resolution of 2.3 A [He and Carter, 
1992; Sugio et al., 1999]. The protein has 67% a-helix but no p-sheet, and it contains 
three homologous domains that assemble to fonn a heart-shaped molecule as shown 
in Figure 1.2.1 The protein has three homologous domains (I-III), each domain 
comprises two subdomains (A and B) that possess common structural elements. The 
A and B subdomains have six and four a-helices, respectively, connected by flexible 
loops. Except one (Cys34), all 34 cysteine residues are involved in the formation of 
stabilizing disulfide bonds. The protein has single tryptophan residue present at 
position 214 of amino acid sequence in drug binding site 1. [Peters, 1996] (Table 
1.2.1). Small-angle X-ray scattering studies and combined phosphorescence 
depolarization-hydrodynamic modeling study has suggested that the overall 
conformation of HSA at neutral pH is very similar to that observed in crystal 
structures [Ferrer et al., 2001; Olivieri and Craievich, 1995]. In a healthy individual, 
the daily turnover of HSA is about 14 g, which amounts to about 25% of the protein 
synthesis activity of the liver. About 120 g is found in the circulation resulting in a 
plasma concentration of about 0.6 mM, the highest concentration of any protein in 
plasma. However, an even larger pool of HSA is found in the extra vascular spaces 
(about 240 g) although at lower concentrations. This fact implies that the functions of 
HSA are not restricted to the blood [Peters, 1996], Furthermore, the high plasma 
concentration and half-life of about 19 days also implies that the protein have a 
significant role in the metabolism. Among many roles of HSA in the body, the 
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detoxification, maintenance of osmolarity in plasma and transportation of variety of 
endogenous and exogenous substances in the body are the most important functions 
[Kragh-Hansen, 2013]. As of its transporting role, it binds substances at two major 
binding region, namely Sudlow's site I and II, which are located within cavities in 
subdomains IIA and IIIA, respectively [Sudlow et al., 1975] (Figure 1.2.1). Thus the 
remarkable properties of HSA account for the central role in both the efficacy and rate 
of delivery of drugs, so detailed knowledge of the binding interaction of a drug with 
HSA becomes an important research field in clinical medicine. So, an extensive 
investigation of the interaction between HSA and many endogenous and exogenous 
compounds is always the topic of utmost investigation as it enucleates the 
transportation and distribution of drug in the body. 
Site II 
Figure 1.2.1. Crystal structure of human serum albumin (HSA) as obtained from PDB having 
PDBldlA06. 
Furthermore, HSA also possess pseudo esterase like activity that makes it potentially 
useful for therapeutic purposes. For example, it is capable of hydrolyzing ester 
prodrugs to their pharmacologically active forms. Drug olmesartan, a novel 
angiotensin II receptor antagonist used in the treatment of hypertension is converted 
from olmesartan medoxomil by HSA [Ma et al., 2005]. This esterase activity is due to 
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the Arg 410 and Tyr 411 which are also important amino acid residues in forming 
Sudlow's binding site II [Watanabe et al., 2000]. This implies that ligand binding to 
that site can inhibit the esterase activity in a competitive maimer. 
1.2.2. Bovine serum fetuin (BSF) 
It is glycosylated, single-chain protein having six carbohydrate chains, three N-linked 
glyco:^ylation sites and three 0-linked glycosylation sites, which comprise 24% of its 
total molecular weight (48.5 kD) along with 8% sialic acid [Green et al., 1988] (Table 
1.2.1). It contains 341 amino acids and their sequence shows over 70% similarities to 
humaii a2-HS glycoprotein [Dziegielewska et al., 1990]. It is a member of the cystatin 
superfamily of cysteine protease inhibitor [Binkert et al., 1999; Galembeck and Cann, 
1974]. 
Figure 1.2.2, Structure of fetuin from fetal calf senim (BSF) modeled using Phyre 2 modeling 
software using sequence from protein database with accession number CAA34596.1 [Kelley 
and Sternberg, 2009]. 
Due to a large number of acidic (41 Glu + Asp) and basic (27 Lys + Arg) residues, the 
protein are highly soluble in aqueous media. Bovine serum fetuin (BSF) has 
frequently been used as model glycoprotein [Hermentin et al., 1996; Kennedy et al., 
1993; Wang et al., 1998a; Wang et al., 1996] because of its easy availability, single 
chain and less complex glycosylation. Although it is used as a model glycoprotein 
[Hermentin et al., 1996; Kennedy et al., 1993; Wang et al., 1998b], but its crystal 
structure is not yet explored. Thus, to get an idea about the molecular structure and 
location of tryptophan (Trp), BSF is modeled by the Protein Homology/analogY 
Recognition Engine (Phyre2) in our study reported as a part of chapter 4 and structure 
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is visualized by Chimeral.7 as shown in Figure 1.2.2. As shown in this figure the 
tryptophan (Trp 51) is located on outer region. 
1.2.3. Hen egg white lysozyme (HEWL) 
Lysozyme is an enzyme that act certain bacterial cell wall by cleaving the 1,4-beta-
linkages between N-acetylmuramic acid and N-acetyl-D glucosamine residues in 
a peptidoglycan and between N-acetyl-D-glucosamine residues in chitodextrins. It is 
abundant in a number of secretions, such as tears, saliva, human milk, mucus and 
cytoplasmic granules of the polymorphonuclear neutrophils. Large amounts of 
lysozyme can be found in egg white and are related to alpha-lactalbumin in sequence 
and structure, making it part of the same family. HEWL is readily available and 
represents an excellent experimental system to study the determinants of protein 
aggregation because of high homology to human lysozyme in structure which is one 
of the proteins that cause an amyloid disease upon mutation [Booth et al., 1997; 
Uversky and Fink, 2007] and for which aggregation is also observed in vitro 
[Morshedi et al., 2007; Sasahara et al., 2007]. 
Figure 1.2.3. Crystal structure of hen egg white lysozyme (HEWL) as obtained from PDB 
having PDB Id IJPO. 
It is a small protein with a molecular weight of 14.3 kD containing 129 amino acids 
and 4 disulfide bridges. Its tertiary structure consists of two domains, an a-domain 
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that contains several helices and a I3-domain comprised largely of B-strands, separated 
by a cleft that comprises the active site as shown in Figure 1.2.3. The protein has six 
tryptophan at position 28, 62, 63,108,111 and 123. It has 30% helical and 10% B-sheet 
content and has isoelectric point of 11 (Table 1.2.1) [Laurents and Baldwin, 1997]. 
Table 1.2.1. Physicochemical properties of proteins used in the study as adapted from 
[Green et al., 1988; Laurents and Baldwin, 1997; Peters, 1996]. 
Properties 
Type of protein 
1 
Molecul 
Number 
Pl 
ar weight (kD) 
of amino acid 
Number of trptophan 
Secondary structure content 
(X-ray crystallography). 
^Circular dichroism 
spectroscopy 
HSA 
Non-
glycosylated 
66.5 
585 
4.7 
1 (Trp2I4) 
64% helix 
BSF 
Glycosylated 
(24%) 
48.5 
341 
5.3 
1 (Trp51) 
*10%a-helix, 
34% B-sheet 
HEWL 
Non 
glycosylated 
14.3 
129 
11 
6 (Trp 28, 62, 
63, 108, 111, 
123) 
30% a-helix, 
10% B-sheet 
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Hippuric acid binding to HSA [ Chapter 2 
A comprehensive insight into binding of hippuric acid 
to human serum albumin: a study to uncover its 
impaired elimination 
2.1. Introduction 
Uremic toxins are the compounds which retained in the blood during kidney failure 
and interact negatively with the nomial biological functions of the body [Miyamoto et 
al., 2010]. Hippuric acid (HA) is one of these compounds that accumulates in the 
blood, and cause stimulation of ammoniagenesis. It may be involved in development 
of muscular weakness in uremia as it also inhibits glucose utilization in muscles 
[Duranton et al, 2012; Dzurik et al, 2001; Spustova et al., 1991]. It has also been 
related to inhibition of organic anion secretion by the kidney [Boumendil-Podevin et 
al., 1975] and transport at the blood-brain barrier [Ohtsuki et al., 2002]. Thus, HA is 
consequently a compound of phannacological interest. It is a glycine conjugate of 
benzoate, which is fonned primarily from aromatic amino acids by gastrointestinal 
flora or may be directly taken as preservatives from_ food and beverages [Niwa, 1996]. 
In a healthy individual, concentration of HA is less than 5 mg/L but increases to 
values higher than 247±112 mg/L in patients with end-stage renal disease [Vanholder 
et al., 2003]. Human serum albumin (HSA) is the most abundant plasma protein, 
single chain, nonglycosylated polypeptide of 66.5 kDa. It is composed of three 
homologous, predominantly helical domains I- III, each of which contains two 
subdomains A and B [Sugio et al., 1999]. HSA has one tryptophan residue, Tip214, 
located in subdomain IIA [He and Carter, 1992; Sudlow et al., 1975]. The principal 
regions of ligand binding to HSA are located in hydrophobic cavities in subdomains 
IIA and IIIA, which are consistent with Sudlow sites I and II, respectively [Sudlow et 
al., 1975]. These binding sites underline the exceptional ability of HSA to interact 
with many organic and inorganic molecules, thereby making this protein an important 
regulator of the pharmacokinetic behavior of many drugs as well as intercellular 
fluxes [Varshney et al., 2011]. In body, it also binds to HA [Duranton et al, 2012] and 
thus elimination of HA through hemodialysis is only 64% [Hung and Chang, 2001; 
Vanholder et al., 1992]. However, there is paucity of information on its binding 
mechanism to HSA. Consequently, it is necessary to investigate its binding energetic, 
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amino acid involved in binding to explore binding mechanism in the biological 
system. So, the scope of this work is to investigate the binding affinity, binding 
enegetics, in details by steady state fluorescence spectroscopy and isothermal titration 
calorimetry. Location of binding sites is detemiined by displacement studies and 
molecular docking studies. Esterase activity of HSA toward p-N?A was used to 
investigate the involvement of Arg410 and Tyr411 of HSA in the binding of HA. 
Theimal stability in presence of HA was detemiined using differential scanning 
calorimetry. 
2.2. Materials and methods 
2.2.1. Materials and sample preparation. Human seijum albumin (A1887; 
essentially globulin and fatty acid free), warfarin (A2250), phenylbutazone (P8386), 
and p-nitrophenyl acetate (N8137) were procured from Sigma Aldrich. Hippuric acid 
(free acid, crystalline; > 99%) was from Hiraedia. Diazepam was the product of 
Ranbaxy Laboratories Ltd. All other reagents were of analytical! grade. HSA and drug 
solutions were prepared in 20 mM sodium phosphate buffer (pH 7.4). The protein was 
dialyzed, and its concentration was estimated spectrophotometirically using £"280 nm 
= 5.3. All drug solutions were prepared by weight/volume (w/v). 
2.2.2. Steady state fluorescence quenching measurements. Fluorescence emission 
spectra were recorded in range of 300-400 nm on Shimadzu 5301PC fluorescence 
spectrophotometer equipped with water circulator (Julabo Eyela) with excitation 
wavelength of 295 nm. Both excitation and emission slits were set at 3 nm. The 
titration of the HA (0-10 |iM) to HSA (5 \M) solutions was earned out at 25, 30, and 
37°C. Respective blanks were subtracted for each set of experiment. 
2.2.3. Binding displacement measurement using si>e marlvers. Different site 
markers warfarin (WAR) for site I and diazepam (DIA) for site 11 [Ghuman et al., 
2005; Petitpas et al., 2001] were used for performing displacement experiments. The 
titration of HA were carried out to the solution having protein (5 )iM) and site marker 
in the molar ratio of 1:1. The fluorescence emission spectta were recorded as 
mentioned in fluorescence measurements and the binding constant values of drug-
protein-marker were evaluated using Stem-Volmer equation. 
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2.2.4. Isothermal titration calorimetric measurements (ITC). The VP-ITC titration 
microcalorimeter (MicroCal Inc., Northampton, MA) were used to gain insight into 
the energetics of the binding of HA to HSA at 25, 30, and 37°C. Prior to the titration 
experiment, ah solutions were degassed properly on a thennovac. The 1.44 mL 
sample and reference cell of the calorimeter were loaded with HSA and 20 mM 
sodium phosphate buffer (pH 7.4), respectively. The HSA (25 fiM) was titrated with 
HA (1.928 mM) using a 288 |iL injection syringe stirring at 307 rpm. Equal volumes 
of HA solutions (10 ^L) were injected into the sample cell containing HSA over 20 s 
with an interval of 180 s between two consecutive injections. The reference power 
was set at 16 (acal s\ The heat associated with each injection was observed as a peak 
that corresponds to the power required to keep the sample and reference cells at 
identical temperatures and the data were plotted as integrated quantities. Control 
experiments were performed by titrating HA into the same buffer to obtain the heats 
of ligand dilution. Heats of dilution for the ligand and protein were subtracted from 
the integrated data before curve fitting. The data were fitted and analyzed with a 
sequential model of two binding sites using Origin 7.0 provided with the MicroCal 
instrument. 
2.2.5. Circular dichroism spectroscopic measurements. To monitor the secondary 
and tertiary structural change of protein upon interaction with HA, CD spectra of 
HSA were collected in far (200-250 nm) and near-UV (250-320 nm) at molar ratio of 
1:0, 1:5, 1:10 and 1:15 in a JASCO-J815 spectropolarimeter equipped with a Peltier-
type temperature controller at 25°C. The CD spectra were collected with 20 nm/min 
scan speed and a response time of 2 s. The HSA concentration and pathlength of the 
cell were 5 (iM and 0.1 cm, respectively, for far UV CD measurement whereas 15 |J,M 
and 1 cm, respectively, for near UV CD measurement. Respective blanks were 
subtracted. 
2.2.6. Differential scanning calorimetric measurements. The differential scanning 
calorimetric measurements were carried out using VP-DSC microcalorimeter 
(MicroCal, Northampton, MA). The buffer and protein solutions were degassed under 
mild vacuum prior to the experiment. Samples were prepared in a 20 mM sodium 
phosphate buffer, pH 7.4. The DSC measurements of HSA (18 i^ iM) in the presence of 
different ratios of HA viz. 1:0, 1:5, and 1:10 were perfomied from 25 to 90°C at a 
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scan rate of 0.5°C/min. Data were analyzed using Origin software provided with the 
instrument to obtain the temperature at the midpoint of the unfolding transition (Tm) 
and calorimetric enthalpy (AH°). 
2.2.7. Effect of HA binding on esterase-like activity of HSA. Drug site II 
(Subdomain III A) of HSA possessed esterase-like activity toward p-nitrophenyl 
acetate (p-NPA) [Watanabe et al., 2000]. Thus, reaction of j??-NPA with HSA in 
absence and presence of HA (i.e. 0-45 |iM) was followed on Perkin-Elmer Lambda 25 
double beam UV-vis spectrophotometer attached with Peltier temperature 
programmer-1 (PTP-1) at 405 nm by monitoring the appearance of yellow product p-
nitrophenol for 1 min at 25°C. The molar extinction coefficient of p-nitrophenol was 
taken as 17800 M"' cm"'. The reaction mixture contained 15 |J,M HSA whereas/»-NPA 
varied from 0 to 600 |iM in 20 mM sodium phosphate buffer (pH 7.4). The control (in 
absence of HSA) was also taken in consideration. 
2.2.8. Molecular docking. The SDF format for 3D structure of HA was downloaded 
from Pubchem database (CID 464) and crystal structure representing HSA was 
extracted from Protein Data Bank (PDB: 1A06). Molecular docking simulation of 
hippuric acid to HSA was perfonned with Autodock Vina program [Trott and Olson, 
2010]. Autodock was used to evaluate ligand binding energies over the 
confonnational search space using Lamarckian genetic algorithm. The residues falling 
within 5 A of the two different binding sites of HSA (site 1 & site II) were extracted 
and combined to define the binding site residues. Default docking parameters were 
used. We considered only the minimum energy confonnation state of ligand bound 
protein complex in our study out of ten generated modes. The hydrogen bonding and 
hydrophobic interactions between ligand and protein were calculated by Accelrys DS 
Visualizer 2.0 [AccelrysSoftwarelnc, 2012] and figure was generated with Chimera 
1.7 [Pettersenetal., 2004]. 
2.2.9. Statistical analysis 
All determinations were triplicates, and mean values and standard deviations were 
calculated, wherever applicable, using SPSS 16.0 programme for windows. 
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2.3. Results and discussion 
2.3.1. Steady state fluorescence quenching measurements. The aromatic 
tluorophores, tryptophan, tyrosine, and phenylalanine are very sensitive to their 
microenvironment and thus used for studying conformational changes associated with 
ligand protein binding. However, tryptophan contributes maximumally to the 
fluorescence [Ahmad et al, 2011]. The fluorescence intensity of HSA decreases with 
gradual addition of HA at 25, 30, and 37°C as shown in Figure 2.1. 
320340360380400 300 320340360380 400°§(^o ^0 340 360 380 400 
Wavelength (nm) 
Figure 2.1. Normalized fluorescence emission spectra of HSA in the presence of different 
concentrations of HA at (A) 25°C (B) 30°C and (C) 37°C. a-k: 0-10 ^M of HA al 
increments of 1 nM. The inset corresponds to the molecular structure of HA. 
Thus to investigate the mechanism of quenching, the fluorescence quenching data at 
25. 30, and 37°C were analyzed according to the linear Stem-Volmer equation 
[Lakowicz. 2006]: 
;^ = Ksv[Q] + l = )feqTjQ]+l (2.1) 
where, Fo and F are the fluorescence intensities in the absence and presence of 
quencher (HA), Ksv and kg are the Stem-Volmer quenching and bimolecular rate 
constant respectively and TQ, the average integral fluorescence life time of tryptophan 
which is ~ 5.71x10"^ s [Zaidi et al., 2013a]. The values of Ksv and kq obtained from 
Stem-Volmer plot (Figure 2.2A) are listed in Table 2.1. It can be seen that, the values 
of Ksv decreases with increasing temperature and kg was founds to be 10 times greater 
than the 2x10'" M"' s'', a maximum scatter collision quenching constant of various 
quenchers with biopolymers. This shows that quenching was not initiated by dynamic 
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diffusion but from the formation of a strong complex between HSA and HA [Zaidi et 
al., 2013a]. 
0 
-0.5 
1 -1 
u. 
w -1.5 
o 
-2.5 
R'=0.99 
R 2 = 0 . 9 9 30°C 
R 2 = 0 . 9 9 A37°C 
O.OE+00 2.0E-05 4.0E-05 6.0E-05 
[HA] 
-5.4 -5 -4.6 
log ([HA]) 
-4.2 
Figure 2.2. Stem—Volmer (A) and log [(Fo-F)/F] versus log[HA] (B) plot at different 
temperatures. 
Table 2.1. Binding and thermodynamic parameters of HA-HSA at different 
temperatures obtained from fluorescence quenching experiments^ 
Temp C^ C) 
n 
Ksv(M-') 
Kb(M-') 
kq (M-' s-') 
AH°(kcal mol"') 
TAS°(kcalmor') 
AG°(kcalmor') 
25 
0.98 ± 0.02 
(7.80 ± 0.36) X10^  
(6.84±0.19)xl0^ 
(1.36±0.06)xl0" 
-23.48 ± 0.24 
-5.21 ±0.02 
30 
0.99 ±0.01 
(3.30 ± 0.02) X10^  
(3.11 ±0.22) xlO^ 
(5.77±0.03)xl0" 
-28.68 ± 0.20 
-23.88 ± 0.24 
-4.88 ± 0.06 
37 
0.97 ± 0.02 
(1.31 ± 0.08) xlO^ 
(1.04 ± 0.01) X10^  
(2.29±0.01)xl0" 
-24.43 ± 0.25 
-4.28 ± 0.01 
^ for all values ranges from 0.98 to 0.99. 
As the quenching mechanism was determined to be static, so the binding constant, Kb, 
can be calculated from the y-axis intercept of plot of log [(Fo - F)/F] versus log [HA] 
(Figure 2,2B) according to equation: 
log u = logKb+nlog[Q] (2.2) 
where, Kb is the binding constant. The values of Kb obtained at different temperature 
are listed in Table 2.1. It can be seen that, the values of Ksv and Kb were almost same 
that further confirm static quenching mechanism [Lakowicz, 2006]. Furthermore, 
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change in standard Gibbs free energy (AG°) was obtained using Gibbs-Helmholtz 
equation: 
AG°=-RTlnKb (2.3) 
whereas, change in standard enthalpy (AH°) and entropy (AS°) were detennined from 
the van't Hoff equation, if AH° do not vary significantly over the temperature range 
studied. 
, „ K . = - ^ . ^ (2.4, 
'' RT R 
where R (1.987 cal mor'K"') is gas constant and T is the absolute temperature (K). 
For protein-ligand interaction, the signs and magnitude of thermodynamic parameters 
(AH° and AS") can be used to determine the main forces that contribute in complex 
fonnation of protein-ligand [Ross and Subramanian, 1981]. Thus, the negative AH° 
indicates the exothemiic nature and dominant involvement of electrostatic interactions 
in the process of HSA-HA complex formation [Thoppil et al., 2008]. However, 
hydrogen bonding also play role as depicted from the negative signs of AH° and AS". 
Moreover, AH° contributes maximally rather than AS" to AG" that indicates the 
binding process is enthalpy driven and the decrease in entropy is due to the formation 
of hydrogen bonds between HA and HSA. In addition, negative sign of AG" indicates 
that the binding of HA with HSA is a spontaneous process. However, the obtained 
value of themiodynamic parameters may not necessarily the actual values as; such 
non-calorimetric approach to the thennodynamics has ruthless shortcomings where 
usually AH° is assumed to be temperature-independent. However, this is the only 
method to detennine an estimate of AH" and AS" from the fluorescence quenching 
data at different temperature [Tian et al., 2004]. Furthermore, the binding affinity 
observed by fluorescence spectroscopy took in consideration the location of quencher, 
fluorophore and so measures local changes around the fluorophores associated with 
the optical transition [Nada and Terazima, 2003]. Hence to overcome all these 
shortcomings, we have done ITC measurements that consider overall global changes 
in protein ligand interaction [Faergeman et al., 1996]. 
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2.3.2. Binding displacement measurement using site markers. Sudlow et al 
[Sudlow et al., 1975] proposed that the HSA has two major binding regions namely 
Sudlow's site I and site II. Site I and II have affinity for WAR and DIA respectively. 
Thus these drugs were used as site specific markers of HSA. To locate the binding site 
of HA on HSA, the emitted fluorescence intensity data in the absence and presence of 
markers were analysed using Stem-Volmer equation. The Ksv value of HSA-HA was 
(7.80±0.36)xlO^M"' that decreases to (2.74±0.04)xlO^M"' and (2.03±0.03)xlO^M'^ in 
presence of WAR and DIA, respectively. These differences in Ksv values in absence 
and presence of site markers are significant enough to deduce the binding sites 
location as reported earlier [Chi and Liu, 2011; Hu et al., 2009]. As evident from 
above values, the Ksv of HSA-HA decreased markedly in presence of WAR and DIA 
both, however, relatively more in later. It indicates competition between markers and 
HA for both site I and site II, however, relatively more for later. Thus, HA binds 
preferably to site II as compared to site I. 
2.3.3. Isotliermal titration calorimetric measurements. ITC was used to measure 
binding affinity and energetics of HA to HSA. Figure 2.3 shows the ITC binding 
isotherm of HA to HSA at 25, 30, and 37°C in which each peak in top panel 
represents a single injection of the ligand into protein solution. Bottom panel of this 
figure shows an integrated plot of the amount of heat liberated per injection as a 
function of the molar ratio of the ligand to protein. The best fits for the integrated 
heats was obtained using a two sites sequential binding model with the lowest x • The 
temperature dependency of the thermodynamic binding parameters of HA to HSA 
obtained after fitting is summarized in Table 2.2. These results showed that the 
binding affinity is in the order of 10 and 10^  for high and low affinity binding site 
respectively which decrease with increase in temperature indicating the formation of 
complex. Further, the free energy change accompanied the binding of HA to HSA 
was calculated from equation 2.3, whereas, association constant (Kb) and enthalpy 
change (AH) were used to obtain entropy change according to the equation: 
AG°=AH°-TAS° (2.5) 
The enthalpic and entropic contributions to the Gibbs free energy of binding were 
used to infer infomiation regarding the mechanism of binding. 
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Table 2.2.Themiodynamic parameters and association constant of HA-HSA obtained 
by isothermal titration calorimetry. 
i . , 
' 
High 
affinity 
site 
Low 
affinity 
site 
Temp 
rc) 
25 
30 
37 
25 
30 
37 
- , - Kf 
. (M"') 
(2.75±0.51)xlO'' 
(1.95±0.05)xl0^ 
(1.54±0.06)xl0^ 
(2.80±0.49)xl0^ 
(1.38±0.03)x]0^ 
(1.29±0.07)xl0^ 
AlPi 
(kcal mol") 
-4.41±0.46 
-5.18±0.07 
-6.14±0.15 
-7.58±0.96 
-9.74±0.34 
-11.11±0.69 
TAS° 
(kcarmol'') 
-1.90±0.30 
-0.76±0.06 
-0.20±0.01 
-2.88±0.40 
-5.39±0.35 
-6.69±0.36 
Ad" 
(kcal mol"') 
-6.05 ±0.10 
-5.94 ±0.01 
-5.93 ± 0.02 
-4.69 ±0.10 
-4.35 ± 0.02 
-4.41 ± 0.03 
It can be seen from Figure 2.3 (insets), that all studied temperature, the enthalpic 
changes for the binding of HA to both classes of binding site of HSA are all negative, 
which indicate that the binding process are all exothermic and involves electrostatic 
interactions [Thoppil et al., 2008]. On contrary, the entropic contributions were 
favourable for higher affinity binding site while unfavourable for low affinity binding 
site. It suggests the involvement of hydrogen bonding in binding of HA to low affinity 
site on HSA [Ross and Subramanian, 1981]. Whereas, negative value of AG° suggest 
that the formation of complex was spontaneous in nature for both set of binding sites 
at all three temperatures. Further, the slope of plot of AH° against TAS° was found to 
be approximately equal to unity which indicates the enthalpy-entropy compensation 
effect, a common phenomenon in protein ligand interaction [Zolotnitsky et al., 2004]. 
Besides, it was also observed that AH° varies almost linearly with examined range of 
temperature and so the change in heat capacity (ACp) was detennined according to 
equation: 
A c ^ ^ p = ^ ^ (2.6) 
" dT 
The values of ACP obtained were -0.14±0.11 and -0.28±0.24 kcal mor'°C"' for high 
and low affinity site respecUvely. As can be seen from Table 2.1 and 2.2, value of 
binding affinity obtained by fluorescence spectroscopy differ from ITC that may be 
due to the consideration of the location of quencher and fluorophore in the 
later[Faergeman et al, 1996; Nada and Terazmia, 2003]. Not only binding affinity, 
but the values of AH° and TAS° also differ whereas the values of AG" obtained from 
44 
Hippuric acid binding to HSA I Chapter 2 
both methods are comparable. It is due to the already discussed limitations of non-
calorimetric approach to the thermodynamics that in this approach usually AH° is 
assumed to be temperature-independent as can be seen in literature [Anand et al., 
2010; Chi and Liu, 2011; Hu et al., 2009; Thoppil et al., 2008]. Moreover, it cannot be 
neglected that the evaluation of the thermodynamic parameters obtained trom the 
spectroscopic measurements also based upon the temperature dependence of the 
binding affinity that may be influence by the location of quencher from the Trp214 as 
discussed [Faergeman et al., 1996]. This leads to miscalculation of temperature-
dependent AH° and AS°. However, in literature non-calorimetric determination of 
thermodynamic parameters from fluorescence quenching data at different temperature 
has been exploited to get an approximate value [Ahmad et al., 2011; Anand et al., 
2010; Chi and Liu, 2011; Hu et al, 2009]. Further the van't Hoff enthalpy (AHl^ at 
each temperature was calculated using equation: 
AH vH = 
In 
K(TJ ACpj^l^^ACpT.f 1 1 
K(T,) R T, R T T 
>xR 
I _ 1 
(2.7) 
here, K(T]) and K(T2) are the values of binding constant at temperatures T) and T2 
respectively. The temperature dependency of binding affinity obtained from ITC, is 
used to calculate the van't Hoff enthalpy values, which do not agree well with the 
calorimetric enthalpies at all studied temperatures. For example, the value of van't 
Hoff enthalpy obtained at 25°C obtained by using equation 2.7 was -11.98 and -24.69 
kcal mof'for high and low affinity site respecfively which differ from calorimetric 
enthalpies. Such difference is also reported in literature [Keswani et al., 2010] and 
may indicite that the confomiational changes are associated with the binding process 
which may be induced either by ligand binding or by an increase in temperature. 
Hence to have better understanding of confonnafional changes on Hgand binding, we 
have done circular dichroism measurements. 
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2.3.4. Circular dichroism measurements. The changes in secondary and tertiary 
structure of the HSA in presence of HA were studied in far-UV CD and near UV CD 
region at different molar ratio of protein to HA. The resuhs were expressed as MRE 
(mean residue eUipticity) in deg cm^ dmol"', which is given by: 
MRE = 
Qobs("^deg) 
lOxnxcx/ 
(2.8) 
where ©obs is the observed eUipticity in millidegrees, c is the concentration of protein 
in moi/1, / is the length of the light path in centimeters and n is the number of peptide 
bonds. The far-UV CD and near UV CD spectra of HSA in presence of [HSA]/[HA] 
ratio of 1:0, 1:5, 1:10 and 1:15 are shown in Figure 2.4 A & B. In the presence of 
HA, slight increase occur in the secondary structure of HSA as evident from the 
increase at two minima at 208 and 222 nm that are characterstic of a-helix [Zaidi et 
al., 2013a]. However, the shape of peaks and the position of peak maximum remained 
almost unchanged in the presence of HA, indicating that HSA has predominantly a-
helix in nature even after binding to the HA. 
o; 
H^  
s 
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o 
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J I L 
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Figure 2.4. Far (A) and near (B) UV CD spectra of HSA in the presence of varying 
concentration of HA. a-d represent spectra of HSA: HA at molar ratio of 1:0, 1:5, 1:10 and 
1:15 respectively in both (A) and (B). 
Further as shown in Figure 2.4B, near-UV CD spectra for the HSA showed two 
minima at 262 and 268 nm and shoulders at 279 and 290 nm, characteristics of 
disulphide and aromatic chromophores, which is in accordance with literature 
[Ahmad et al., 2006]. But, change in HSA spectra in presence of HA was observed 
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that indicates the alteration of tertiary structure at different molar ratio of protein to 
HA. This confirms that conformational changes occur in the protein upon ligation and 
thus difference is observed in the values of van't Hoff and calorimetric enthalpies 
obtained from ITC. 
2.3,5. Thermostability measurement by differential scanning calorimetry. Figure 
2.5A—C shows the typical excess heat capacity curves for HSA:HA in the molar ratio 
of 1:0, 1:5, and 1:10 and thermodynamic parameters obtained accompanying 
thermodynamic denaturation of HSA under these conditions are reported in Table 2.3. 
It is observed that the thermal unfolding of HSA is irreversible process in absence and 
presence of HA by reheating the samples after cooling just after the first run. Hence to 
minimize the kinetic factors, slower scanning rate have been chosen. The changes in 
the Tm and AH° of the protein in presence of ligand are the most obvious 
manifestation of ligand binding effects that can be estimated by DSC [Celej et al., 
2006]. Thus, to confimi binding of HA to HSA, changes in the Tm and AH° have been 
monitored by DSC. The denaturation of HSA yielded more than one endothermic 
peak that reflects the domain denaturation mechanism [Privalov, 1982]. So, it was 
deconvoluted with the assumption of three sub-transitions and each of which might be 
related to the links between the three structural domains of HSA. 
15.^  , 15r 
30 40 50 60 70" 80" 90 30 40 50 60 70 80 90 30 40 50 60 70 80 90 
Temperature (Q 
Figure 2.5, Excess heat capacity curves obtained by differential scanning calorimetry for 
HSA:HA in the molar ratio of (A) 1:0, (B) 1:5, and (C) 1:10. 
Further, it is also established that domain 111 melts prior to domain II, so Xn^^Y 
coiTCsponds to domain III [Sudlow et al, 1975];[Rezaei Tavirani et al., 2006]. Table 
2.3 shows 7j|,, T^^ and ^^and respective AH° of native HSA that are in accordance 
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_^  _ _ _ ^ _ ^  . _ 
with the Uterature [Uversky et al., 1997]. Upon increasing molar ratio to 1:10, the 7^ 
increases appreciably, T^ changes slightly whereas, T^ donot change at all. 
Table 2.3. Thermodynamic parameters of HSA in presence of HA obtained by DSC. 
Ti (°C) 56.91±0.09 57.25±0.01 58.36±0.08 
r,^(°C) 61.37±0.07 62.51±0.09 63.83±0.02 
j3^og 73.65±0.06 73.87±0.04 73.96±0.03 
Mf^ (kcalmol') 
A ^ (kcalmol"') 
52.21±0.69 54.41±0.10 68.47±0.80 
55.37±0.71 56.13±0.12 57.37±0.60 
A/f3 (kcalmof) K 13.96±0.08 13.92±0.07 13.90±0.09 
This indicates that, binding of HA to domain 111 is stronger as compare to domain II 
whereas, negligible to domain I as higher energy is required to change from the 
liganded native state into the free unfolded state in case of domain III followed by 
domain II. Thus, HA preferential binds to the folded or native fonn of the HSA 
which causes stabilization of the folded state and hence unfolding of HSA become 
progressively less favorable as HA concentration increases [Celej et al., 2005; Neelam 
et al, 2010; Sharma et al., 2012]. 
2.3,6. Measurement of esterase-like activity of hsa in presence of ha. The Arg410 
and Tyr411, crucial amino acid residue present in the centre of drug binding site II of 
HSA are involved in its esterase-like activity [Watanabe et al., 2000]. Catalytic 
activity of HSA toward /^ -NPA was investigated to know the involvement of these 
residues in the binding of HA to HSA. The kinetic constants (Km and V„iax ) were 
obtained by fitting the initial rates to Michaelis-Menten equation using Graph-Pad 
Prism, version 5.0, software as shown in Figure 2.6 by fitting the initial rates tc 
Michaelis-Menten equation: 
I y^ Vn.ax[S] .2.9) 
\ K,„+[S] 
where ?, V a^x, K ,^ and [S] represent the initial reaction velocity, maximum velocity, 
Michaelis-Menten constant, and molar concentration of substrate, respectively. 
Whereas, Kj was calculated from equation: 
49 
Hippuric acid binding to HSA i Chapter 2 
(2.10) 
where, K^ , is the apparent Km in presence of competitive inhibitor concentration lo. 
> 
0.15 
0.10 
0.05 
n fin ' 
1^ ^ ^ ^^9L 
r 
1 
I Y 
- • - 1:0 
- » - 1:0.5 
- * - 1:1 
-*~ 1:1.5 
1:2 
1 1 
200 400 
[S](^iM) 
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Figure 2.6. Michalies-Menten plot of HSA for/7-NPA at HSA: HA ratio of 1:0, 1:0.5 1:1, 
1:1.5, and 1:2. 
Further, the reciprocal of substrate concentration against reciprocal of respective 
product formation rate are plotted as Lineweaver-Burk plot (Figure 2.7). 
-25 -20 -15 -10 -5 0 5 10 15 
Ix 10'V[S](|LiM)'' 
Figure 2.7. Lineweaver-Burk plots of reaction velocity versus substrate concentration 
for enzyme kinetics of HSA in absence and presence of HA. The molar ratio of HSA:HA 
examined are 1:0, 1:0.5, 1:1, 1:1:5, and 1:2. 
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As shown in Table 2.4, the activity of HSA toward p-NP A gives Km and Vmax equal to 
59.36± 05.55 )xM and 0.16±0.01 i^ Ms"' respectively whereas in presence of HA, Vmax 
remain same while Km increases. This indicates that the HA inhibits the esterase-like 
activity of HSA competitively with Kj equals to 21.68 |iM and hence Arg410 and 
Tyr411, of drug binding site II of HSA are involved in binding of HA. 
Table 2.4. Kinetic parameters for the hydrolysis of/»-NPA by HSA in presence of 
FUR 
HSA: FUR 
1:0 
1:0.5 
1:1 
1:1.5 
1:2 
Km 
(uM) 
59.36 ±05.55 
93.50 ±04.52 
109.5 ±07.25 
126.20 ±10.16 
153.90 ±09.50 
V max 
(^Ms"') 
0.16 ±0.01 
0.16 ±0.02 
0.16 ±0.01 
0.16 ±0.02 
0.16 ±0.01 
lO'xkcai/Km 
(nM"'s"') 
17.95 ±1.69 
11.40 ±0.55 
09.74 ± 0.64 
08.45 ± 0.68 
06.93 ± 0.42 
2.3.7. Molecular docking. The molecular docking has been employed to further 
understand the interaction of HA and HSA. The HSA comprises of three homologous 
domains (I-III): I (residues 1-195), II (196-383), III (384-585), each domain 
comprises subdomains that posses common structural motifs. The principal regions of 
ligand binding to HSA are located in hydrophobic cavities in subdomains IIA and 
IIIA, which are consistent with Sudlow sites 1 and II, respectively [Sudlow et al., 
1975]. In the present study, Autodock Vina program is applied to calculate the 
possible conformation of the HA that binds to the protein. The best energy ranked 
results are summarized in Table 2.5 and Figure 2.8, which shows that HA binds to 
both sites of HSA. Figure 2.8B & D show that HA more favourably fit in the 
hydrophobic cavity in subdomains IIIA, that corresponds to site 11, with AG and Kb 
of -5.9 kcal moF', 2.12x10^ respectively. The Leu387, lle388, Asn391, Cys392, 
Leu407, Arg410, Tyr411, Leu430, Val433, Cys438, Ala449 and Leu453 of site II 
were involved in hydrophobic interaction. However as shown in Figure2.8A & C, HA 
also fit in cavity of the subdomains IIA, that corresponds to site I, with AG and Kb of-
5.6 kcal mol"' and 1.28 xio'* respectively. The HA interacts hydrophobically with 
Lysl99, Arg222, Tyrl50, Glul53, Serl92, Lysl95, Glnl96, Trp214, His242, Arg257, 
Ala291 and Glu292 of site 1. Moreover, HA forms two hydrogen bonds with LysI99 
having bond length of 2.05A, 2.16A and one with Arg222, having bond length of 
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2.36A. Thus, HA binds to site II with the high affinity binding site whereas with 
relatively low affinity to site I. 
Figure 2.8. Molecular docking of HA and HSA. Molecular surface representation of docked 
HA in a (A) site II and (B) site I of HSA. Representation of interacting residue of HSA (C) 
site II and (D) site I interacting with HA. 
For site II, values of AG obtained by docking are very close to the calorimetrically 
obtained values whereas, slightly different for site I. The probable explanation for this 
is that docking was based upon the static and fixed X-ray crystals structure of protein 
where protein significant structural freedom is not allowed to acquire different 
conformations upon ligand binding. Unlikely, the calorimetry results are based upon 
full freedom in the structural flexibility of the protein in aqueous system [Ahmad et 
al., 2011; Neelam et al., 2010]. Thus, structural rearrangements observed in the HSA 
that occurred upon HA binding in solution, is a plausible cause of this difference. 
Further, docking is based on some crucial approximations including the limited 
number of ligand positions in the trial and omission of protein dynamics. Therefore, 
molecular docking in this study yields useful information about the specific residues 
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of HSA involved in the interactions with the HA for better understanding of protein-
ligand interaction at the molecular level. 
Table 2.5. Molecular docking results of HSA-HA interaction 
i 
binding site amino acid forces involved AG(kcalmor') Kb(M'') 
Site I 
Site II 
Lysl99 
Arg222 
Tyrl50 
Glul53 
Serl92 
Lysl95 
Glnl96 
Trp214 
His242 
Arg257 
Ala29I 
Glu292 
Leu387 
Ile388 
Asn391 
Cys392 
Leu407 
Arg4I0 
Tyr411 
Leu430 
Val433 
Cys438 
H-bonding and Hydrophobic 
H-bonding and Hydrophobic -5.6 
Hydrophobic 
Hydrophobic 
Hydrophobic 
Hydrophobic 
Hydrophobic 
Hydrophobic 
Hydrophobic 
Hydrophobic 
Hydrophobic 
Hydrophobic 
Hydrophobic 
Hydrophobic -5.9 
Hydrophobic 
Hydrophobic 
Hydrophobic 
Hydrophobic 
Hydrophobic 
Hydrophobic 
Hydrophobic 
Hydrophobic 
1.28x10' 
2.12x10" 
2.3.8. Binding of HA to HSA affect its elemination. HA is fonned primarily from 
aromatic amino acids by gastrointestinal flora or may be directly taken as 
preservatives from food and beverages [Niwa, 1996]. In patients with end-stage renal 
disease, excretion through kidney is hampered and consequently, the concentration of 
HA increases to values higher than 247±112 mg/L [Vanholder et al., 1992]. So it is 
believed that it may bind to the HSA and thus its removal may hamper. So to confirm, 
we examine the binding energetics and amino acid involved in binding of HA to 
HSA. From above studies, it is found that, HA binds with high affinity to site II while 
with relatively low affinity to site I of HSA via hydrogen bonding, electrostatic and 
hydrophobic interaction. Therefore it is confiiTned that it bounds to HSA and thus it 
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elimination may be hampered as shown in Figure 2.9. Moreover, Arg410 and Tyr411 
are involved in binding of HA to site II of HSA, that are also crucial for esterase-like 
activity of HSA. Thus, HA also impinges esterase-like activity of HSA. 
Gastrointestinal tract 
Flora of Gl tract 
Preservatives in 
food & beverages 
© Aromatic amino 
acids 
Hippuric acid 
Human serum albumin j Elimination 
1 affected 
Figure 2.9. Schematic representation of mechanism of HA binding to HSA under uremic 
condition. 
2.4. Conclusions 
The present work reports the interaction of HA, a uremic toxin, to HSA. Results 
indicated that it markedly binds to both drug binding sites of HSA; however binding 
at site II is relatively more. Further, the quenching mechanism of fluorescence of 
HSA by HA is a static procedure and their binding is a spontaneous, enthalpically 
driven, entropically opposed process that involves hydrogen bonding, electrostatic, 
and hydrophobic interaction. Since it binds to HSA and thus its elimination may 
hinder. Moreover, it increases the thermostabilty of HSA on binding and inhibits the 
esterase-like activity of HSA in a competitive manner. 
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Biophysical insight into furosemide binding to human 
serum albumin: a study to unveil its impaired 
albumin binding in uremia 
3.1. Introduction 
Human serum albumin (HSA) is a main carrier for a variety of endogenous and 
exogenous substances in the body and also plays a key role in maintaining normal 
osmolarity in plasma and in interstitial fluid [Kragh-Hansen, 1981; Varshney et al., 
2010]. It is a single chain nonglycosylated polypeptide of 66.5 kDa. The protein has 
three homologous domains (I-III), each domain comprises two subdomains (A and B) 
that possess common structural elements [He and Carter, 1992; Sugio et al., 1999]. As 
of its transporting role, it binds substances at two major binding regions, namely 
Sudlow's site I and II, which are located within cavities in subdomains IIA and IIIA, 
respectively [Sudlow et al., 1975]. Generally, upon absorption exogenous substances 
like drugs enter into the circulatory system and bind reversibly to semm albumin, 
which assists in their distribution and deposition [Reed et al., 2001; Seetharamappa 
and Kamat, 2005]. But, transport of various drugs via albumin in pathological ill 
condition like uremia, is seriously compromised [Mingrone et al., 1997; Varshney et 
al., 2011], Among them, binding of furosemide (FUR), a diuretic drug, is most 
adversely impaired, which normally binds 99 % to albumin at its total concentration 
of 10 ^g mU' [Bojko et al., 2010a; Takamura et al., 2005]. Hence, decrease in the 
protein bound fraction of FUR may affect the phamiacokinetics of the drug, which 
includes its tubular secretion and increased metabolic clearance in uremic patients 
[Wilcox, 2002]. Although the molecular mechanism underlying impaired albumin 
FUR binding in uremic conditions is poorly understood, two major reasons have been 
suggested. First, it may be due to some confomiational changes in albumin under 
chronic renal disease but putative structural modifications of pathological HSA have 
been disputed for decades [Ivanov et al, 2002; Sjoholm et al., 1976; Takamura et al., 
1996]. Second, according to the most accepted hypothesis, HSA binding sites might 
be occupied by uremic toxins, viz. hippuric acid (HA), indoxyl sulfate (IS), and 3-
carboxy-4-methyl-5-propyl-2-furanpropionic acid (CMPF), indole 3 acetic acid 
(lAA), etc [Sarnatskaya et al., 2003]. However, from the available literature, it is 
found that FUR binds to site I of HSA [Bojko et al., 2010a; Bojko et al, 2010b; 
55 
Furosemide binding to HSA , Chapter 3 
Ivanov et al, 2002] whereas all predominant uremic toxins except CMPF bind mainly 
to site II of HSA [Bowmer and Lindup, 1982; Ikeda et al., 1984; Sakai et al., 1995]. 
So, only CMPF is the uremic toxin that directly inhibits the binding of FUR to 
albumin as they share the same binding site. But, the reason behind inhibition by site 
II bound uremic toxins of FUR binding to albumin is still unclear. Thus, to elucidate 
the plausible reason behind impaired albumin binding of FUR, energetic and binding 
parameters along with the location of FUR binding sites on albumin are determined 
by fluorescence spectroscopy (steady state and time-resolved), ITC, FRET, esterase 
activity of HSA, and molecular docking and then the binding site location is 
correlated with the binding sites of uremic toxins available in the literature. Further, 
secondary structural changes on the binding of FUR to HSA are monitored by circular 
dichroism and Fourier transform infrared spectroscopy. This study is the first to 
utilize ITC, FRET, activity assay, and molecular docking to obtain the binding 
parameters, energetics, and structural infonnation for binding of FUR to human serum 
albumin. 
3.2. IMaterials and methods 
3.2.1. Materials and sample preparation. Human serum albumin (A1887; 
essentially globulin and fatty acid free), furosemide (F4381), warfarin (A2250), 
phenylbutazone (P8386), and p-nitrophenyl acetate (N8130) were procured fom 
Sigiua Aldrich. Diazepam was the product of Ranbaxy Laboratories Ltd. All other 
reagents were of analytical grade. HSA and drug solutions were prepared in 20 mM 
sodium phosphate buffer (pH 7.4). The protein was dialyzed and its concentration was 
estimated spectrophotometerically using E^J^^ ^^^^= 5.3. All drug solutions were 
prepared by weight/volume (w/v). 
3.2.2. Steady state measurements. Steady state absorption measurements were 
earned out on a Perkin-Elmer Lambda 25 double beam UV-vis spectrophotometer 
attached with Peltier temperature programmer-1 (PTP-1). All the steady state 
fluorescence measurements were recorded on Shimadzu 5301 PC fluorescence 
spectrophotometer equipped with water circulator (Julabo Eyela). For fluorescence 
quenching measurements, HSA (5 liM) was titrated with varying concentrations of 
FUR (0-11 fiM) at 25, 30, and 37°C. These samples were excited at 295 nm, and the 
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fluorescence emission was collected from 310 to 410 nm. However, for steady state 
FRET measurements, the fluorescence emission was collected from 300 to 500 nm. 
The excitation and emission slits were set at 3 nm. Respective blanks were subtracted. 
The fluorescence intensity was corrected for imier filter effects of protein and ligand 
using the equation: [Lakowicz, 2006] 
'^^?QSnm+^340nni) 
Fcor=Fobs%10 2 (3.1) 
where, Feci and Fobs are corrected and observed fluorescence intensities, Df^  is the 
dilution factor, and A295 mn and A340 nm are the sum of the absorbance of protein and 
ligand at the excitation (295 nm) and emission (340 nm) wavelengths, respectively. 
The average of A295 nm and A340 „,„ for HSA and FUR lay in the range from 0,02 to 
0.07. 
3.2.3. Time-resolved fluorescence measurements. Fluorescence lifetime 
measurements were performed using the time-coirelated single photon counting 
(TCSPC) model 5000 U (Horiba Jobin Yvon). The samples were excited at 295 nm 
using a NanoLED pulsed laser. The instrument response function (IRF) was obtained 
using LudoxTM suspension. The full width at half-maxima (fwhm) of the IRF was 
750 ps. The emission decay data at 340 nm were analyzed using the software, DAS6, 
provided with the instrument. 
3.2.4. Isothermal titration calorimetric measurements (ITC). The energetics of the 
binding of FUR to HSA at 25, 30, and 37°C were measured using a VP-ITC titration 
microcalorimeter (MicroCal Inc., Northampton, MA). Prior to the titration 
experiment, all samples were degassed properly on a thennovac. The sample and 
reference cell of the calorimeter were loaded with HSA solution C 8 iiM) and 20 mM 
sodium phosphate buffer (pH 7.4), respectively. Then 10 |iL of FUR solution (1.285 
mM) were added into the sample cell containing HSA. Each injection was made over 
20 s with an interval of 180 s between successive injections. The reference power and 
stirring speed were set at 16 |icals"' and 307 rpm, respecflvely. Heats of dilution for 
the ligands were determined in control experiments, and these were subtracted from 
the integrated data before curve fitting. 
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3.2.5. Circular dichroism spectroscopic measurements. The far-UV CD spectra of 
HSA (5 |iM) were collected in the presence of FUR at molar ratio of 1:0, 1:1, and 1:2 
in a JASCO-J815 spectropolarimeter equipped with a Peltier-type temperature 
controller at 25, 30, and 37°C. Spectra were collected from 200 to 250 nm with 20 
nm/min scan speed and a response time of 2 s. Respective blanks were subtracted. 
3.2.6. FT-IR spectroscopic measurements. Spectra of HSA in the presence and 
absence of drug were collected on a Nicolet 6700 FT-IR spectrophotometer (DTGS 
detector, Ni-chrome source and KBr beamsplitter) from 1700 to 1600 cm"' using a 
ZnSe window at room temperature. For each spectrum, 256 scans were averaged with 
a resolution of 4 cm' . The drug with HSA was incubated for 1 h prior to scanning. 
Respective blanks were subtracted. The curve fitting was done by assuming mixed 
Lorentzian-Gaussian line shape function. The curve fitting, smoothing, baselines 
correction, and area calculation were carried out using the built-in software (OMNIC 
version). The resulting fitted curve was analyzed by taking into account the band 
assignment for the secondary structure previously reported in the literature [Barth, 
2007] a-helix (1648-1657 cm''), B-sheet (1623-1641 cm''), turn (1662-1686 cm''), 
random coil (1642-1657 cm''), and B-antiparallel (1674-1696 cmf'). 
3.2.7. Effect of drug binding on esterase activity of HSA. Drug site II of HSA 
possessed a well-known esterase-like activity toward p-nitrophenyl acetate [Watanabe 
et al., 2000]. Thus the reaction of/?-NPA with HSA in the absence and presence of 
drug (i.e., 0-45 pM) was followed at 405 nm by monitoring the appearance of yellow 
product p-nitrophenol for 1 min at 25°C. The molar extinction coefficient of p-
nitrophenol was taken as 17800 M' cm' . The reaction mixture contained 15 pM HSA 
whereas p-'NFA varied from 0 to 600 pM in 20 mM sodium phosphate buffer (pH 
7.4). The control (in the absence of HSA) was also taken into consideration. 
3.2.8. Molecular docking. The crystal structure of HSA (PDB: 1A06) was retrieved 
from the Protein Data Bank on which addition of hydrogen atoms was done followed 
by minimization and optimization using the OPLS 2005 force field in the premin 
option of Schrodinger GLIDE in Schrodinger protein preparation wizard. The grids 
were generated and cover all the residues in a 5 A neighborhood of the 
phenylbutazone (PBZ) and warfarin (WAR) for site I and DIA for site II. The FUR 
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molecule was then prepared in the Schrodinger ligprep wizard and predocking 
preparations were done as that for protein. Docking was then perfomied using GLIDE 
and its output G score was calculated as [Friesner et al., 2004] 
G score =Hbond +eLipo +metal +site + 0.13Coul +0.065vdW -BuryP -RotB (3.2) 
where, H bond=hydrogen bonds, Lipo=hydrophobic interactions, metal=metal-
binding term, site=polar interactions in the binding site, vdW=van der Waals forces, 
Coul = Columbic forces, BuryP=penalty for buried polar group, RotB=freezing 
rotable bonds. 
X-Score vl.2.1, was used to calculate negative logarithm of dissociation constant of 
the ligand to the protein, -log (Kj), and binding energy (kcal mol"'). X-Score was 
reported to have an accuracy of ±2.2 kcal mol"' to the actual binding energies. The 
Ligplot program and PyMOL were used for analyzation and visualization of the 
interaction of docked protein-ligand complex, respectively. 
3.2.9. Statistical analysis 
All detenninations were triplicates, and mean values and standard deviations were 
calculated, wherever applicable, using SPSS 16.0 programme for windows. 
3.3. Results and discussion 
3.3.1. Steady state fluorescence results. Tryptophan, tyrosine, and phenylalanine are 
the three aromatic fluorophores that are used for studying confonnational changes on 
drug binding. However, among them, contribution of tryptophan is maximum [Ahmad 
et al., 2011]. Fluorescence quenching of aromatic fluorophores in HSA by FUR at 
three different temperatures viz. 25, 30, and 37°C is evaluated in the presence of 
varying concentrations of FUR. As shown in Figure 3.1, HSA has the strong emission 
peak at 340 nm on excitation at 295 nm, which decreases with gradual addition of 
FUR at all three temperatures [Ahmad et al., 2006; Anand et al., 2011]. However, the 
quenching of Trp fluorescence emission is maximum at 25°C and minimum at 37°C. 
3.3.1.1. Binding affinity. To obtain the Stem-Volmer quenching constant (Ksv) and 
binding constant (Kb), the fluorescence quenching data of HSA-FUR binding at 
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different temperatures are analyzed by the Stern-Volmer equation and plot of log 
(Fo/F-1) vs log[Q] respectively: [Lakowicz, 2006] 
^ = Ksv[Q]+l = kqTjQ]+l (3.3) 
log 
U 
-1 =logK,+nlog[Q] (3.4) 
where Fo and F are the fluorescence intensities in the absence and presence of 
quencher (FUR). Kjv and kq are the Stem-Volmer quenching and bimolecular rate 
constants, respectively, and To, is the average integral fluorescence lifetime of 
tryptophan, which is ~ 5.7x10'^ s. 
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Figure 3.1. Normalized fluorescence emission spectra of HSA in presence of different 
concentrations of FUR at (A) 25°C B) 30°C, and (C) 37°C. a-1: 0-11 nM of FUR at 
increments of 1 fiM. The inset corresponds to the molecular structure of FUR. 
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The Ksv was calculated from the slope of plot FQ/F VS [Q], whereas the slope and 
intercept of plot log (Fo/F-1) vs log[Q] give n and Kb, respectively (Figure 3.2 A, B). 
1 
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Figure 2. Stem-Volmer (A) and modified Stern-Voimer plots (B) of fluorescence quenching 
of HSA by FUR at different temperatures. 
As shown in Table 3.1, the values for binding constant are on the order of 10'^  and 
decrease with increasing temperature. This suggests static quenching phenomenon, 
which is also the reason behind the fall in fluorescence emission of Trp with the rise 
in FUR concentration [Chi and Liu, 2011; Ibrahim et al., 2010]. 
3.3.1,2. Mechanism of binding. Fluorescence quenching can be either dynamic or 
static in nature. In order to know about the quenching mechanism of HSA by FUR, 
the mechanism assimied to be dynamic. Thus by equation 3.3, kq was obtained which 
lies in order of 10 as shown in Table 3.1. However, the kq for the HSA-FUR system 
is 1000 times lower than the maximum scatter collision quenching constant of various 
quenchers with biopolymers (2xl0"^ M"'s'') [Ahmad et al., 2011]. This shows that 
quenching is not initiated by dynamic diffusion but occurs by formation of a strong 
complex between HSA and FUR [Anand et al., 2011]. Further, the temperature 
dependence of Ksv is studied as a type of quenching and can be distinguished by the 
differential response toward temperature and viscosity. In static quenching, Ksv 
decreases with an increase in temperature due to the formation of complex with 
protein, which undergoes dissociation on increasing temperature. However, for 
dynamic quenching, Ksv increases with temperature as in this case higher temperature 
results in faster diffusion of quencher and hence larger extent of collisional quenching 
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[Chi and Liu, 2011]. To further confirm the mechanism, time-resolved fluorescence 
spectroscopy has been done. 
Table 3.1. Binding and thennodynamic parameters of FUR-HSA at different 
temperatures obtained from fluorescence quenching experiments" 
Temp (°C) 
n 
Ksv(M-') 
Kb(M-') 
kq (M"' s"') 
AH°(kcal mol"') 
TAS° (kcal mol"') 
AG" (kcal mol'') 
" 25 : 
1.05 ±0.01 
(2.29 ± 0.06) X10^  
(4.09 ± 0.07) X10^  
(4.01±0.05)xl0'^ 
-3.41 ±0.04 
-7.65 ± 0.03 
30 
1.05 ±0.02 
(1.90 ± 0.03) xlO^ 
(3.13 ± 0.08) xlO^ 
(3.33±0.04)xl0'^ 
-11.07 ±0.08 
-3.47 ±0.05 
-7.61 ±0.02 
'. 37: 
1.03 ±0.03 
(1.52 ± 0.04) X10^  
(1.99 ± 0.03) X10^  
(2.66±0.02)xl0'^ 
-3.55 ±0.05 
-7.51 ±0.01 
'R^ for all values ranges from 0.98 to 0.99. 
3.3.1.3. Mode of binding. The signs and magnitude of change in enthalpy (AH"), 
entropy (AS"), and free energy (AG") for protein-drug interaction can be exploited to 
evaluate the main forces contributing to fonuation of a protein-drug complex [Ross 
and Subramanian, 1981]. According to equation 3.5, AH" and AS" are obtained from 
the slope and intercept of a linear van't Hoff plot between In Kb vs 1/T (not shown). 
lnKb= + (3.5) 
RT R 
and the change in free energy (AG) is calculated from Gibbs-Helmholtz equation: 
•^o 
AG =-RTlnK b (3.6) 
where R (1.987 cal moF'K'') is the gas constant and T is the absolute temperature (K). 
The calculated theimodynamic parameter AH", AS", and AG" are summarized in Table 
3.1. The negative AH" and AG" signify the exothemiic and spontaneous nature of 
process at all studied temperature. According to [Ross and Subramanian, 1981], 
negative AH" and AS" value suggest the involvement of hydrogen bonding in HSA-
FUR complex fomiation and a decrease in entropy is attributed to the formation of 
hydrogen bonds between FUR and HSA. Furthermore, it is found that the major 
contribution to AG" arises from AH" rather than AS", so the binding process is 
enthalpy driven. 
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3.3.1.4. Probing binding site using site mariners. The detennination of binding site 
location of FUR on HSA is perfomied by using the simple approach of competitive 
binding between FUR and site specific markers, viz. warfarin (WAR), 
phenylbutazone (PBZ) for site I and diazepam (DIA) for site II, [Ghuman et al., 2005; 
Petitpas et al., 2001] by keeping a constant concentration of protein and marker in the 
ratio of l.i and varying the concentration of FUR (0-11 ^M). The ligands bind HSA 
at two major binding regions, namely Sudlow's site I and site II, which are located 
within specialized cavities in subdomains IIA and IIIA, respectively [Sudlow et al., 
1975]. To probe the binding site of FUR on HSA, Ksv values in the absence and 
presence of markers are calculated by the Stern-Volmer equation and presented in 
Table 3.2. The values of Kgv for FUR decrease in the presence of PBZ and WAR (site 
I markers). It suggests that FUR binds to site I because in the presence of site markers 
having the same binding site as that of the test dmg, the value of quenching constant 
should decrease due to competition [Chi and Liu, 2011]. However, a decrease in the 
values of Ksv, for FUR in the presence of DIA (site II marker) is also not negligible, 
which is suggestive of binding of FUR to site II. But the decrease in Ksv of later is 
small so FUR has a low affinity for site II. 
Table 3.2. Effect of site markers on binding of FUR to HSA. 
without the site with PBZ with WAR with DIA 
marker 
Ksv (2.29±0.08)xl0^ (5.01±0.02)xl0'' (I.03±0.03)xlO' (1.32±0.05)xlO^ 
R- 0.99 0.99 0.99 0.99 
'R^ for all values ranges from 0.98 to 0.99. 
3.3.2. Steady state fluorescence resonance energy transfer (FRET). According to 
Forster nonradiation energy transfer theory, the parameters related to energy transfer 
can be calculated on the basis of equations as follows [Forster, 1948; Il'ichev st al., 
2002]. The efficiency of energy transfer (E) can be calculated as 
^ F R E T • R^r^ 
(3.7) 
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where FQ and F are the fluorescence intensities of HSA in the absence and presence of 
drug, respectively, r is the distance between donor and acceptor, and RQ is the distance 
at which transfer efficiency equals 50 %, which can be calculated as 
R ' = 8 . 7 9 x l O ' ^ ^ ^ V ^ / (3.8) 
where K is the factor related to the geometry of the donor and acceptor of dipoles, n 
is the refractive index of the medium, (p is the fluorescence quantum yield of the 
donor in the absence of acceptor and J is the overlap integral of donor fluorescence 
emission and the acceptor absorption, which can be calculated by 
J=--J^ (3.9) 
V{X)dX 
Jo 
where F{X) is the fluorescence intensity of the donor at wavelength range X which is 
dimensionless, and e(k) is the molar absorptivity (extinction coefficient) of the 
acceptor at wavelength A, in M" cm •'. ForHSA, K^(pand n are taken as 2/3, 0.118, 
and 1.33, respectively [Cyril et al., 1961]. By using eq 7-9, values of J, EFRET, RO and 
r are calculated and listed in Table 3.3. 
Table 3.3. Steady state and time-resolved fluorescence parameters of HSA-FUR. 
Steady state Time resolved 
J (M" cm" nm) Ro(nm) r(mTi) EFRET r(nm) EFRET 
rn' 2.45x10" 1.93 2.02 0.43 2.97 0.07 
The overlap spectra of normalized fluorescence intensity of donor (Trp214 of HSA) 
emission and acceptor absoiption are shown in Figure 3.3. The binding distance (r) 
obtained for the system is found to be 2.02 nm. However, it must be mentioned here 
that if FRET is done by steady state measurements, then the value of EFRET is 
overestimated as steady state measurements have a contribution from static 
quenching, which also seems to be the principal reason for lowering the HSA 
fluorescence emission in the presence of FUR. Hence, to have a better understanding 
of exclusive FRET, we have characterized HSA-FUR system by time-resolved 
fluorescence measurements. 
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Figure 3.3. Overlap spectra of normalized absorbance of FUR (solid) and normalized 
fluorescence intensity of HSA (dashed). Equimolar (5 ^M) concentration of drug and 
protein were taken. 
3.3.3. Time-resolved fluorescence quenching measurements: Fluorescence lifetime 
measurement serves as an indicator for exploring the local environment around 
fluorophores and so can be implicated to understand the interaction between drug and 
protein [Anand et al., 2010]. At neutral pH in aqueous solution, Trp exhibits multiple 
exponential decay, which has been attributed to the existence of rotamers 
(conformational isomers) in determining lifetimes [Anand et al., 2011]. The time-
resolved decay profile of HSA in buffer and in the presence of FUR are displayed in 
Figure 3.4. All the experimental decay curves are well reproduced with biexponential 
decay function as evidenced by the statistical parameters like % which is close to 1 
and distribution of weighted residuals. When the biexponential decay law is used, it is 
often useful to determine intensity-averaged lifetime (tavg) from the deacy times (T) 
and pre-exponential factors (ai and 02) using [Lakowicz, 2006] 
T = 
avg 
(3.10) 
The intensity-averaged lifetimes (tavg) obtained were compared with those calculated 
by amplitude-averaged lifetime method (data not shown) using [Kelkar et al., 2005] 
ir^' 
S 
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<T,,g)=a,T,+a2T2 (3.11) 
Although differences are observed in values of Xavg and (r^^g) but, they are acceptable 
as reported in literature [Haldar et al., 2008; Haldar et al , 2012; Kelkar et al., 2005]. 
Table 3.4.Time-resolved fluorescence decay parameters of HSA in presence of FUR 
HSA:FUR 
1:0 
1:1 
1:2 
Ol 
0.39 
0.40 
0.46 
T,(ns) 
2.17 
1.80 
1.86 
02 
0.61 
0.60 
0.54 
h(ns) 
6.45 
6.13 
6.18 
T 
avg 
5.70 
5.41 
5.29 
The Xavg of HSA is found to be 5.7 ns, which decreases marginally even in the 
presence of a saturating concentration of FUR, as shown in Figure 3.4 and Table 3.4. 
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Figure 3.4. Time-resolved fluorescence decay profile of HSA in absence and presence of 
FUR. Panels A-C show the distribution of weighted residuals for biexponential fitting for 
1:0, 1:1, and 1:2 HSA:FUR.. IRF indicates the instrument response function. The panel D 
shows the fluorescence lifetime decay of HSA: FUR at ratio of (1)1:0, (2)1:1, and (3)1:2. 
This is due to the charge transfer process from the indole ring of Trp214 to the nearby 
substituent which slightly enhances on binding with FUR and thus causes a slight 
decrease in the fluorescence lifetime. It is indicative of a small contribution of 
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dynamic quenching as only those molecules that suffer dynamic quenching have an 
exclusive contribution in decrease of the fluorescence lifetime [Beechem and Brand, 
1985]. Thus, the time-resolved transfer efficiency (E) calculated from fluorescence 
lifetime measurements exclusively reports the energy transfer during the process of 
dynamic quenching and is obtained by using the following equation; 
E = l - — (3.12) 
where x and XQ are the lifetime of Trp in the presence and absence of FUR, 
respectively. Table 3.3 represents the FRET parameters obtained from steady state 
and time-resolved measurements. The magnitudes of ERRET estimated from time-
resolved lifetime measurements are found to be much lower than the value obtained 
by steady state measurements because of the exclusive contribution of dynamic 
quenching in the former. Thus it can be said that the mechanism of FRET is indeed 
operational but the magnitude of transfer efficiency is small. 
3.3.4. Isothermal titration calorimetric measurements. ITC allows the 
measurement of the magnitude of binding affinity, and the two contributing 
thermodynamic terms: enthalpy (AH") and entropy (AS") changes. A representative 
calorimetric titration profile of the binding of FUR to HSA at 25, 30 and 37°C is 
shown in Figure 3.5(A-C). In the top panel, each peak represents a single injection of 
the drug into protein solution. The bottom panel shows an integrated plot of the 
amount of heat liberated per injection as a function of the molar ratio of the drug to 
protein. Association constant (K.b) and enthalpy change (AH") were directly obtained 
after fitting whereas free energy change is calculated from equation 3.6. The entropy 
change is calculated by 
AG°=AH°-TAS° (3.13) 
and change in specific heat capacity can be calculated from [Ladbury and Williams, 
2004]. 
1 AU° 
ACT' '= -=^ (3.14) 
" dT 
Further the van't Hoff enthalpy (A HVH) at each temperature is calculated with 
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AH vH = 
,K(T2) ACpj^T. AC„T, 
: i n " ^ ^ ^ - ^ ^ l n ^ + ^^''^' 
K(T,) R R 
l_ 1 
T T 
>xR 
1 1 
(3.15) 
Here, K(Ti) and K(T2) are the values of binding constant at temperatures Ti and T2, 
respectively. The temperature dependency of the themiodynamic binding parameters 
of FUR to HSA is summarized in Table 3.5. The titration of FUR to HSA results in 
negative heat deflection at all studied temperatures, indicating that the binding is an 
exothennic process (Figure 3.5). Because albumin can bind ligand at multiple 
binding sites, we fit the data for two sites by the sequential binding model. The values 
of binding constant obtained are of the order of 10"* and 10^  and thus can be referred as 
high and low affinity sites, respectively, at each studied temperature. However, the 
binding constants for both types of binding sites decrease with an increase in 
temperature, indicafing the formation of FUR-HSA complex. Besides, it is observed 
that at both sites of HSA, a strong dependence of AH" and TAS" exists with 
temperature whereas AG° was insensitive to it (Table 3.5). As evident from the value 
of AH" and AS", the binding become more exothennic with a rise in temperature, 
though it is entropically opposed. The negative AH" and AS" values at all studied 
temperatures suggest the involvement of hydrogen bonding in HSA-FUR complex 
formation [Chi and Liu, 2011]. Furthemiore, the plot between AH" vs TAS" at high 
and low affinity sites shows the slope of 1.02 and 0.99, respectively, which indicates 
the enthalpy-entropy compensation effect in which enthalpy gain due to the foiTnation 
of H-bond is counterbalanced by entropic penalty due to the burial of involved 
groups. This effect is common in protein-ligand interaction [Zolotnitsky et al., 2004]. 
Almost linear dependency of the AH with the temperature was observed in an 
examined range of temperature, whose slope was used to detennine the change in heat 
capacity (ACp). The values of ACp were -0.18±0.11 and -0.94±0.24 kcal mor'°C"' for 
high and low affinity sites, respectively. The negative value of ACp is suggestive of 
specific binding accompanied by the burial of nonpolar residues [Kumaran and Jez, 
2007]. The results of ITC were in agreement with that of fluorescence spectroscopy. 
However, variation in magnitude of binding affinity and thermodynamic parameters 
was observed, which may be due to the fact that the calorimetric analysis measures a 
global change in property of the system whereas spectroscopic analysis measures 
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local changes around the fluorophores/chromophores associated with the optical 
transition [Faergeman et al, 1996; Nada and Terazima, 2003]. 
Table 3.5. Thennodynamic parameters and association constant of FUR-HSA 
obtained by ITC. 
- : 
; 
High 
affinity 
site 
Low 
affinity 
site 
Temp 
(°C) ^ 
25 
30 
37 
25 
30 
37 
Kb • 
(M-") 
(8.24±0.45)xl0' 
(7.03±0.25)xl0^ 
(5.58±0.12)xlO^ 
(6.47±0.41)xl0^ 
(6.21±0.24)xl0^ 
(2.76±0.11)xl0^ 
AW 
(kcalmof') 
-12.61±0.29 
-14.74±0.24 
-14.91±0.15 
-12.37±0.55 
-14.34±0.42 
-23.40±0.72 
TAS '^ 
(kcal mol"') 
-5.91±0.02 
-8.03±0.04 
-8.18±0.07 
-7.18±0.05 
-9.09±0.04 
-18.52±0.03 
AG" •• . 
(kcal mol-') . 
-6.70 ±0.01 
-6.71 ± 0.02 
-6.73 ±0.01 
-5.19 ±0.02 
-5.25 ±0.03 
-4.88 ±0.01 
The binding stoichiometry obtained from spectroscopy and calorimetry was also 
different, which may be due to photophysical problem because of the presence of 
single Trp214 in HSA [Ahmad et al., 2011]. Further, using equation 3.15 and data 
presented in Table 3.5, it is observed that the values of calorimetric enthalpies do not 
agree well with the van't Hoff enthalpy calculated at all studied temperatures. It 
indicates linkage of contribution of displacement of solvent ions and conformational 
changes with the binding process, which may be induced either by ligand binding or 
by an increase in temperature [Faegerman et al., 1996]. This observation is further 
supported by non linear van't Hoff plot between temperature and InK, which is also 
an important indication of conformational alterations linked to the binding process. 
So, FTIR and far-UV CD measurements are perfonned to monitor the secondary 
structure alteration on FUR binding. 
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3.3.5. Circular dichroism measurements. To monitor the secondary structural 
change of protein upon interaction with FUR, we perfomi far UV circular dichroism. 
The results are expressed as MRE (mean residue ellipticity) in deg cm^ dmoF , which 
is given by 
.0ob,,(mdeg) 
MRE=-
lOxnxcx/ 
(3.16) 
where Bobs is the observed ellipticity in millidegrees, c is the concentration of protein 
in mol/L, 1 is the length of the light path in centimeters, and n is the number of peptide 
bonds. 
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Figure 3.6. Circular dichroism spectra of HSA (5 ^M) in the presence of FUR at ratios of 
(1)1:0, (2)1:1, and (3)1:2 at (A) 25°C, (B) 30°C, and (C) 37°C. 
Panels A-C of Figure 3.6 shows the far-UV CD spectra of HSA m the absence and 
presence of FUR at 25, 30, and 37°C, respectively. The far-UV CD spectra of HSA 
exhibit two negative bands at 208 and 222 nm, which is characteristic of the typical a-
helix structure of protein [Ahmad et al., 2006; Ahmad et al., 2011]. Furthennore, to 
investigate the change in percent a helical stracture of HSA on addition of FUR, we 
analyze CD data by the method of [Chen et al., 1972]: 
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%a-helix= 
MRE222nm-2,340 
30,300 
KlOO (3.17) 
The estimated percent a-helical content in free HSA is 55, 54, and 53 % at 25, 30, and 
37°C respectively, which is in reasonable accord with the available literature [Ahmad 
et al., 2006; Ahmad et al., 2011; Beauchemin et al., 2007]. The data compiled in the 
inset of Figure 3.6A-C indicate the slight decrease in a-helical content on addition of 
FUR in ratios of 1:1 and 1:2 (HSA:FUR) at all studied temperatures. The observed 
decrease in percent a-helical content might be induced by the formation of the FUR-
HSA complex. However, the shape of peaks and the position of peak maximum 
remain almost unchanged in the presence and absence of FUR, indicating that HSA is 
predominantly a-helix in nature even after binding to the drug. 
3.3.6. FTIR spectroscopic measurements. Band frequencies due to amide I, II, and 
III vibrations in the IR region are sensitive to the secondary structure of protein. 
Wavenumber (cm') 
Figure 3.7. The fitted amide I band of HSA-FUR complex at (A) 1:0, (B) 1:1 HSA to FUR 
ratio in 20 mM sodium phosphate, pH 7.4 in the region of 1700-1600 cm''. 
But, generally, amide 1 (1700-1600 cm ' ) is analyzed to investigate the change in 
secondary structure of protein as it reflects C=0 stretching vibration of the amide 
gi'oup weakly coupled with in plane NH bending and CN stretching [Tian et a l , 
2004]Figure 3.7A, B shows the fitted curve of HSA and HSA-FUR complex in a 
molar ratio of 1:1. The free HSA has 54% a-helix, 18% B-sheet, 4% B-antiparallel, 
11%) disordered, and 13%) turn, which is reasonable accord with the literature 
[Froehlich et al., 2009]. From Figure 3.7, it can be seen that there is not much 
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difference in the position of amide I components, but their intensities differ. So, from 
quantitative analysis of the amide I band, it was observed that amount of a-hehx 
decreases on HSA-FUR complex formation, which agrees with far-UV CD results. 
3.3.7, Effect of drug binding on esterase-lilce activity of HSA. The Arg410 and 
Tyr411 present in the center of drug binding site II of HSA are the two crucial amino 
acid residues involved in esterase-like activity [Watanabe et al., 2000]. Thus, esterase-
like activity of HSA using p-nitrophenyl acetate as the substrate is investigated in the 
presence and absence of FUR to know the involvement of Arg410 and Tyr411 in FUR 
binding. Kinetic constants are obtained using Graph-Pad Prism, version 5.0, software 
by fitting the initial rates to Michaelis-Menten equation: 
v= ^""^^^ (3.18) 
K,„+[S] 
where v, Vmax, Km, and [S] represent the initial reaction velocity, maximum velocity, 
Michaelis-Menten constant, and molar concentration of substrate, respectively. 
Further, Ki was calculated from equation. 
K' = ^ i +K (3.19) 
t 
where K^ ^^ , is the apparent Km in the presence of competitive inhibitor concentration 
lo. Figure 3.7 shows the Michaelis-Menten and double reciprocal plot in the absence 
and presence of different drug to HSA molar ratios. HSA acts as esterase toward p-
NPA and shows Km and Vmax equals 59.36 ]xM and 0.16 |iM s"' respectively (Table 
3.6), which remain similar even in the presence of a FUR to HSA ratio of 0.5. 
However, on a further increase in the ratio of FUR to HSA, there occurs inhibition of 
activity in a competitive manner with K; equal to 28.72 |j.M; i.e.. Km changes while 
Vmax remain nearly unaltered, as shown in Figure 3.8 and Table 3.6. Because FUR has 
drug site I as a high affinity site up to a FUR to HSA ratio of 0.5, the drug binds 
mainly to site I on HSA and thus no changes occur in Km,Vmax and kcai/K.^ ratio. But 
on a further increase in FUR concentration over HSA, the drug starts binding to its 
low affinity site, which has Arg410 and Tyr411 amino acid residues, and thus 
competitively inhibits esterase-like activity of HSA and hence a decrease in catalytic 
efficiency is observed. This confimis the involvement of these amino acids in FUR 
binding to HSA. 
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Figure 3.8. Plot between lA'^  and l/[Sj for esterase-like activity of HSA at varying molar 
ratio of HSA:FUR (inhibitor). The inset shows the MichaHes-Menten plot of HSA for p-
NPA under same condition. The effect of varying concentration of FUR on the apparent K^ 
for/7-NPA(S) was examined in 20 mM sodium phosphate, pH 7.4 at 25°C. HSA (15 \iM) and 
HSA:FUR ratios of 1:0, 1:1, 1:2, and 1:3 were used. 
Table 3.6. Kinetic parameters for the hydrolysis of/7-NPA by HSA in presence of 
FUR 
HSA: FUR 
1:0 
1:0.5 
1:1 
1:2 
1:3 
Km(^M) 
59.36 ±05.55 
60.12 ±05.52 
86.60 ±06.47 
120.40 ±09.42 
149.60 ±10.67 
V„,ax(^Ms-') 
0.16 ±0.01 
0.16 ±0.01 
0.16 ±0.02 
0.16 ±0.01 
0.16 ±0.02 
10^  xkcat/Km(^M-'s-') 
17.95 ±1.23 
17.73 ±0.55 
12.30 ±0.65 
08.85 ±1.11 
07.12 ±2.41 
3.3.8. Molecular docking studies of FUR-HSA interaction. The binding sites of 
FUR on HSA were located by using docking software GLIDE [Friesner et al., 2004]. 
Figure 3.9A, B and Table 3.7 represent the involvement of crucial amino acid residues 
in the binding of FUR to the two different sites on HSA. The residues that overlap 
with specific site markers of site I (i.e., PBZ, WAR) and site II (DIA) are also shown. 
According to the GLIDE score, the FUR fit most favorably in site I of HSA with 
GLIDE and X-score of-7.32 and -7.99 kcal mol"', respectively. 
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Figure 3.9. Cartoon representation of docked FUR (red) in site I (A) of HSA and new site 
near site II (B). Residue interacting with FUR only (blue), PBZ and DIA only (purple), and 
common to FUR, PBZ, or DIA (green) 
Figure 3.1 OB and Table 3.7 show that at site I, FUR hydrophobically interacts with 
Ala291, Leu238, Lysl95, TyrlSO, and Trp214 whereas 01 , 04, and Nl groups 
involved in hydrogen bonding with the NH2 group of Lysl99 of HSA with bond 
length of 3.10, 2.69, and 2.98 A, respectively. The two side chain NH2 groups of 
Arg222 also interact with 05 of FUR having hydrogen bond length of 2.85 and 2.66 
A. However, FUR also binds to a site that is in the vicinity of site II of HSA with 
GLIDE and X-score of-5.53 and -6.89 kcal moF', respectively. This site shares some 
of the amino acid residues of site II like Arg410, Lys414, Ser489, and Glu492. The 
NH2 group of the side chain of Arg410 and Lys414 and OH of carboxylate group of 
Glu492 of HSA interact with 01 , 05, and 02 of FUR with hydrogen bond lengths of 
3.24, 2.62, and 2.66 A, respectively. Moreover, FUR interacts hydrophobically with 
Lys413, Gln390, Leu394, Ala406, Val493, and others (Figure 3.10A). 
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B 
Figure 3.10. Lig plots of FUR with HSA at (C) new site and (D) site 1. 
Figure 3.11 A &B show the molecular surface representation of FUR in the binding 
pockets of HSA. Thus FUR has drug binding site 1 as the high affinity binding site 
whereas a new site that shares Arg410 and some other amino acid residues like 
Lys414 and Ser489 has site II as the low affinity binding site. Further, it is also 
established that FUR-HSA binding involves hydrogen bonding and hydrophobic 
interaction as the main binding forces. 
Figure 3.11.Molecular surface structure of HSA with FUR (red) at (A) new site (B) and site I. 
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3.3.9. Correlation between binding sites of FUR and uremic toxins. To account for 
the mechanisms that govern inhibition of FUR binding to HSA in uremia, we 
carefully examined the relationship between the FUR and the uremic toxin binding 
sites. From the above studies, it is found that the FUR primarily binds to site I of HSA 
while with relatively low affinity to a site having some crucial residues (Arg410, 
Lys414 and Ser489) of site II. However, available literature [Bowmer and Lindup, 
1982; Ikeda et al., 1984; Sakai et al., 1995] suggests that uremic toxins like IS, lAA, 
HA bind mainly to site II while CMPF binds to site I of HSA. Thus, these findings 
suggest that FUR competes directly with site I bound uremic toxins (CMPF) while 
indirectly competes with site II bound uremic toxins (lA, IS, HA) for some residue as 
shown in Figure 3.12. 
BloodI 
4 I I I \ 
I II 
Blooci 
High affinity site of 
FlIR 
II I 
• A t 
•^ ^ "^ ^ , Low affinity site of 
I I I - ' x ' " " - - - , FIR 
1 ^ II I 
Uremic condition 
FUR 
Site 1 bound Uremic toxins 
HSA 
Site 11 bound Uremic toxins 
Figure 3.12. Schematic representation of mechanism of FUR binding to HSA under normal 
and uremic condition. 
3.4. Conclusions 
In this study, the mechanism of impaired binding of FUR to HSA in uremia is 
uncovered by determining binding energetic and binding sites of FUR on HSA. 
Results indicated that the quenching mechanism of fluorescence of HSA by FUR is 
static procedure and their binding is spontaneous, enthalpically driven, entropically 
opposed process which involves both hydrogen bonding and hydrophobic interaction. 
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Moreover, FUR strongly binds to site I of HSA and with relatively low affinity to a 
site having some crucial amino acid residue like Arg410 and Lys414 and Ser489 of 
site II. Thus it directly competes with the site I bound uremic toxins (CMPF) and 
indirectly competes with site II bound uremic toxins (lA, IS, HA). Furthemiore, our 
study could also be helpful to explicate the reason behind impaired albumin binding 
of all those drugs which possess similar binding site. 
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Different modes of interaction of sodium dodecyl 
sulphate (SDS) to bovine serum fetuin at acidic and 
neutral pH: a mechanistic study 
4.1. Introduction 
Surfactants are amphiphilic molecules that preferentially absorbed at interfaces 
[Tanford, 1973]. They have wide range of applications from food industry to 
cosmetics and the drug industry [Moore et al., 2003; Rangel-Yagui et al, 2005]. They 
are regularly used in biochemical laboratories for membrane protein solubilization 
and crystallization [Keller et al., 2006; Prive, 2007]. Therefore, their effects on 
biological macromolecules, particularly on proteins are always the topic of utmost 
investigation. Among surfactants, sodium dodecyl sulphate (SDS) occupies a special 
place in regular laboratory due to its extensive use in protein purification and 
characterization [Tulumello et al., 2012; Wieprecht et al., 2001]. It is an anionic 
surfactant with a 12-carbon hydrophobic tail and a negatively charged sulfate 
hydrophilic head group. It is known to interact with globular proteins, and in general, 
causes denaturation almost 1000 times lower concentration that is generally needed 
for other chemical denaturants such as urea [Chamani et al., 2006; Lee et al., 2011; 
Moosavi-Movahedi et al., 2005; Nielsen et al., 2007]. Moreover, it also help in 
renaturation of proteins [Lanckriet and Middelberg, 2004; Moriyama et al, 2003]. 
The mode of SDS binding to proteins distinguished according to the concentration. At 
the sub-critical micellar concentratios (sub-CMC), SDS monomers bind to proteins by 
predominantly hydrophobic interactions causing unfolding of the tertiary structure, 
and at concentrations higher than CMC, the micelles nucleate on the hydrophobic 
patches of the protein chain driving it to expand [Bhuyan, 2010]. SDS also alter the 
activities of many proteins [Bhattachary.^  and Bhattacharyya, 2009]. Even though the 
classical binding characteristics of SDS-protein complexes [Chakraborty and Basak, 
2008; La Mesa, 2005; Moriyama et al., 2012; Naidu and Prabhu, 2011; Otzen, 2002; 
Tanford, 1968] and the binding phenomenon used in the commonly employed 
procedure of SDS-polyacrylamide gel electrophoresis (PAGE) have been established 
[Reynolds and Tanford, 1970], the mode of interaction of SDS with glycoproteins 
especially more negatively charged (sialic acid) is still not understood well. 
Furthemiore, SDS mimics the native hydrophobic milieu of the phospholipids bilayer 
Different modes of interaction of SDS to BSF at pH 2 and 7.4 Chapter 4 
in vivo and thus study of protein surfactant interaction serves as model for membrane 
proteins and lipids interaction [Gangabadage et al., 2008; Ulmer and Bax, 2005]. 
Increased knowledge in this area may play a role in understanding the membrane 
protein-lipid interaction and analysis of glycoprotein in SDS gel electrophoresis. 
Bovine serum fetuin (BSF) has frequently been used as model glycoprotein 
[Hermentin et al, 1996; Keimedy et al., 1993; Wang et al., 1998a; Wang et al., 1996] 
and so taken as model protein in present study. It contains six carbohydrate chains, 
three N-linked glycosylation sites and three 0-linked glycosylation sites, which 
comprise 24% of its total molecular weight (48,585) along with 8% sialic acid [Green 
et al, 1988]. It contains 341 amino acids and their sequence shows over 70% 
similarities to human a2-HS glycoprotein [Dziegielewska et al., 1990]. It is a member 
of the cystatin superfamily of cysteine protease inhibitors [Binkert et al., 1999; 
Galembeck and Cann, 1974]. 
Interaction of surfactants with proteins depends on the charge on the head group, 
length of the hydrophobic tail [Moriyama and Takeda, 2005]. Thus keeping in mind 
these criteria, the mode of interaction of SDS with a glycoprotein, bovine serum 
fetuin (BSF) is studied in sub- critical micellar concentration at pH above (pH 7.4) 
and below (pH 2) pi to know the effect of solution condition on mode of interaction of 
SDS to glycoprotein. The binding of SDS with BSF was studied by steady state, time 
resolved fluorescence spectroscopy and isothennal titration calorimetry (ITC) at sub-
micellar concentration (sub-CMC), as proteins interact differently with the 
monomeric and the micellar forms of surfactants [Otzen, 2002]. The changes in 
secondary stmctures were elucidated by far-UV circular dichroism. The Thioflavin-T 
(ThT) binding, turbidity measurements and transmission electron microscopy was 
used to analyze the nature of aggregates formed. To the best of our knowledge, such 
study 01 glycoprotein has been seldom reported in the literature. 
4.2. IMaterials and JVIethods 
4.2,1. Materials and sample preparation. Fetuin from fetal bovine semm (BSF) 
(F3004), sodium dodecyl sulphate (SDS) (L-3125), were procured from Sigma 
Aldrich. All other reagents and buffer components used were of analytical grade. The 
protein was dialyzed and its concentration was estimated spectrophotometerically 
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1 % 
using £"278 nm ='^ -^  [Murray et al., 1969]. SDS solutions were prepared by 
weight/volume (w/v) in 20 mM buffer of pH 2 (glycine-HCl buffer) and 7.4 (sodium 
phosphate buffer). The pH measurements were carried out on Mettler Toledo pH 
meter (Seven Easy S20-K) model using a Expert "Pro3 in 1" type electrode. 
4.2.2. Critical micellar concentration measurements (CMC). The CMC of SDS 
was detemiined at pH 2 and 7.4 by isothennal titration calorimetry (ITC). For CMC 
determination by ITC, concentrated surfactant solution of SDS micelle systems (40 
mM) were titrated into 20 mM buffer of pH 2 and 7.4 in a VP-ITC titration 
microcalorimeter (MicroCal Inc., Northampton, MA) at 25 °C. 
4.2.3. Molecular modeling and solvent accessible surface analysis. The protein 
molecule was modeled by Protein Homology/analogY Recognition Engine (Phyre2) 
[Kelley and Sternberg, 2009]. Phyre2 takes a sequence, builds a profile using PSI-
BLASTs, and automatically compares it to templates deposited in the structural 
classification of proteins database and PDB. The amino acid sequence of BSF was 
directly taken from the protein database having accession number CAA34596.1. The 
solvent accessible surface area was calculated by InterProSurf [Negi et al., 2007] and 
stmcture was visualized with Chimera 1.7 [Pettersen et al., 2004]. 
4.2.4. Turbidity measurements. Turbidity measurements of BSF (5 |iM ) in presence 
of SDS at sub-micellar concentrations in 20 mM buffer of pH 2 and 7.4 after the 
overnight incubation were taken. The measurements were carried out at 350 nm on 
Perkin Elmer Lambda 25 double beam spectrometer using sample cell of pathlength 
10mmat25°C. 
4.2.5. Steady state fluorescence spectroscopic measurements. The fluorescence 
measurements of BSF (5 jiM ) in presence of SDS at sub-micellar concentrations in 
20 mM buffer of pH 2 and 7.4 were taken after overnight incubation. All fluorescence 
measurements were done using Shimadzu 5301PC fluorescence spectrophotometer 
equipped with water circulator (Julabo Eyela) at 25°C. The excitation and emission 
slits were set at 5 nm for ThT and intrinsic fluorescence measurements. Samples were 
excited at 295 and 440 nm for intrinsic fluorescence and ThT measurements 
respectively. The emission spectra were recorded in the range of 300-500 nm for 
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intrinsic fluorescence and 450-600 nm for ThT measurements. A stock solution of 
ThT was prepared in distilled water and its concentration was detennined using molar 
extinction coefficient of 8M = 36,000 M''cm' at 412 nm[Biancalana and Koide, 2010]. 
ThT was added to protein samples in the molar ratio of 1:2. The intrinsic fluorescence 
was of BSF in presence of SDS (ImM) at different ionic strength (0-3.5 mM NaCl) at 
pH 7.4. 
4.2.6. Isothermal titration calorimetric measurements (ITC). The energetics of the 
binding of SDS to BSF at 25°C was measured using a VP-ITC titration 
microcalorimeter (MicroCal Inc., Northampton, MA). Prior to the titration 
experiment, all samples were degassed properly on a thennovac. The sample and 
reference cell of the calorimeter were loaded with protein solution (20 ^M) and 20 
mM sodium phosphate buffer (pH 7.4), respectively. Then multiple injections of 10 
)iL of SDS solution (17 mM) were made into the sample cell containing protein in 
absence and presence of 1, 2 mM NaCl. Each injection was made over 20 s with an 
interval of 180 s between successive injections. The reference power and stirring 
speed were set at 16 lical" and 307 rpm, respectively. Heats of dilution for protein 
and heat of micellization of SDS were subtracted from the integrated data before 
cui-ve fitting. The titration of SDS with BSF was also done with same methodology in 
presence of 1 and 2 mM NaCl. 
4.2.7. Circular dichroism spectroscopic measurements. To monitor the secondary 
structural changes of BSF (5 ^M ) in presence of SDS at sub-micellar concentrations 
in 20 mM buffer of pH 2 and 7.4 after the overnight incubation, CD spectra were 
collected in far (200-250 nm) in JASCO-J815 spectropolarimeter equipped with a 
Peltier-type temperature controller at 25°C with a cuvette 0.1 cm pathlength. The scan 
speed and a response time were set as 20 nm/min and 2 s respectively. The secondary 
structural changes of BSF in presence of SDS (ImM) at different ionic strength (0-3.5 
mM NaCl) at pH 7.4 were also observed. 
4.2.8.Time-resolved fluorescence measurements. Fluorescence lifetime 
measurements were performed using the time-coiTelated single photon counting 
(TCSPC) model 5000 U (Horiba Jobin Yvon) equipped with water circulator at 25°C. 
The BSF in presence of varying concentration of SDS (0-3,5 mM) after overnight 
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incubation were excited at 295 nm using a NanoLED pulsed laser. The instrument 
response function (IRF) was obtained using LudoxTM suspension. The full width at 
half-maxima (fwhm) of the IRF was 750 ps. The emission decay data at 340 nm were 
analyzed using the software, DAS6, provided with the instrument. 
4.2.9. Transmission electron microscopic measurements (TEM). Transmission 
electron micrographs of BSF in presence 0.75 mM SDS in 20 mM buffer of pH 2 and 
7.4 were on transmission electron microscope operating at an accelerating voltage of 
120kV.The samples were diluted appropriately and applied to Fomiavar/carboncoated 
grids (300-mesh), blotted and air dried. The samples were then negatively stained 
with 2% (w/v) uranyl acetate prior to imaging. 
4.2.10. Statistical analysis 
All detenninations were triplicates, and mean values and standard deviations were 
calculated, wherever applicable, using SPSS 16.0 programme for windows. 
4.3. Results and Discussion 
4.3.1. Critical micelle concentration determination (CMC). To understand the 
mode of interaction of monomeric SDS to BSF, it is necessary to determine CMC 
value as proteins interact differently with the monomeric and the micellar fonns of 
SDS [Otzen, 2002]. The CMC can be determined in a single titration experiment by 
ITC. To illustrate this, concentrated surfactant solution of SDS micelle systems were 
titrated into 20 mM buffer of pH 2 and 7.4. At concentrations below the CMC the 
reaction is 
micelles -^ monomers, (4.1) 
and at concentrations above the CMC, the reaction is 
concentrated micelles -^ dilute micelles (4.2) 
At 25°C, titration of concentrated SDS into water elicits a titration profile with 
endothemiic peaks (Figure 4.1 A & B). The endothemiic peaks represent the 
dispersion of the concentrated micelle solution (demicellization) upon titration into 
buffer [Liu and Guo, 2007]. 
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Figure 4.1. Determination of critical micellar concentration (CMC) of SDS by 
isothermal titration calorimetry (A) at pH 7.4 (B) 2. Upper panel in each figure represents 
integrated heat per injection, normalized with respect to the injected number of moles of SDS 
(0-7 mM). Bottom panel represents first derivative of the above transition curve. 
As the surfactant concentration increases, the process of demicellization comes to a 
halt and the reaction enthalpy approaches zero. Since CMC is not seen as a sharp 
'phase boundary' but is defined as the midpoint of a rather broad transition range 
[Garavito and Ferguson-Miller, 2001]. Therefore, a more precise quantitation of the 
midpoint and the width of the micellization process, it is advantageous to plot the first 
derivative of the AH vs [SDS] curve [Heerklotz and Seelig, 2000] as shown in bottom 
panel of Figure 4.1 A & B. Thus, the CMC value of SDS in pH 2 and 7.4 
coiTesponding to the midpoint of inflection was found to be 2.16 and 3.10 mM that 
agrees well as reported earlier [Liu and Guo, 2007; Naidu and Prabhu, 2011]. 
4.3.2. Molecular Modeling. Although BSF has frequently been used as model 
glycoprotein [Hermentin et al., 1996; Kennedy et al., 1993; Wang et al., 1998a; Wang 
et al., 1996] but its crystal stmcture is not yet explored. However, it is well 
established that it contains 341 amino acid residues and has a single tryptophan at 
posifion 51 [Wang et al., 1998a]. Furthermore, it shows high sequence homology to 
the members of cystatin family [Dziegielewska et al., 1990]. Thus, to get an idea 
about the molecular structure and location of tryptophan (Trp), BSF is modeled by the 
Protein Homology/analogY Recognition Engine (Phyre2) and visualized by 
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Chimeral.7 as shown in Figure 4.2A & B. Figure 4.2A, clearly shows that the 
tryptophan (Trp 51) is located on outer region as for the monellin, another member of 
cystatin family and thus it may show similar characterstic features in solution. Figure 
4.2B shows the molecular surface of BSF colored by amino acid hydrophobicity 
according to Kyte and Doolittle scale [Kyte and Doolittle, 1982]. The most 
hydrophilic amino acid represented by blue then white and the most hydrophobic by 
orange red. Furthermore to get an idea of surface occupied by nonpolar amino acid 
residues, solvent accessible surface area was calculated from InterProSurf [Negi et al., 
2007]. It was found that out of total solvent accessible surface area of 19649 A ,^ non-
polar amino acid residues occupy maximal area (12895 A^). Thus it can be said that 
hydrophobic regions were distributed all over the protein molecule. 
Figure 4.2. Molecular structure of BSF as obtained from molecular modeling by Pliyre2. 
(A) The molecular structure of BSF showing its secondary structure. (B) molecular surface of 
BSF colored by amino acid hydrophobicity according to Kyte and Doolittle scale [Kyte and 
Doolittle, 1982]. The most hydrophobic by orange red, most hydrophilic by blue. 
Sub-micellar concentrations of SDS induce aggregation in BSF at pH 
2. 
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4.3.3. Turbidity measurements. Turbidity of samples at a non-absorbing wavelength 
can be used to rapidly detect insoluble protein aggregates [Pellaud et al., 1999]. Thus 
optical density at 350 nm (OD350) of BSF in presence of sub-micellar concentrations 
of SDS in buffer of pH 2 (pH below pi) and 7.4 (pH above pi) was taken and 
summarized in Figure 4.3. It was observed that the solution of BSF in presente of 
sub-micellar SDS concentrations have significant values of OD350 for pH 2 whereas it 
was insignificant for pH 7.4. 
SDS (mM) 
Figure 4J. Turbidity profile of BSF in varying concentration of SDS (0-2 mM) at pH 2 and 
7.4. 
Furthermore it was observed that at pH 2, the turbidity increases in presence of SDS < 
0.75 mM. It may be due to aggregation of BSF on interaction with SDS. However, 
there are two possible scenario of SDS interaction to BSF at pH 2. Firstly, at pH 
below isoelectric point, protein carries a net positive charge, so when anionic SDS 
interacts with protein, charge neutralization occurs and a point is reached where the 
net charge on protein in presence of SDS becomes zero and that leads to aggregation 
of protein. However, the net charge becomes zero only in presence of a specific 
concentration of SDS, below and above of that, protein-SDS complex has either net 
positive or negative charge. Therefore, SDS causes aggregation of BSF only at 
specific concentration of SDS which is not the case in present study. Secondly, when 
SDS interacts with BSF through its negatively charged head groups then the 
hydrophobic tails of SDS on protein-SDS complex become free, that increases surface 
hydrophobicity of protein-SDS complex. As a resuh, the protein-SDS complex 
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interacts with each other, not the water, and cause protein to undergo aggregation. The 
formation of aggregates, however, decreases in presence of SDS above 0.75 mM due 
to repulsion between the protein-SDS complexes having excess net negative charge 
acquired as a result of interaction with more SDS. However, since the turbidity of 
BSF at pH 2 in presence of SDS was observed for a range of of 0-2 mM SDS. thus the 
second scenario is most fitted for the studied condition. Aggregation of the protein-
SDS complex at pH values below the isoelectric point at low surfactant concentration 
is common and has been reported for the lysozyme-SDS system [Hung et al., 2010] 
as well as for the bovine serum aibumin-SDS system [Santos et al., 2003]. However, 
to detect the nature of aggregates formed in presence of sub-micellar concentration of 
SDS at pH 2, ThT and CD measurements were performed. 
4.3.4. Circular dichroism measurements. Circular dichroism spectroscopy was used 
to analyze the protein secondary structures in solution. Figure 4.4A shows the far-UV 
CD spectra of BSF in sub-micellar concentrations of SDS at pH 2. The spectra of BSF 
at pH 2 in absence of SDS, has a minimum at 208 nm and a small shoulder at 220 irai. 
The essentially small minimum at 222 nm suggests that the protein has low a-helical 
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Figure 4.4.Secondary structural changes in presence of SDS by far-UV CD at pH 2. (A) 
far-UV CD spectra of BSF in presence of SDS {0-2mM) (B) percent secondary structure 
content of BSF in presence of SDS (0-2mM). 
The secondary structural contents of BSF in presence of varying concentration of SDS 
at pH 2 were obtained by K2D3 software [Louis-Jeune et al., 2012] and summarized 
in Table 4.1 and shown in Figure 4.4B. It was observed that on increasing 
concentration of SDS, transition from a-helix to P-sheet occurs with peak at 218 nm 
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which may be attributed to the formation of amyloid fibrils. Furthermore, the pattern 
of increment of P-sheet content as mentioned in Table 4.1 was same as observed for 
turbidity measurements. However, to confirm the formation of amyloid fibrils in 
presence of SDS at pH 2, ThT measurements were performed. 
Table 4.1. The percent secondary structure content of BSF in presence of SDS (0-
2mM) at pH 2 as obtained by K2D3 software of secondary structure analysis. 
SDS (mM) % a-helix % p-sheet 
0 
0.25 
0.5 
0.75 
1 
1.5 
2 
6.45 
5.53 
5.28 
3.61 
4.18 
4.63 
6.08 
34.51 
38.58 
42.35 
43.59 
43.26 
41.99 
35.78 
4.3.5. Thioflavin-T binding measurements. A standard fluorescent dye, ThT, which 
experiences a marked enhancement in its fluorescence intensity upon binding to 
amyloid structures, was introduced as a regular characteristic molecular probe to 
detect the formation of amyloid fibrils [Biancalana and Koide, 2010]. 
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Figure 4.5. Effect of SDS (0-2 mM) on ThT fluorescence. (A) ThT fluorescence spectra of 
BSF and (B) ThT fluorescence intensity profile (at 484 nm) of BSF in presence of 0-2 mM 
SDS at pH 2. 
ThT has a low fluorescence quantum yield in solution which increases considerably 
when bound to amyloid fibrils, displaying its high propensity to interact with amyloid 
fibrils [Morshedi et al., 2007]. Figure 4.5A & B show ThT fluorescence spectra of 
BSF and the change in ThT fluorescence intensity at 484 nm in presence of SDS (0-2 
mM) at pH 2. As shown in figure, BSF has negligible ThT fluorescence intensity in 
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absence of SDS (Figure 4.5A). But, on addition of SDS, an increase in ThT 
fluorescence intensity occurs till 0.75 mM. It may be due to the fact that at pH 2, 
protein exists in partial unfolded fonn with exposed hydrophobic patches and 
positively charge residues [Naseem et al., 2003]. These charged residues exert the 
electrostatic repulsion between protein molecules and so prevents aggregation. But 
when SDS interacts with BSF through its negatively charged head groups then the 
hydrophobic tails of SDS on protein-SDS complex become free, that increases surface 
hydrophobicity of protein-SDS complex. As a result, the protein-SDS complex 
interacts with each other, not the water, and cause protein to undergo aggregation as 
indicated by increase in ThT fluorescence intensity. The formation of aggregates, 
however, decreases in presence of SDS above 0.75 mM due to repulsion between the 
protein-SDS complexes having excess net negative charge acquired as a result of 
interaction with more SDS and thus decreases in ThT fluorescence intensity at higher 
sub-micellar SDS concentration. 
4.3.6. Transmission electron microscopic measurements (TEM). In parallel to 
spectroscopic measurements, aggregates of BSF in presence of SDS at pH 2 were 
clearly visible in transmission electron microscopic images however, no such 
structure were observed at pH 7.4 as shown in Figure 4.6A & B. The similar 
aggregates were also reported in lysozyme [Hung et al, 2010], bovine serum albumin 
[Santos et al, 2003] in presence of SDS at low pH. 
A J B 
Figure 4.6.TEM images of BSF m presence of 0.75 mM SDS (A) at pH 2 and (B) at 
pH 7.4. 
In sub-micellar concentration, SDS binds to BSF at pH 7.4. 
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4.3,7, Isothermal titration calorimetric measurements (ITC). The binding affinity 
and binding energetics of SDS to BSF were measured using ITC. Figure 4.7 shows 
the ITC binding isotherms of SDS to BSF in different ionic strength at 25°C in which 
each peak in top panel represents a single injection of the SDS into protein solution. 
Bottom panel of each figure shows an integrated plot of the amount of heat liberated 
per injection as a function of the molar ratio of the SDS to protein. As shown in 
Figure 4.7A, the complete titration profile can be divided into three characteristic 
regions: (A) at low SDS concentrations starting nearly at 0.22 mM, a small 
endothermic heat flow is observed with a inclination toward exothermic effects, 
followed by (B) a significant shift in heat flow from the endothennic to exothermic, 
(C) the exothermic heat flow then levels out at an intermediate concentration range of 
molar ratio 93 (approximately 1.86 mM SDS), and this ends with an upward bend. At 
still higher concentrations of SDS, the endothermic contribution increases, and the 
inflection point signifies that there is a reduction in the protein-surfactant interactions. 
These profiles are best fitted for the integrated heats having lowest % using a two 
independent binding site model with each site binding to more than one molecule of 
SDS. The binding parameters of SDS with BSF at different ionic strength obtained 
after fitting are summarized in Table 4.2. Results shows that the SDS binds to BSF at 
two sites, one with high affinity (Ki~ 10^ ) whereas to other with low affinity (Ki~ 
10"). More SDS molecules interacts with lower affinity binding sites whereas lesser 
with higher affinity sites of BSF. Furthermore, from the themiodynamic parameters, 
enthalpy changes (AH°) and entropy changes (AS"), the forces involved in binding of 
SDS to proteins can be predicted [Ross and Subramanian, 1981]. It can be seen from 
Table 4.2, values of AH" and AS" were zero/slight negafive and positive respectively 
at both sites. The positive AS" indicates disruption of the hydrogen bonding network 
between water molecules. The hydrogen bonds are reoriented tangentially to non 
polar surface to minimize disruption of the hydrogen bonded 3D network of water 
molecules and thus leads to a structured water "cage" around the nonpolar surface. 
Thus, a positive entropic effect originating from the hydrophobic interaction that 
results in disruption of highly dynamic hydrogen bonds between molecules of water 
by the non polar solute [Singh and Kishore, 2006]. 
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Table 4.2. Thermodynamic parameters obtained by isothermal titration calorimetric 
measurements of BSF with SDS. 
N, 
Ki(M-') 
AHi^Ckcalmof') 
TASi^fkcalmol"') 
AG|"(kcalmor') 
N2 
K2 
AH2" (kcal mol"') 
TAS2° (kcal mol"') 
AG2° (kcal mol'') 
BSF 
55.0± 1.01 
(2.01 ± 1.65) X 
0.04 ±0.01 
7.20 
-7.16 
103 ±1.72 
(9.13 ± 0.36) X 
-0.63 ± 0.01 
5.30 
-5.93 
10^  
10^  
BSF 
(1 m.M NaCI) 
56.8 ± 1.21 
(2.02 ± 0.63) X 10^  
0.07 ±0.01 
7.30 
-7.23 
103 ±2.84 
(9.20 ± 1.07) X 10^  
-0.62 ± 0.03 
5.56 
-6.18 
BSF 
(2 niM NaCI) 
56.50± 0.89 
(2.93 ± 0.82) X 10^  
0.03 ± 0.01 
7.47 
-7.44 
104 ±2.07 
(9.83 ± 1.65) X 10^  
-0.64 ± 0.01 
5.82 
-6.46 
Thus it can be said that, at the sub-CMC concentrations, SDS monomers bind to 
proteins predominantly by hydrophobic interactions via hydrophobic tails. Further, 
the values of AG" were negative and mainly obtained by the entropic components, so 
the interactions of SDS to BSF were spontaneous. Further, to rule out the role of 
electrostatic interaction, the effect of ionic strength on binding of SDS to BSF was 
studied by perfonning titration of SDS to BSF in presence of 1, 2 mM NaCI at pH 7.4 
and 25"C. The binding profiles are shown in Figure 4.7(A- C) and data summarized in 
Table 4.2. As shown, the value of the binding constants for low and high affinity sites 
increases with the rise in the ionic strength which indicates the affinity sites increases 
with increase in ionic strength. This behavior indicates SDS binding to BSF donot 
involves electrostatic interaction in which case the binding affinity is expected to 
decrease with an increase in the ionic strength since the ions of NaCI also competes 
for binding to protein. The results that SDS interacfion with BSF are hydrophobic in 
nature draws further support from the fact that at neutral pH, BSF are negatively 
charged (pl~5) and thus have lesser chances of interaction with negatively charged 
head group of SDS via electrostatic interaction. These types of findings were also 
observed by [Bhuyan, 2010]. 
4.3.8. Intrinsic fluorescence spectroscopic measurements. Fluorescence 
spectroscopy is widely employed to study proteins and peptides conformation [Zaidi 
et al., 2013b]. Among three aromatic amino acids Trp, Tyr and Phe, Trp has highest 
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fluorescence yield which is influenced by the microenvironment due to presence of 
indole group [Liu and Guo, 2007]. Thus to get the information on the effect of SDS 
on BSF, Trp was excited and fluorescence intensities were taken at 340 ran. 
Furthermore, the changes in the wavelength of the emission maximum (^ax), a 
parameter sensitive to protein conformation, were also taken in consideration for 
analysis since the ?in,ax depends on the environment of the tryptophanyl residues 
[Naeem and Khan, 2004]. BSF has a single Trp at position 51 [Wang et al., 1998a], 
located on outer region as evident from molecular modeling results. 
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Figure 4.8. Steady state fluorescence results of BSF in presence of SDS (0-3.5 mM). (A) 
fluorescence spectra of BSF in presence of SDS (0-3.5 mM) (B) changes in emission 
maximum of BSF in presence of SDS (0-3.5 mM) (C) fluorescence intensity profile of BSF in 
presence of SDS (0-3.5 mM) (D) fluorescence intensity profile of BSF in presence of SDS 
ImM at different ionic strength (0-3.5 mM). 
The fluorescence emission spectra, changes in the wavelength of the emission 
maximum and fluorescence intensity at 340 nm of BSF in presence of SDS (0-3.5 
mM) were shown in Figure 4.8 A, B & C respectively. As shown, on increasing SDS 
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concentration, there occurs sharp decrease in fluorescence intensity up to ImM, 
followed by gradual decrease till 2 mM and beyond which almost no change was 
observed. Furtheraiore, decrease in fluorescence intensities was accompanied by 
concomitant blue shifts of 5 in }^ ,nax. It is noticeable that the changes in X^ax also show 
same pattern as that of fluorescence intensities upon increasing SDS concentration. 
The observed decrease in fluorescence intensities might be due to the interaction of 
SDS to Trp51 whereas blue shift in iVmax occurs as a result of the non-polar 
environment around Trp that may be generated due to alkyl chain of SDS molecules 
as suggested by ITC results also. However to confirm that the SDS molecules at pH 
7.4 in sub-micellar concentration interact via alkyl chain and not by charged head 
group, the effect of ionic strength on binding of SDS (1 mM) to BSF was studied at 0-
3.5 mM NaCl at pH 7.4 and results are shown in Figure 4.8D. On increasing ionic 
strength, fluorescence intensity donot show any demarcated changes and thus it 
confirms that the SDS donot interact via electrostatic interaction and thus 
hydrophobic interacfion are the leading forces. The hydrophobic environment 
generated around Trp 51 may induce secondary structural changes in BSF as reported 
earlier for other protein system [Blondelle et al., 1995; Chakraborty and Basak, 2008; 
Hugonin et al., 2008; Roman et al, 2010; Wieprecht et al., 2001]. Thus far-UV 
circular dichroism measurements were perfonned to know the secondary structural 
changes of BSF in presence of SDS (0-3.5 mM). 
4.3,9. Far-UV circular dichroism measurements. The SDS-induced secondary 
structural changes of BSF were illustrated by far-UV CD. Figure 4.9A shows the CD 
spectra of BSF in presence of different concentration of SDS (0-3.5 mM). To monitor 
the secondary structural change of protein upon interaction with SDS, results are 
expressed as MRE (mean residue ellipticity) in deg cm" dmoF , which is given by 
M R E . 0 * > M (4.3) 
10 X n X c X / 
where Gobs is the observed ellipticity in millidegrees, c is the concentration of protein 
in mol/L, 1 is the length of the light path in centimeters, and n is the number of peptide 
bonds. Further, percent secondary structural content in presence of varying 
concentration of SDS were calculated by K2D3. As shown in Figure 4.9A, on 
increasing the SDS concentration, the minima at 208 and 222 mn of BSF deepens. 
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Further from Figure 4.9B, percent helical content increases with increasing SDS 
concentration. The a-helix and p-sheet contents of BSF were found to be 10 and 34% 
respectively. 
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Figure 4.9. Secondary' structural changes in presence of SDS by far-UV CD. (A) far-UV 
CD spectra of BSF (B) percent helical content of BSF in presence of SDS (0-3.5 mM) (C) 
percent helical content of BSF in presence of ImM SDS at varying ionic strength (0-3.5 mM 
NaCl). 
When SDS was added, there occurs sharp increase in percent a-helical content with 
concomitant loss in P-sheet contents up to ImM, followed by gradual increase till 2 
mM and beyond which almost no change was observed. The pattern observed in 
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increment of percent helical content has direct correlation with the steady state 
fluorescence results. Thus it can be said that the interaction of alkyl chain of SDS 
around TrpSl generates hydrophobic environment that may cause induction of 
secondary structural changes as reported earlier for other protein system [Blondelle et 
al., 1995; Chakraborty and Basak, 2008; Hugonin et al., 2008; Roman et al., 2010; 
Wieprecht et al, 2001]. Further from Figure 4.9C, it is clear that the a-helical content 
of BSF in presence of 1 mM SDS donot vary at different ionic strength. It indicates 
that NaCl (0-0.35 mM) donot perturb the secondary structure of protein under studied 
condition, which is necessary prerequisite for detennining the type of interaction by 
studying the effect of ionic strength. 
4.3.10. Time-resolved fluorescence spectroscopic measurements. To understand the 
interaction between SDS and protein, the local environment around fluorophore (Trp) 
can be explored by measurement of fluorescence lifetime [Anand et al, 2010]. It is 
observed that at neutral pH in aqueous solution, Trp exhibits multiple exponential 
decay which has been attributed to the existence of confomiers (conformational 
isomers) in determining lifetimes [Lakowicz, 2006]. The time-resolved decay profiles 
of BSF at submicellar concentrations of SDS with bi-exponential fitting are shown in 
Figure 4.10A & B. All the experimental decay curves are well fitted as evidenced by 
the statistical parameters like chi-square (yj) which was close to 1 and distribution of 
weighted residuals. When using the bi-exponential decay law it is often useful to 
determine the average lifetime (Xavg) which is given by [Kelkar et al, 2005; Zaidi et 
al., 2013a] 
T = a fT ^ +a-,T ^ (4.5) 
The decay parameters obtained are summarized in Table 4.3. BSF has Trp51 in polar 
and non-constrained environment in absence of SDS as evident from the low a-helical 
content and molecular modeling results, so fluorescence lifetime value is 3.97 ns. This 
value is near to the fluorescence lifetime of a member from the same cystatin family, 
monellin, that also possess Tip exposed to the solvent environment [Peon et al., 
2002]. As can be seen from Figure 4.10B and Table 4.3, the average fluorescence 
lifetime first decrease till 2.5 mM and beyond which almost no change is observed. 
The decrease in fluorescence lifetime may be due to the transition among Trp 
conformers as well as charge transfer process from indole ring of Trp51 to nearby 
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substituent which enhanced on binding with SDS. Thus to understand contribution of 
individual lifetime in multiexponential decay, an effort has been made by observing 
the relative amplitudes of lifetime. It is believed that Trp has three conformers, A, B 
and C [Lakowicz, 2006]. 
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Figure 4.10. Time-resolved fluorescence decay profile of (A) BSF and (B) average 
fluorescence lifetime as a function of SDS. IRF indicates the instrument response function. 
Out of these, conformer C is rather stable and conversion from C to either A or B is 
difficult on a nanosecond time scale. Because Trp exhibits multiexponential decays in 
aqueous solutions, the faster component can be attributed to conversion of rapidly 
interconverting A and B conformers into conformer C whereas the longer lifetime 
mainly arises due to the conversion of conformer C into rapidly interconverting A and 
B conformers [Alcala et al., 1987]. As evident from the relative amplitude values 
from Table 4.3, the contribution from relatively stable conformer C, (shorter lifetime) 
and rapidly interconverting conformer A and B, (longer lifetime) of BSF are 27.16, 
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72.84% respectively. But due to increase in secondary structural content on increasing 
SDS concentrations to 2.5 mM, Trp51 experiences non polar constrained 
environment. As a consequence, the conversion from conformers C to A/B decreases 
that increase the relative amplitude of the shorter lifetime. Furthennore, beyond 2.5 
mM, not much change in secondary structure was observed, thus no change is seen in 
relative amplitude. Thus the change in secondary structure may be associated with the 
transition among Trp conformers. Furthermore, a small contribution of dynamic 
quenching cannot be neglected in decrement of fluorescence lifetime in presence of 
SDS. 
Table 4.3. Time resolved fluorescence decay parameters of BSF in presence of SDS. 
SDS (mM) 
0 
0.5 
1 
1.5 
2 
2.5 
3 
3.5 
a, 
27.16 
30.21 
40.10 
40.72 
43.18 
43.91 
43.97 
45.22 
r,(ns) 
1.48 
1.46 
1.36 
1.26 
1.20 
1.14 
1.14 
1.14 
a^ 
72.84 
69.79 
59.90 
59.28 
56.82 
56.09 
56.03 
54.78 
r , (ns) 
4.91 
4.88 
4.86 
4.64 
4.61 
4.38 
4.27 
4.31 
r (ns) 
3.97 
3.84 
3.45 
3.26 
3.13 
2.95 
2.89 
2.87 
4.4. Conclusions 
The mode of interaction of anionic detergent, SDS with BSF in sub- critical micellar 
concentration is different at pH above (pH 7.4) and below (pH 2) pi and is shown in 
Figure 4.11. At pH 2, SDS interacts with BSF through its negatively charged head 
groups and thus the hydrophobic tails of SDS on protein-SDS complex become free, 
that increases surface hydrophobicity of protein-SDS complex. As a result, the 
protein-SDS complex interacts with each other, not the water, and cause protein to 
undergo aggregation. The nature of aggregates is amyloid due to enhance ThT 
binding and B-sheet fonnation. The formation of amyloid fibrils, however, decreases 
in presence of SDS above certain concentration (0.75 mM) due to repulsion between 
the protein-SDS complexes having excess net negative charge acquired as a result of 
interaction with more SDS. However, at pH 7.4, SDS interacts with BSF at two sites, 
high affinity (Kn 10') and low affinity (K|~ lO^. Bindmg of SDS to BSF occurs 
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with the positive AS° that indicates disruption of the hydrogen bonding network 
between water molecules. The hydrogen bonds are reoriented tangentially to non 
polar surface to minimize disruption of the hydrogen bonded 3D network of water 
molecules and thus leads to a structured water "cage" around the nonpolar surface. 
Thus, a positive entropic effect is originating from the hydrophobic interaction that 
results in disruption of highly dynamic hydrogen bonds between molecules of water 
by the SDS molecules. Moreover, due to hydrophobic environment generated by alkyl 
chain of SDS molecules around tryptophan, induction of a-helical structure in BSF 
occurs. This increase in a-helical content on increasing SDS concentrations constrain 
environment around tryptophan. As a consequence, the interconversion of confonners 
decreases and resulted in decrement of fluorescence lifetime for BSF. These findings 
demonstrate that the mode of interaction of SDS to protein is different under different 
solution condition. 
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Figure 4.11.Mode of interaction of SDS with BSF at pH 2 and 7.4. 
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N-Acetylneuraminic acid inhibits heat-induced 
amyloid fibrillization of hen egg white lysozyme: a 
plausible rescue from amyloid based 
neurodegenerative disorders 
5.1. Introduction 
A number of neurodegenerative disorders, including Parkinson's, Alzheimer's, and 
prion diseases are linked to protein misfolding and aggregation [Safar and Prusiner, 
1998; Sipe, 1992]. There is a range of globular proteins [Chiti and Dobson, 2009] and 
in particular amyloid B (AB) peptide, microtubule-associated protein tau and a-
synuclein (aS), that underwent structural transformations from native functional forni 
into fibrillar assemblies [Uversky and Fink, 2004]. The emergent class of protein 
misfolding diseases paves a way for development of therapeutic molecules. Though a 
large number of small molecules including polyphenols [Porat et al., 2006], glycol-
acridines [Vuong et al., 2013], osmolytes [Kar and Kishore, 2007] have been shown 
to inhibit fibril fomiation but presently, there is no approved therapeutic agent exists 
that blocks the fomiation of amyloid stmctures. There are many reasons that affect the 
development of protein aggregation inhibitors including the specificity of inhibitor 
that limits its use for specific type of protein misfolding disease [Lendel et al, 2009], 
inability to cross blood brain barrier, elevation of immunological response and 
unstability in biological fluids and tissues. Thus a potential inhibitor should overcome 
all these problems and affect one or more of the steps involved in the course of 
amyloid formation that includes destabilization of the native state, nucleation, 
elongation and lateral accumulation of fibrils [Morshedi et al, 2007]. Thus keeping in 
mind all these criteria, extensive research is going on the determination of sugars 
effect on the amyloid formation in biologically safe concentrations. Generally sugars 
are believed to stabilize the native state of proteins [James and McManus, 2012] and 
are part of our biological system. It has also been reported that glucose utilization 
declines in the brain of Alzheimer's patients. Thus impaimient of brain glucose 
metabolism might be a cause of Alzheimer's disease [Chen and Zhong, 2013]. 
Another sugar molecule, trehalose also receives special interest because of its 
effectiveness in the treatment of neurodegenerative diseases associated with peptide 
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or protein aggregation [Liu et al., 2009; Perucho et al., 2012]. These studies direct our 
attention towards a sugar molecule which is associated to brain i.e. n-
acetylneuraminic acid (NeuSAc). It is a nine-carbon, non reducing, acidic, 
monosaccharide that occur naturally at the end of sugar chains attached to the surfaces 
of cells and soluble proteins and is found in human body, hi the human body, the 
highest concentration of Neu5Ac occurs in the brain where it participates as an 
integral part of ganglioside structure in synaptogenesis and neural transmission. The 
majority is present in gangliosides (65%), glycoproteins (32%) whereas only 3%> is 
free. It is also find in body fluids like cerebrospinal fluid, saliva, urine, tears and 
human milk. Moreover, NeuSAc has potential to act as antimicrobial agent and is also 
associated with brain development and memory [Wang and Brand-Miller, 2003]. The 
fact that emphasizes the association of Neu5Ac to brain and memory development is 
the benefit of human milk in the brain development. In human milk, 70% NeuSAc is 
found attached to the terminal end of free oligosaccharides which get hydrolysed in 
the intestine by sialidase and free NeuSAc is released. The concentrafion of NeuSAc 
in human milk was found to be around 3.S6 mM; however it may vary with various 
lactational intervals [Carlson 198S]. In recent studies it is observed that in 
Alzheimer's patients, ganglioside NeuSAc content in cerebral cortex was decreased 
and thus may be associated with the neurodegenerative disorders. Since it is a part of 
physiological system, so it is able to cross blood brain barrier, immunologically non-
responsive and remain stabile in biological fluids and fissues. Thus NeuSAc is 
consequently compound of phamiacological interest and hence its inhibition potency 
against amyloid fibril fonnation of model protein, hen egg-white lysozyme (HEWL) 
is examined in present study. HEWL is an excellent experimental system to study the 
protein amyloid fibrillizafion because of high homology to human lysozyme in 
structure which is one of the proteins that cause an amyloid disease upon mutafion 
[Booth et al., 1997; Uversky, 2007]. Thus in this study, the kinetics of heat induced 
amyloid formation in HEWL and then its attenuation by NeuSAc by using various 
spectroscopic, microscopic and calorimetric techniques was investigated. The 
mechanism of inhibition of heat induced amyloid fonnation in HEWL by NeuSAc 
was also detennined. 
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5.2. Materials and methods 
5.2.1. Materials. Hen egg-white lysozyme, HEWL (L6876), N-acetyl neuraminic 
acid, NeuSAc (A0812), thioflavin-T, and l-anilino-8-naphthalene sulfonic acids, 
ANS, were obtained fom Sigma Aldrich. All other reagents were of anal)/tical grade. 
HEWL was dialyzed and its concentration was estimated spectrophotometerically 
using E2S0 „,n= 26.4 [Williams et al, 1965]. NeuSAc solution was prepared in 20 mM 
sodium phosphate buffer (pH 7.4) by weight/volume (w/v). ThT and ANS solutions 
were prepared using .£'412 „^= 36,000 M"'cm'' [Groenning, 2010] and using E '°'^ ° 350 nm 
5000 M''cm"' [Qadeer et al, 2012] respectively. 
5.2.2. Samples preparation. HEWL was dissolved to a final concentrafion of 10 \iM 
in 20 mM sodium phosphate buffer (pH 7.4) in absence and presence of different 
concentrations of NeuSAc (0-8 mM) for 7 days at 6S°C under constant sfirring. 
Aliquots were taken from each set after regular intervals for analysis. It should be 
noted that the NeuSAc is a non reducing sugar and thus it remain stable in solution 
over extended time periods and no "browning" of the solution was observed even 
after heating over 168 hours at studied concentration. 
5.2.3. Turbidity measurements. Turbidity measurements of samples were earned 
out at 350 nm on Perkin Elmer Lambda 25 double beam spectrometer. The pathlength 
of sample cell used was 1 cm. 
5.2.4. ThT fluorescence measurements. ThT fluorescence measurements were 
recorded on Shimadzu 530IPC fluorescence spectrophotometer equipped with water 
circulator (Julabo Eyela) from 460 to 600 nm. The excitafion was set at 440 nm and 
emission was recorded at 485 nm. The excitation and emission slits were set at 3 and 
5 nm respecfively. The samples were incubated for 30 min after adding ThT in the 
ratio of 1:2 (protein: ThT). 
5.2.5. ANS fluorescence measurements. ANS was added to the samples in the ratio 
of 1:20 and fluorescence was recorded from 400 to 600 nm on Shimadzu 5301 PC 
fluorescence spectrophotometer. The excitation and emission slits were set at 3 and 5 
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nm respectively. The samples were incubated for 30 min after adding ANS in the ratio 
of 1:20 (protein: ANS). 
5.2.6. Circular dichroism spectroscopic measurements. The far-UV CD spectra of 
samples were collected in a JASCO-J815 spectropolarimeter equipped with a Peltier-
type temperature controller at 25°C. Spectra were collected from 190 to 250 nm with 
20 nm/min scan speed and a response time of 2 s. Respective blanks were subtracted. 
5.2.7. FTIR spectroscopic measurements. Spectra of HEWL in the presence and 
absence of Neu5Ac were collected on a FTIR (Interspec 2020) spectrophotometer 
from 1700 to 1600 cm" using a KBr window at room temperature. For each spectrum, 
256 scans were averaged with a resolution of 4 cm'. Respective blanks were 
subtracted. The curve was analyzed by taking into account the band assignment for 
the secondary structure previously reported in the literature [Barth, 2007] a-helix 
(1647^1657 cm"'), B-sheet (1623-1641 cm"'), turn (1662-1686 cm"'), random coil 
(1642-1657 cm"'), and B-antiparallel (1674-1696 cm"'). 
5.2.8. Transmission electron microscopic measurements (TEM). Transmission 
electron micrographs were collected on transmission electron microscope operating at 
an accelerating voltage of 120 kV. The samples were diluted appropriately and 
applied to Formavar/carboncoated grids (300-mesh), blotted and air dried. The 
samples were then negatively stained with 2% (w/v) uranyl acetate prior to imaging. 
5.2.9. Cell viability assay (MTT). The U-87MG (human neuronal glioblastoma) cells 
were cultured in DMEM medium supplemented with fetal bovine seum in a 5% CO2 
humified atmosphere. Cells were plated at a 5x10 of cells/ well in 96-well plates for 
cell viability assay, incubated for 24 h, and then the medium was changed before 
incubation with samples. Samples were initially diluted in culture medium and then 
added to the cells to achieve the required final concentration. In order to evaluate cell 
viability, 10 |uL of 3-(4,5-dimethylthiazo]-2-yl)-2,5 diphenyltetrazolium Bromide 
(MTT) dye (5 mg/ml) in PBS) was added to each well (150 \iL) and incubated for 2 h. 
Extraction buffer was added and then absorbance was measured at 570 nm after 
overnight incubation on Elisa plate reader (96-well multiscanner autoreader) (Bio Rad 
model 680). The untreated cells were used as controls. It should be noted that the 
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cytotoxicities of HEWL and NeuSAc in working concentration were also assessed but 
no significant changes with respect to control was observed. 
5.2.10. Differential scanning calorimetric measurements. The differential scanning 
calorimetric measurements were carried out using VP-DSC microcalorimeter 
(MicroCal, Northampton, MA). The buffer and protein solutions were degassed under 
mild vacuum prior to the experiment. Samples were prepared in a 20 mM sodium 
phosphate buffer, pH 7.4. The DSC measurements of HEWL (40 ^M) in the absence 
and presence of 4 and 8 mM NeuSAc were perfonned from 25 to 90°C at a scan rate 
of 1 °C/min. Data were analyzed using Origin software provided with the instrument 
to obtain the temperature at the midpoint of the unfolding transition (T„i) and 
calorimetric enthalpy (? H°). 
5.2.11. Isothermal titration calorimetric measurements (ITC). The binding 
energetic of NeuSAc to HEWL at 2S°C was measured using a VP-ITC titration 
microcalorimeter (MicroCal Inc., Northampton, MA). Prior to the titration 
experiment, all samples were degassed properly on a themiovac. The sample and 
reference cell of the calorimeter were loaded with HEWL solution (20 |iM) and 20 
mM sodium phosphate buffer (pH 7.4), respectively. Then 10 pL of NeuSAc solution 
(43 mM) were added into the sample cell containing HEWL. Each injection was made 
over 20 s with an interval of 180 s between successive injections. The reference 
power and stiiring speed were set at 16 peals'' and 307 rpm, respectively. Heats of 
dilution for the ligand were determined in control experiment, and were subtracted 
from the integrated data before curve fitting. 
5.2.12. Statistical analysis 
All expenninents were done in triplicates, and mean values and standard deviations 
were calculated, wherever applicable, using SPSS 16.0 programme for windows. 
5.3. Results and discussion 
The formation of HEWL amyloid aggregates was achieved by incubating the protein 
at 65 °C for 168 hours (7 days). Under these conditions the partially folded state of 
HEWL is most likely to be highly populated [Arnaudov and de Vries, 2005]. When 
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the populations of the intennediate states become very high, the fomiation of amyloid 
fibrils is highly favored. Thus the presence and kinetics of aggregates fonned was 
confirmed by several independent methods viz turbidity measurements, ThT binding, 
ANS binding, CD spectroscopy, FTIR and TEM. Furthermore, the effect of NeuSAc 
was also observed on the heat-induced fibrillization of HEWL. 
5.3.1. Turbidity measurements. Turbidity at a non-absorbing wavelength can be 
used to rapidly detect insoluble protein aggi'egates [Cascella et al., 2013; Pellaud et 
al., 1999]. Thus, absorbance at 350 nm was taken over a course of 168 hours (7days) 
and presented in Figure 5.1A. As shown in Figure 5.1A, there occurs an increase in 
absorbance values at 350 nm till 96 hours, beyond which no flirther increment was 
observed. It indicates the scattering of light by sample that may be due to the 
formation of aggregates in HEWL. 
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Figure 5.1. Turbidity measurements. (A) Turbidity of HEWL incubated at 65 "C over a 
period of 168 hours (7 days) at different time interval and (B) turbidity after 168 hours 
incubation of HEWL in presence of varying concentration (0-8 mM) of Neu5Ac. 
However in presence of Neu5Ac, there occurs a decrease in turbidity after 168 hours 
incubation of HEWL in presence of varying concentration (0-8 mM) of Neu5Ac as 
shown in Figure 5.IB. This indicates that the Neu5Ac inhibits the formation of 
aggregates in HEWL. 
5.3.2. ThT fluorescence measurements. For probing the kinetics of amyloid 
formation of HEWL and its inhibition by Neu5Ac under studied condition, ThT 
fluorescence was monitored as it binds to cross 6 sheet-stnacture, which cause 
increase in fluorescence intensity [Groenning, 2010]. Figure 5.2A & B shows the ThT 
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fluorescence emission spectra and ThT fluorescence intensity at 484 nm of HEWL at 
different time intervals over a time course of 168 hours (7 days) respectively. 
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Figure 5.2. ThT fluorescence intensity measurements. A) ThT fluorescence spectra of 
HEWL incubated at 65°C over a f^ riod of 168 hours (7 days) at different time interval and 
(B) ThT fluorescence intensity profile (at 484 nm) of HEWL incubated at 65°C over a period 
of 168 hours (7 days) at different time interval (C) ThT fluorescence spectra of HEWL 
incubated at 65°C after 168 hours incubation in presence of varying concentration (0-8 mM) 
of NeuSAc. (D) ThT fluorescence intensity of HEWL incubated at 65°C after 168 hours 
incubation in presence of varying concentration (0-8 mM) of NeuSAc. 
As shown in Figure 5.2B, increase in ThT fluorescence intensity was observed after a 
lag phase (nucleation) of Ihr, followed by the log phase (elongation) of 95 hours and 
the system reached its saturation (equilibration) after 96 hours. It indicates that the 
formation of amyloid fibrils. However, in presence of NeuSAc, there occurs a 
decrease in ThT fluorescence intensity after 168 hours incubation of HEWL in 
presence of varying concentration (0-8 mM) of NeuSAc as shown in Figure S.2C & 
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D. This indicates that formation of amyloid fibrils of HEWL were inhibited by the 
Neu5Ac. Furthermore from the nature of curve presented in Figure 5.3, all of the 
known stages nucleation, elongation and equilibration seem to be affected by 
NeuSAc. 
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Figure 5J. ThT fluorescence intensity measurements of HEWL in presence of 4mM NeuSAc 
at different time intervals over a period of 168 hours (7 days). 
5.3.3. ANS binding measurements. On amyloid formation, hydrophobicity of 
solvent-exposed surfaces increases [Cheon et al., 2007]. Thus, change in surface 
hydrophobicity of HEWL under studied condition was monitored by ANS 
fluorescence intensity. Figure 5.4A & B shows the fluorescence emission spectra of 
ANS over a time course of 168 hours (7 days) and the profile of ANS fluorescence 
intensity at 480 nm respectively. As shown in Figure 5.4B, HEWL at zero hour have 
negligible ANS fluorescence with wavelength maximum (X,max) equal to 500 nm. 
However, as time increases, there occurs an increase in ANS fluorescence with 
concomitant blue shift till 96 hours, beyond which no increment was observed. It 
indicates increased hydrophobicity of solvent-exposed surfaces that indirectly 
demonstrates the formation of amyloid fibrils. However, in presence of Neu5Ac, there 
occurs a decrease in ANS fluorescence intensity after 168 hours incubation of HEWL 
at varying concentrations (0-8 mM) of Neu5Ac as shown in Figure 5.4C & D. This 
indicates that in presence of Neu5Ac, the hydrophobicity of solvent-exposed surfaces 
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decreases. It may be due to the inhibition of amyloid fibrils formation of HEWL by 
the Neu5Ac. 
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Figure 5.4. ANS fluorescence measurements. A) ANS fluorescence spectra of HEWL 
incubated at 65 °C over a period of 168 hours (7 days) at different time interval and (B) ANS 
fluorescence intensity profile (at 480 nm) of HEWL incubated at 65''C over a period of 168 
hours (7 days) at different time interval (C) ANS fluorescence spectra of HEWL incubated at 
65''C after 168 hours incubation at varying concentration (0-8 mM) of NeuSAc. (D) ANS 
fluorescence intensity of HEWL incubated at 65°C after 168 hours incubation in presence of 
varying concentration (0-8 mM) of NeuSAc. 
5.3.4. Circular dichroism measurements. The change in secondary structures of 
HEWL samples incubated at 65 °C for different time over a period of 168 hotirs was 
observed by far-UV CD and shown in Figure 5.5A. The spectra of HEWL at pH 7.4 at 
zero hour have a minimum at 208 and 222 nm, a characterstic of a-helix. To monitor 
the secondary structural change of protein, results are expressed as MRE (mean 
residue ellipticity) in deg cm^ dmof', which is given by 
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- IF^W^^ lav-SC-S--.-
^iRE^eu^M ,5,) 
lOxnxcx/ 
where ?obs is the observed eUipticity in millidegrees, c is the concentration of protein 
in mol/L, 1 is the length of the light path in centimeters, and n is the number of peptide 
bonds. As shown in Figure 5.5A, with increase in time of incubation, the negative 
MRE values decreases at both minimum that indicates the decrement in a-helical 
content. However to calculate the percent secondary structure content, K2D3 [Louis-
Jeune et al., 2012] was used and results are shown in Figure 5.5B and Table 5.1. 
Table 5.1. The percent secondary structure content of HEWL incubated at pH 7.4, 65 
"C as measured by CD spectroscopy and estimated by K2D3 software of secondary 
structure analysis. 
Incubation time 
(at 65 "C)(hours) 
0 
1 
2 
3 
4 
5 
6 
24 
48 
72 
96 
120 
144 
168 
The HEWL at zero hour contain a-helix and B-sheet content equals to 36.37 and 
12.25% respectively that agrees well with the literature [Morshedi et al., 2007]. 
However, with increase in incubation time, a-helical content decreases with 
concomitant increase in B-sheet content till 96 hours beyond which no significant 
changes was observed. This transition from a-helix to B-sheet is attributed to the 
fonnation of amyloid fibrils. Furthermore, the changes in secondary structural 
changes of HEWL incubated at 65"C after 168 hours incubation in presence of 
Neu5Ac cannot be monitored by far-UV CD spectroscopic measurements because it 
% a-sheet 
36.37 
35.92 
29.48 
23.49 
13.98 
12.32 
10.92 
4.36 
4.26 
3.58 
3.41 
3.31 
3.30 
3.21 
% B-sheet 
12.25 
15.42 
18.07 
21.30 
26.62 
28.55 
30.71 
36.60 
36.76 
37.91 
38.13 
38.57 
38.66 
38.80 
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give noise in the far-UV region. Thus to determine the effect of NeuSAc on secondary 
structure of HEWL incubated at 65°C after 168 hours, FTIR spectroscopic 
measurements were performed. 
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Figure 5.5. Far-UV circular dichroism measurements. (A) Far-UV CD spectra of HEWL 
incubated at 65T over a period of 168 hours (7 days) at different time interval (B) Percent 
secondary structural changes as obtained by K2D3. 
5.3.5. FTIR spectroscopic measurements. Band frequencies due to amide L H, and 
III vibrations in the IR region are sensitive to the secondary structure of protein. But, 
generally, amide I (1700-1600 cm'') is analyzed to investigate the change in 
secondary structure of protein as it reflects C-0 stretching vibration of the amide 
group weakly coupled with in plane NH bending and CN stretching [Tian et al., 
2004]. Figure 5.6A & B shows the amide I band of HEWL incubated at 65°C for zero 
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and 168 hours and Figure 5.6B shows the amide I band of HEWL incubated at 65°C 
after 168 hours in presence of 4, 8 mM Neu5Ac. As summarized in Table 5.2, the 
HEWL at zero hour has peak at 1652 cm"' that attribute to the presence of a-helix as 
the major secondary structure which is reasonable accord with the literature [Sassi et 
al.,2011]. 
Table 5.2. Amide 1 band peak of HEWL in absence and presence of Neu5Ac as 
obtained by FTIR measurements. 
Samples Amide I band peak Predominant 
secondary structure 
HEWL (at zero hour) 1652 
HEWL (at 168 hours) 1637 
HEWL (at 168 hours) in presence of 1648 
4 mM Neu5Ac 
HEWL (at 168 hours) in presence of 1650 
8 mM Neu5Ac 
a-helix 
P-sheet 
a-helix 
a-helix 
However, as time of incubation increases to 168 hours, the peak in amide I region 
shifts to 1637 cm'' that attribute to the presence of P-sheet. These observations agree 
well with far-UV CD results. The transition from a-helix to p-sheet is due to the 
formation of amyloid fibrils as formation of P-sheet is prerequisite for amyloid fibrils 
formation. 
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Figure 5.6. FTIR measurements of HEWL incubated for (A) zero hours and (B) 168 hours. 
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However, peak in amide I band shifts back to 1650 cm"' after 168 hours incubation of 
HEWL in presence of 8 mM Neu5Ac. It indicates that Neu5Ac resists the transition 
from a-helix to p-sheet and consequently inhibits the amyloid formation in HEWL. 
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Figure 5.7. FTIR measurements of HEWL incubated at 65 °C after 168 hours incubation in 
presence of (A) 4 mM and (B) 8 mM of NeuSAc. 
5.3.6. Transmission electron microscopy (TEM). Figure 5.8A & B represents the 
TEM images of HEWL incubated at 65°C for zero hours and 168 hours. The HEWL 
at zero hour was taken as control. In parallel to spectroscopic measurements, 
aggregation was clearly visible in HEWL incubated at 65°C for 168 hours, as compare 
to control. In presence of Neu5Ac, aggregation of HEWL decreases as shown by 
lower density of aggregates on increasing concentration of Neu5Ac to 4 and 8 mM. 
(Figure 5.8C & D). Thus it indicates that NeuSAc inhibits the formation of heat 
induced aggregates in HEWL 
•ft. - -M. 
% 
fP 
. - > ; • 
. . > • • " • 
A ' 
Figure 5.8. TEM images of (A) HEWL incubated at 65T for zero hour (B) HEWL incubated 
at 65°C for 168 hours (C) HEWL incubated at 65°C after 168 hours in presence of NeuSAc 
4mM and (C) HEWL incubated at 65 °C after 168 hours in presence of 8mM NeuSAc 
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5.3.7. Cell Viability Assay (MTT). The aggregated/amyloid fibrils are believed to be 
toxic to neurons [Brorsson et al., 2010; Gharibyan et al., 2007]. Thus the cytotoxicity 
of different aged HEWL fibrils was examined on U-87MG 
(human neuronal glioblastoma) cells by MTT reduction assay at 48 and 72 hours as 
shown in Figure 5.9. 
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Figure 5.9. Time-dependent cytotoxic effect of different age HEWL fibrils by MTT reduction 
assay. 
MTT undergoes reduction by mitochondrial dehydrogenses to soluble formazan that 
serves as the indicator of metabolically active cells and inhibition of this reaction is 
indicative of cytotoxicity. The percentage of cell viability (or the percentage of MTT 
reduction) was observed to decreases with the age of amyloid fibrils and with time as 
shown in Figure 5.9. It indicates that the 168 hours old fibrillar species of HEWL 
have most pronounced cytotoxic effect after 72 hours. Thus, the effect of different 
aged HEWL amyloid fibrils formed in presence of Neu5Ac on U-87MG cells, was 
observed after 72 hours and presented in Figure 5.10. As shown in Figure 5.10, 
HEWL amyloid fibrils formed in presence of Neu5Ac shows an increase in 
percentage of cell viability and thus it can be said that the cytotoxic effect of HEWL 
amyloid fibrils is significantly attenuated in presence of Neu5Ac. 
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Figure 5.10. Time-dependent cytotoxic effect of different age HEWL fibrils in absence and 
presence of 4 mM Neu5Ac after 72 hours by MTT reduction assay. 
Mechanism of inhibition of heat-induced fibrillization of HEWL by 
NeuSAc. 
In the present study, it is observed that NeuSAc inhibits the heat-induced fibrillization 
of HEWL. The various events occurring in the course of amyloid formation of HEWL 
includes destabilization of the native state, nucleation, elongation and lateral 
accumulation of fibrils and thus it is expected that the potential inhibitor may affect 
one or more of the steps involved. Thus DSC measurements have been done to know 
the effect of Neu5Ac on stabilization of native state of HEWL. 
5.3.8. Thermostability measurement by differential scanning calorimetric 
measurements. 
The thermal denaturation of a protein occurs at the thermal transition temperature 
(Tm) which is calculated as the midpoint of the thermogram peak, and integration of 
the area under the peak gives the calorimetric enthalpy (AHcai°). Figure 5.11 (A—C) 
» 
shows the 'typical excess heat capacity curves for HEWL in presence of varying 
concentration (0-1 OmM) of NeuSAc. The excess heat capacity curves were 
deconvoluted with the assumption of single-transition and obtained thermodynamic 
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parameters are reported in Table 5.3. The concentration of HEWL selected for this 
study was chosen such that it remains in solution. As summarized in Table 5.3, the 
ATm and AHc° of HEWL were 73.47 "C and 61.85 kcal mol"' that agrees well with the 
values earlier reported [Bruzdziak et al., 2013]. The value of change in thermal 
transition temperature (ATm) increases to 74.41 and 76.32 in presence of 4 and 8 mM 
Neu5Ac respectively. Furthemiore the value of calorimetric enthalpy (A Hcai°) also 
increases with increase in concentration of Neu5Ac. It indicates that the Neu5Ac 
cause stabilization of HEWL and hence thermal unfolding of HEWL become 
progressively less favorable as evident from the increase in value of AHcai° with 
increase in concentration of Neu5Ac [Celej et al., 2005; Neelam et al., 2010; Sharma 
et al, 2012]. These results suggest that the Neu5Ac protects HEWL against thermal 
unfolding and thus prevent its conversion to aggregated prone species. However, this 
stabilization may results from the binding of Neu5Ac to HEWL as the changes in the 
Tm and AHcal° of the protein in presence of ligand are the most obvious manifestation 
of ligand binding [Zaidi et al., 2013b]. Thus to know whether these changes in T^ and 
AHcal° are manifestation of binding of Neu5Ac to HEWL, ITC measurements were 
performed. 
Table 5.3.Thermodynamic parameters of HEWL in presence Neu5Ac as obtained by 
differential scanning calorimetry 
Neu5Ac T T T C T AtC, (kcal mol') AH^^.AH;, , , 
(mM) 
~0 73.47 ±0.012 61.85 ±0.02 (X99 
4 74.41 ± 0.020 62.55 ± 0.01 0.98 
8 76.32 ±0.010 68.72 ±0.01 0.99 
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5.3.9. Isothermal titration calorimetric measurements. ITC was used to measure 
binding affinity and energetics of NeuiAc to HEWL at 25 °C. Figure 5.12 shows the 
ITC binding isotherm of Neu5Ac to HEWL at 25''C in which each peak in top panel 
represents a single injection of the Neu5Ac into 20 mM sodium phosphate buffer, 7.4 
(red) and in protein solution (black). Bottom panel of this figure shows an integrated 
plot of the amount of heat liberated per injection as a function of the molar ratio of the 
NeuSAc to protein. As shown in Figure 5.12, there were no significant changes 
observed in heat on Neu5Ac mixing into buffer and protein. 
Time (min) 
-10 0 10 20 30 40 50 60 70 80 90 
T r 
100 200 300 400 500 
Molar Ratio 
Figure 5.12. Isothermal titration calorimetric profile of NeuSAc to HEWL. 
It leads to absence of the binding profile in the titration of Neu5Ac to HEWL. Thus 
results clearly indictes that NeuSAc donot bind to HEWL and remain excluded and 
thus increase in stability of HEWL as observed by DSC measurements is not the 
consequence of NeuSAc binding. However increase in stability of HEWL without 
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binding NeuSAc may be due to the mechanism of preferential hydration like other 
sugar molecules [Abe et al., 2013; Liu et al., 2009]. According to which, the sugar 
molecules get excluded from the environment around the protein and are replaced by 
water. 
5.4. Conclusions 
In the present study, the kinetics of heat induced amyloid fomiation in HEWL and its 
attenuation by Neu5Ac have been studied. When HEWL incubated at 65T for 168 
hours then the amyloid formation occurs as evident from the increase in ThT binding, 
increased hydrophobicity of solvent-exposed surfaces, transition of a-helix to B-sheet. 
Furthennore the amyloid fibrils of HEWL generated under studied condition are 
cytotoxic to the human neuronal glioblastoma. However this fibrillization process is 
inhibited by NeuSAc as it decreases ThT binding, hydrophobicity of solvent-exposed 
surfaces, and transition of a-helical structure to B-sheet. Furthermore, NeuSAc also 
protect cells against cytotoxic nature of HEWL amyloid fibrils. The mechanism by 
which NeuSAc attenuates the heat induced amyloid formation in HEWL was also 
determined. It is observed that the NeuSAc donot bind to protein and stabilizes the 
native state of HEWL according to the effect of preferential hydration rather than 
direct interaction with protein. In preferential hydration mechanism, NeuSAc 
molecules gets excluded from the environment around the protein and are replaced by 
water that stabilizes the protein against thermal stress and consequently donot pennit 
HEWL to undergo fibrillization. Thus NeuSAc may be a potential therapeutic 
candidate for inhibition of amyloid fibril fonnation. 
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ABSTRACT: Exogenous substances like drugs, when absorbed, enter into the h(U|Mf)r|f^lkf|l'iflfW^^lt^fif f 
circulatory system and bind reversibly and extensively to human serum albumin 
(HSA). But transport of various drugs like a diuretic, furosemide (FUR), via albumin 
in uremia is seriously compromised due to accumulation of uremic toxins. The reason 
behind it is explored by investigating the binding mechanism of FUR to HSA 
Isothermal titration calorimehy results show that FUR binds with HSA at high {K^ ~ 
lO'') and low affinity (^j, ~ 10 )^ sites whereas spectroscopic results predict binding at 
a single site ( i^ ~ 10^). Thennodynamic analysis shows that the HSA-FUR complex 
formation occurs via hydrogen bonds and hydrophobic interactions and undergoes 
slight structural changes, as ewdent by FTIR and far-UV CD. Further, the lifetime of 
HSA decreases only marginally and thus the magnitude of energy transfer efficiency is 
smaE, as obtained by time-resolved measurements. A displacement esperiment 
predicts that the FUR binds mainly to site I but a new site having lower affinity is also 
observed, whidi shares some residues with site II as supported by molecular docking results. Results revealed that in uremia, FUR 
indirectly competes for Arg410, Lys414, and Ser489 vrith site II bound uremic toxins and directly competes for site I with site 1 
bound uremic toxins. 
NomMl condttion 
1. INTRODUaiON 
Human serum albumin (HSA) is a main carrier for a variety of 
endogenous and exogenous substances in the body and also 
plays a key role in maintaining normal osmolarity in plasma and 
in interstitial fluid. ~ It is a single chain nonglycosylated 
polypeptide of 66.5 kDa. The protein has three homologous 
domains (I—III), each domain comprises two subdomains (A 
and B) that possess common structural elements. ' As of its 
transporting role, it binds substances at two major binding 
regions, namely Sudlow's site I and II, which are located within 
cavities in subdomains UA and IIIA, respectively. Generally, 
upon absorption exogenous substances like drugs enter into the 
circulatory system and bind reversibly to serum albumin, which 
assists in their distribution and deposition.''' But, transport of 
various drugs via albumin in a pathological ill condition hke 
uremia, is seriously compromised. ''" Among them, binding of 
fiirosemide (FUR), a diuretic drug, is most adversely impaired, 
which normally binds 99% to albumin at its total concentration 
of 10 /ig mL~'.''''^ Hence, a decrease in the protein bound 
fraction of FUR may affect the pharmacokinetics of the drug, 
which includes its tubular seaetion and increased metabolic 
clearance in uremic patients. Although the molecular 
mechanism underlying impaired albumin FUR binding in 
uremic conditions is poorly imderstood, two major reasons 
have been suggested. First, it may be due to some conforma-
tional changes in albumin under chronic renal disease but 
putative structural modifications of pathological HSA have been 
disputed for decades. ""' Second, according to the most 
accepted hypothesis, HSA binding sites might be occupied by 
uremic toxins, viz. hippuric add (HA), indoxyl sulfate (IS), 3-
carboxy-4-methyl-5-propyl-2-fiiranpropionic acid (CMPF), in-
dole-3 acetic add (lAA), etc. However, from the available 
literature, it is found that FUR. binds to site I of HSA ''' ' 
whereas all predominant uremic toxins except CMPF bind 
mainly to site II of HSA ~ So, only CMPF is the uremic 
toxin that directly inhibits the binding of FUR to albumin as 
they share the same binding site. But, the reason behind 
inhibition by site II bound uremic toxins of FUR binding to 
albumin is still unclear. Thus, to eluddate the plausible reason 
behind impaired albumin binding of FUR, energetic and 
binding parameters along with the location of FUR binding 
sites on albumin are determined by fluorescence spectroscopy 
(steady state and time-resolved), ITC, FRET, esterase activity 
of HSA, and molecular docking and then the binding site 
location is correlated with the binding .sites of uremic toxins 
available in the literature. Further, secondary structural changes 
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A Comprehensive Insight into Binding of Hippuric Acid 
to Human Serum Albumin: A Study to Uncover Its 
Impaired Elimination through Hemodialysis 
Nida Zaidi, Mohammad Rehan Ajmal, Gulam Rabbani, Ejaz Ahmad, Rizwan Hasan Khan* 
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Abstract 
Binding of hippuric acid (HA), a uremic toxin, with human serum albumin (HSA) has been examined by isothermal titration 
calorimetry (ITC), differential scanning catorimetry (DSC), molecular docking, circular dichroism (CD) and fluorescence 
spectroscopy to understand the reason that govern its impaired elimination through hemodialysis. ITC results shows that 
the HA binds with HSA at high [K^ - lO' ') and low affinity (/fb ~10^) sites whereas spectroscopic results predict binding at a 
single site (/<ij~10^). The HA form complex with HSA that involves electrostatic, hydrogen and hydrophobic binding forces 
as illustrated by calculated thermodynamic parameters. Molecular docking and displacement studies collectively revealed 
that HA bound to both site I and site il; however, relatively strongly to the later. Esterase-like activity of HSA confirms the 
involvement of Arg410 and Tyr411 of Sudlow site 11 In binding of HA. CO results show slight conformational changes occurs 
in the protein upon ligation that may be responsible for the discrepancy in van't Hoff and calorimetric enthalpy change. 
Furthermore, an increase in T^and r^is observed from DSC results that indicate increase in stability of HSA upon binding to 
HA. The combined results provide that HA binds to HSA and thus its elimination is hindered. 
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Introduction making this protein an important regulator of the pharmacokinetic 
behavior of many drugs as well, as intercellular fluxes [13]. In 
Uremic toxins arc the compounds which retained in (he blood hojy jj ai^o binds to HA [2] and thus elimination of HA through 
during kidney faUurc and interact negatively with the normal hemodi,alysis is only 64% [14,15], However, there is paucit)' of 
biological fiinctions of the body [1]. Hippuric acid (HA) is one of infoniiadon on iLs binding mediajiLsm to HSA. Consequendy,'it is 
these compounds that accumulates in the blood, and cause necessary to investigate the binding energetic, amino acid involved 
siimulation of ammoniagenesis. It is involved in development of i„ binding of HA to H,SA to explore its binding mechanism in the 
muscular weakness in uremia as il also inhibits glucose utilization body. So, the scope of diis work is to evaluate these in details by 
in muscles [2-4]. Il has also been related to inhibition of organic studying the binding energetic using .steady state fluorescence 
anion secretion by die kidney [5] and tran.sport at the blood-brain spectroscopy and isothermal titrarion calorimetry. Binding sites is 
barrier [6], Consequently, HA is a compound of pharmacological detennined by displacement studies whereas csdmauon of amino 
interest. It is a glycine conjugate of benzoatc, which is formed acid involved in binding, by molecular docking and estcrase-likc 
primarily from aromatic amino acids by gasirointesdnal flora or acti\-ity of HSA toward p-NPA. Thermal stability in presence of 
may be directly taken as presen-aliv'cs from food and beverages H A is determined using differential scanning calorimetry. 
[7J. In a healdiy individual, concentration of HA is less dian 
5 mg/I . but increases to values higher than 247 ±112 mg/L in Materials and A/iethods 
patients vridi end-stage renal disease [8], 
Human .serum albumin (HSA) is die most abundant plasma Materials and Sample Preparation 
protein, sin^e chain, nonglycosylated polypeptide of 66..T kDa. It Human scrum albumin (A1887; >96%), warfarin (A22.'JO; 
iscomposedofthreehornologous, predominantly helical domains >98%), phenylbutazone (P8386; >99%), and ^nitrophenyl 
I i n , each of which contains two subdomains A and B [9]. HSA acetate (N8137; >99%) were procured from Sigma .-Udrich. 
has one tryptophan residue, Trp214, located in subdomain IIA Hippuric acid (free acid, crystalline; >99%) wa.s from Himedia. 
[10.11]. The principal regions of ligand binding to HSA are The number in the parcndicsis corresponds to the purity of the 
lorated in hydrophobic cavities m subdomains IIA and IIIA, compounds. All other reagent.s were of analylical grade. HSA and 
which are consistent widi Sudlow sites 1 and II, respectively [12]. drug solutions were prepared in 20 mM .sodium phosphate buffer 
These binding siles underline the exceptional ability of HSA to (pH 7.4). HSA was passed dirough Sephat;ryl-S200 gel filfr-ation 
interact with' many organic and inorganic molecules, ihercby column, dialy/ed, and its concentration was estimated spcctro-
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Revisiting ligand-induced conformational clianges in proteins: essence, advancements, 
implications and future challenges 
Ejaz Ahmad", Gulam Rabbani", Nida Zaidi^ Mohammad Azam Khan", Atiyatul Qadeel•^ Mohd Ishtikhar'', Saurabh 
Singh and Rizwan Hasan KJian^* 
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Institute oj Science. Rehovot 76100, Israel 
Communicated by Ramaswamy H. Sanna 
(Received 23 March 2012; final version received 5 June 2012) 
Ligand-induced confonnational changes are of immense importance for the biological activity of a protein. An in-depth 
understanding of salutaiy and deleterious effects of ligand-induced conformational alterations in single- and multi-chain 
proteins would lend a hand in human welfare. Unlike single-chain proteins, the function of multichain proteins depends 
upon the inherent properties of the subunit interfaces. The interfaces of temporary oligomeric proteins and the active 
sites of enzymes are of similar characteristics but the interfaces are more conservative than the active sites. Therefore, 
these interfaces may possibly be represented as drug targets by inhibition or induction of the oligomerization process. 
Thus without detailed structural understanding of ligand-induced conformational changes in a protein, structure-based 
rational drug designing is a great challenging task. So the purpose of this review is to clarity or enlighten the reader at 
the degree of internal motions related to protein backbone and side-chain flexibility which occur on binding of small 
molecule to a protein target. This can prove helpful to improve the confonnational prediction for a protein-ligand com-
plex. Besides a detailed description of protein-ligand interaction, this review also focuses on structure-activity relation-
ships of protein which will surely help in the rational drug designing. 
Keywords: aggregation; conformational alteration; drug designing; protein-ligand interactions; protein stability; struc-
ture-function relationship 
Introduction 
Most of the physiological processes are associated with 
complex formation between protein and ligand. The pro-
teins associated with the physiological process are eitlier 
directly or indirectly affected by ligands (Alberts et a!., 
2002). These ligands may be protein, peptide, small 
chemical compound, metal or ions. For instance an 
enzyme adenylyl cyclase, which involves in the break-
down of glycogen and fats, is stimulated by epinephrine 
and glucagon (Tomheimm & Ruderman, 2011). It is also 
stimulated by luteinizing hormone and antiditiretic hor-
mone in the synthesis of estrogen/progesterone and in 
conservation of water respectively. Furthemiore, phos-
pholipase C is affected by Angiotensin during contrac-
tion of smooth muscles in blood vessels while in 
myocardial contraction, acetylcholine affect K^ channel. 
Moreover, enkephalins, endorphins and opioids cause 
stimulation of Ca^"^, K"^  channels which bring change in 
neuro-electrical activity (Lodish et a l , 2000). Thus most 
of the endogenous and exogenous ligands are associated 
with enzymes, receptors and channels and bring changes 
in protein strucUire. The small changes are acquired from 
the rearrangement of side-chains flexibility and/or back-
bone flexibility of loops in the vicinity of the active site 
ultimately changes in the radius of gyration. However, 
large-scale motions like partial unfolding/refolding of the 
protein structure, domain reorientations, domain closure 
(closed state) accompanied by loop motions (hinge-bend-
ing motions) were also observed. So, to understand how 
universal factors such as extent of hydrophobicity, degree 
of polarity, hydrogen bonding, solvation characteristics, 
electrostatic potential, conformational dynamics and con-
formational flexibility of a protein are altered upon 
ligand binding is of enormous significance. 
Besides the detailed mode of protein-ligand interac-
tions, the puipose of the present review is to enlighten the 
various ligand-induced conformations adopted by the pro-
tein molecules as the protein molecule adopts different 
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1-Anrlino-8-Naphthalene Sulfonate (ANS) Is Not a 
Desirable Probe for Determining the Molten Globule 
State of Chymopapain 
AtiyatuI Qadeer, Gulam Rabbani, Nida Zaidi, Ejaz Ahmad, Javed M. Khan, Rizwan H. Khan* 
Interellsciplinary Biotechnology Unit, Aligarh Muslim Univeraty, Aligarh, India 
Abstract 
The molten globule (MG) state of proteins is widely detected through binding with 1-anilino-8-naphthalene sulphonate 
(ANS), a fluorescent dye. This strategy is based upon the assumption that when in molten globule state, the exposed 
hydrophobic clusters of protein are readily bound by the nonpolar anilino-naphthalene moiety of ANS molecules which 
then produce brilliant fluorescence. In this work, we explored the acid-induced unfolding pathway of chymopapain, a 
cysteine proteases from Carica papaya, by monitoring the conformational changes over a pH range 1.0-7.4 by circular 
dichroism, intrinsic fluorescence, ANS binding, acrylamide quenching, isothermal titration calorimetry (ITC) and dynamic 
light scattering (DLS). The spearoscopic measurements showed that although maximum ANS fluorescence intensity was 
obsen/ed at pH 1.0, however protein exhibited - 8 0 % loss of secondary structure which does not comply with the 
characteristics of a typical MG-state. In contrast at pH 1.5, chymopapain retains substantial amount of secondary stnjcture, 
disrupted side chain interactions, increased hydrodynamic radii and nearly 30-fold increase in ANS fluorescence with respect 
to the native state, indicating that MG-state exists at pH 1.5 and not at pH 1.0. ITC measurements revealed that ANS 
molecules bound to chymopapain via hydrophobic interaction were more at pH 1.5 than at pH 1.0. However, a large 
number of ANS molecules were also involved in elertrostatic interaction with protein at pH 1.0 which, together with 
hydrophobically interacted molecules, may be responsible for maximum ANS fluorescence. We conclude that maximum 
ANS-fluorescence alone may not be the criteria for determining the MG of chymopapain. Hence a comprehensive structural 
analysis of the intermediate is essentially required. 
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Introduction 
The process of protein folding, despite being one of the most 
intensely investigated areas, remains obscure in icmis of its 
detailed molecular mechanism. The spontaneity and extreme 
coopcrativity of this process makes it a challenging task lo uru-avel 
the entire mechanism mainly because of the inability to populate 
the di.stinct intermediate slates that encompass the folding pathway 
of a nascent polypeptide [1-3]. Characterization of these 
inteiTnediales is the key to unlock the step by step mechanism 
and lo extend our knowledge on the principles governing protein 
folding [4,5]. 
In past, a lot of attention has been paid to molten globule (MG), 
an intermediate with feasible occurrence as a general physical state 
in the folding pathway of globtilar proteins [6-8]. The MG state 
generally corresponds lo lale iblding intermediate and has been 
obtained for many proteins under difTcrenl solvent conditions [9-
12], In order to be defined as a t>pical molten globule, an 
intermcdialc requires being a compact collapsed state with 
substanrial amount of secondary structure, loose tertiary contacts 
widiout tight side chain packing and a solvent accessible 
hydrophobic core [13]. Conventionally, the exposed hydrophobic 
clusters of folding intermediates ai-e detected through l-anilino-S-
naphthalene sulfonate (ANS) binding, a much utilized fluorescence 
probe for delecting the non-polar character of proteins and 
membranes [14], In fact, the available litcratiu-c reveals that 
molten globule state is mostly pinpointed from its maximum ANS 
binding ability under the conditions studied since the other typical 
feamres vk pronounced secondary' .structure and dismpted tertiary 
contacts olien seem to merge with intermediates !>'ing in the 
vicinity of MG-state [12,15-20]. Such utilization of ANS which is 
based upon the principle that ANS Ls jjractically non fluorescent in 
Wdtcr but produces brilliant fluorescence upon binding to 
hydrophobic sites of protein [21] generally ignores the contribu-
tion of sulfonate group that was eariier considered as a mere 
solublizing agent for otherwase almo.st water-insoluble anilino-
naphthalene moiety. However, the role of electrostatic interactions 
in ANS-protein interaction was highlighted later in die findings 
that ANS binding to proteins depends upon protein cationic 
charge and pH of the solution and occurs precisely through ion-
pair formation between sulfonate group of ANS and side chams of 
Arg/I,ys/His residues of polypeptide chain [22,23]. A more recent 
study has revealed (hat interaction of sulionale group of ANS with 
charged centers of .Arg and Lys residues resulted in enhanced 
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Stereo-Selectivity of Human Serum Albumin to 
Enantiomeric and Isoelectronic Pollutants Dissected by 
Spectroscopy, Calorimetry and Bioinformatics 
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Abstract 
l-naphthol (IN), 2-naphthol (2N) and 8-quinolinol (8H) are general water pollutants. IN and 2N are the configurational 
enantiomers and 8H Is isoelectronic to IN and 2N. These pollutants when ingested are transported in the blood by proteins 
like human serum albumin (HSA). Binding of these pollutants to HSA has been explored to elucidate the specific selectivity 
of molecular recognition by this multiligand binding protein. The association constants (Kb) of these pollutants to HSA were 
moderate (10*-10 M '). The proximity of the tigands to HSA is also revealed by their average binding distance, r, which is 
estimated to be in the range of 4.39-5.37 nm. The binding free energy (AG) in each case remains effectively the same for 
each site because of enthalpy-entropy compensation (EEC). The difference observed between ACp*"* and ACp"'^ are 
suggested to be caused by binding-induced flexibility changes in the HSA. Efforts are also made to elaborate the 
differences observed in binding isotherms obtained through multiple approaches of calorimetry, spectroscopy and 
bioinformatics. We suggest that difference in dissociation constants of pollutants by calorimetry, spectroscopic and 
computational approaches could correspond to occurrence of different set of populations of pollutants having different 
molecular characteristics in ground state and excited state. Furthermore, our observation of enhanced binding of pollutants 
(2N and 8H) in the presence of hemin signifies that ligands like hemin may enhance the storage period of these pollutants in 
blood that may even facilitate the HI effects of these poHutams. 
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Introduction 
.a-naphthol |l -naphthol (IN)], P-naphthol [2 naphlhol (2N)] 
and 8-qumoliitol [8-hydoxy quinoline (8H)j arc non-persistent 
organic watci poUulanLs. Tliey have similar properties. They are 
.sparingly soluble in water and exhibit antiseptic pro)3erties. (.5ne 
wa>- in which naphihols differ from each oiher is the form of their 
crystals. IN crystallizes in prisms and 2N in plates. Cellular 
presence of IN causes dcpolymerization of spindle microtubules 
and apparent uncoupling of karyokinesis and cytokinesis in mitotic 
cells. i\lthough at a much lovver frequency, presence of 2N also 
causes similar configurations. IN has been investigated as a 
mutagen and reprodurtivc effector and has also been associated 
with reduced testosterone levels [1]. Naphthols are used in the 
synthesis of certain azo-dyes and anOo.xidants for rubbers and as 
indicators in chemical analyses. 8H is used as a metal chelating 
agent, in preparing antiseptics, deodoranLs, (iingicides etc. Their 
accumulation in body causes cyanosis, liver damage, ncphnns, 
circulatory collapse and wen death. 
All these three pollutants are transported in blood by plasma 
proteins like human serum albumin (HSA). HSA is a ,585 amino 
acid long hcarl-shape monomer comprising three structurally 
homologous domains each of which displays specific and functional 
characteristics. Each of these three domains is composed of sub-
domains A and B providing flexibility to tlie protein molecule so that 
tlie protein can bind to a variety of ligands. HSA is responsible for 
the transport, storage and metabolism of many therapeutic drugs in 
the blood thereby restricting their free, active concentrations and 
therefore can significandy affect their pharmacokinetics and 
melaboEsm. Two distinct binding sites, commonly referred to as 
Sudlow site 1 and site 2, have been identified in HSA for various 
drugs [2]. Site 1 binds to bullcy hydrophobic and heterocyclic 
molecules with a centrally located negative charge (e.g. waifarin, 
phenylbutazone). Site 2 binds to aromatic caxboxylic acids with a 
negati\c charge at one end distal from the remaining hydrophobic 
.structure (e.g. diazepam, ibuprofen). Binding of hgands to albumin 
alters the pattern and volume of distribution, lowers die rate of 
clearance, and increases the plasma half-life of the ligand. A detailed 
characterization of the protein's binding property to different 
hgands is therefore necessary not only to understand its key 
physiological functions but also to understand its impact on ligand 
transport and delivery. 
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pH-Dependent Conformational Transitions in Conalbumin 
(Ovotransferrin), a Metalloproteinase from Hen Egg White 
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Abstract Acid unfolding pathway of conalbumin (CA), a 
monomeric glycoprotein from hen egg white, has been 
investigated using far- and near-UV CD spectroscopy, 
intrinsic fluorescence emission, extrinsic fluorescence 
probe l-anilino-8-napthalene sulfonate (ANS) and dynamic 
light scattering (DLS). We observe pH-dependent changes 
in secondary and tertiary structure of CA. It has native-like 
a-helical secondary structure at pH 4.0 but loss structure at 
pH 3.0. The CA existed exclusively as a pre-molten 
globule state and molten globule state in solution at pH 4.0 
and pH 3.0, respectively. The effect of pH on the confor-
mation and thermostability of CA points toward its heat 
resistance at neutral pH. DLS results show that MG state 
existed as compact form in aqueous solutions with hydro-
dynamic radii of 4.7 nm. Quenching of tryptophan fluo-
rescence by acrylamide further confirmed the accumulation 
of an intermediate state, partly unfolded, in-between native 
and unfolded states. 
Keywords Conalbumin • DLS • Hydrodynamic radii • 
Molten globule • pH denaturation • Translational diffusion 
coefficients 
Abbreviations 
ANS 1-anilino-8-napthalene sulfonate 
CA Conalbumin 
DLS Dynamic light scattering 
GnHCl Guanidine hydrochloride 
MG Molten globule 
MRE Mean residue ellipticity 
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Pd Polydispersity 
Tin Mid-point temperature 
Introduction 
Equilibrium and kinetic intermediates have been identified 
in the unfolding/refolding reactions of several proteins [1 -
3]. Several globular proteins when exposed to extreme pH 
conditions undergo significant conformational changes 
resulting in formation of intermediate states, with varying 
stability, such as molten globule (MG) state. Structural 
characterization of intermediates or MG state that populate 
in the folding/unfolding process is essential to understand the 
protein folding mechanism [4]. At MG state, the protein 
retains most of the secondary structures, but has a tendency 
to lose some of the tertiary structures [5-7]. The MG states 
are believed to be general folding intermediates because they 
populate both in the equilibrium and kinetic folding/ 
unfolding pathways [S]. 
Egg white proteins are considered model of choice for 
studying proteins because of their high nutritional and bio-
logical value [9]. Conalbumin (CA), one of the main iron-
binding monomeric glycoproteins containing D-mannose 
and D-galactose sugar moiety, is present in egg white. It 
transports and scavenges Fe(III) in poultry eggs. It belongs to 
transferrin family and exhibits features typical for a-helical 
proteins. The function of CA is generally accepted as that of 
iron transport. It binds two atoms of Fe(III), one in each 
domain. The order of iron binding is pH dependent; at pH 6.0, 
it binds first to the C-domain, but at pH 8.5, it first binds to the 
N-domain. It is a major contributor to the natural defense 
system in egg white, which provides protective barrier 
against infection by microbial flora [10]. An important 
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pH-Induced Molten Globule State of Rhizopus niveus Lipase 
is More Resistant Against Thermal and Chemical Denaturation 
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Abstract Here, we have characterized four pH-dependent 
states: alkaHne state, "B" (pH 9.0), native state, "N" (pH 
7.4), acid-induced state, "A" (pH 2.2) and molten globule 
state, "MG" (pH 1.8) oi Rhizopus niveus lipase (RNL) by 
CD, tryptophanyl fluorescence, ANS binding, DLS, and 
enzyme activity assay. This "MG" state lacks catalytic 
activity and tertiary structure but it has native-like signif-
icant secondary structure. The "/?h" of ail the four states of 
RNL obtained from DLS study suggests that the molecular 
compactness of the protein increases as the pH of solution 
decreases. Kinetic analysis of RNL shows that it has 
maximum catalytic efficiency at state "B" which is 15-fold 
higher than state "N." The CD and tryptophanyl fluores-
cence studies of RNL on GuHCl and temperature-induced 
unfolding reveal that the "MG" state is more stable than 
the other states. The DSC endotherms of RNL obtained at 
pH 9.0, 7.4, and 2.2 were with two transitions, while at pH 
1.8 it showed only a single transition. 
Keywords Lipase • pH denaturation • Molten globule • 
Rhizopus niveus lipase • Thermal stability • 
GuHCl denaturation 
Abbreviations 
ANS l-Anilino-8-napthalene .sulfonate 
Cm Midpoint concentration 
DSC Differential scanning calorimetry 
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GuHCl Guanidine hydrochloride 
hH Enthalpy 
MG Molten globule 
Tn, Midpoint temperature 
RNL Rhizopus niveus lipase 
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Introduction 
Understanding of the molecular basis of protein stability 
draws attention of investigators both for perspective com-
prehension of the principles of the protein structure and for 
the possible biotechnological applications through devel-
opment of solvent-protein engineering. Maintenance of a 
proper structure is an essential prerequisite for a functional 
activity of a protein. Hence, one of the primary require-
ments for a protein to be of industrial importance is its 
functional stability, which is guided by both thermody-
namic and kinetic parameters [I]. Enzymatic activity and 
conformational stability of proteins can be measured by pH 
denaturation [2], thermal denaturation [3] and by chemical 
unfolding such as guanidine hydrochloride (GuHCl) and 
urea as these two chaotropic agents are commonly used as 
protein denaturants [4]. 
The characterization of unfolded and partially folded 
state of protein is essential to understand the protein fold-
ing and its stability. It is well known that the protein 
folding is a highly cooperative and spontaneous process, 
which does not need the presence of any additional factors. 
The folded conformation adapted by a protein is generally 
governed by its amino acid sequence suggesting the 
underlying stereo chemical code for protein folding [5]. 
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Pollutant-Induced Modulation in Conformation and p-
Lactamase Activity of Human Serum Albumin 
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Abstract 
Structural changes in human serum albumin (HSA) induced by the pollutants 1-naphthol, 2-naphthol and 8-quinolinol were 
analyzed by circular dichroism, fluorescence spectroscopy and dynamic light scattering. The alteration in protein 
conformational stability was detemiined by helical content induction (from 55 to 75%) upon protein-pollutant interactions. 
Domain plasticity is responsible for the temperature-mediated unfolding of HSA. These findings were compared to HSA-
hydrolase activity. We found that though HSA is a monomeric protein, it shows heterotropic allostericity for p-lactamase 
activity in the presence of pollutants, which act as K- and V-type non-essential activators. Pollutants cause conformational 
changes and catalytic modifications of the protein (increase in p-lactamase activity from 100 to 200%). HSA-pollutant 
interactions mediate other protein-ligand interactions, such as HSA-nitrocefin. Therefore, this protein can exist in different 
conformations with different catalytic properties depending on activator binding. This is the first report to demonstrate the 
catalytic allostericity of HSA through a mechanistic approach. We also show a correlation with non-microbial drug resistance 
as HSA is capable of self-hydrolysis of p-laaam drugs, which is further potentiated by pollutants due to conformational 
changes in HSA. 
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Introduction 
Human serum albumin (HSA) is tlic most abundant multifunc-
tional single cliain protein in blood plasma. HSA plays important 
physioiogical and pharmacokinetica! roks by binding and 
tian.sporling exo- and endo-genous tonip(junds [1,2]. Il also 
pos.sc.s.scs .some enola.se, esterase and hydrola.se actiwtics [3]. Thus, 
this protein contains both binding and catalytic sites [4]. This is 
heart-shaped and 80x80x30 A in size [5] and the molcculai-
topology can be easily changed because of its flexible nature as 
demonstrated in physicochemical studies [6]. Transportation of 
solute is one of the best characterized roles of this protein which 
solublizcs ligands and targets them to cells through binding to 
specific cell receptors. HSA bound to specific ligands are 
recognized by specific cellular receptors through the ligand-
dependent conformations of this protejn [7]. Additionally, upon 
ligand binding, albumin undergoes physiologically relevant 
slnictural changes as in case of HSA-oleale interaction. As a 
consequence of the allerauon in die nature of die local 
cmiionmcnt sunounding Cys-34, die long chain of fatty acid 
regulates ihc radical-Uapping antioxidant activity fS]. These 
ligand-dependent changes in protein conformations are specific 
to the type of ligands and more precisely to their capacity' to 
accuiTiulate in the binding pockets. ITie ligand-induced strucmral 
changes in HSA are suggested to mediate its role in receptor-
mediated cellular interaction as well as solute transport m 
physiological conditioas. 
We have studied the efi'ect of pollutants on the stnicatre and 
function of HSA. l-naphthol (IK), 2-naphtliol (2N) and 8-
quinolinol (8H) showni in Figure 1 are direct or indirect 
(metabolite) organic pollutants and their accumulation in body 
can cause cyanosis, liver damage, nephritis, circulatory collapse 
and even death. A detailed study on the mode of interaction 
between HSA and diese pollutants has been already performed 
and reponed by our group [9] and the amino acid residues to 
which the jiollutants bind are shown in Figure 2. In the pre,sent 
study, the effects of pollutant binding to HSA have been 
analyzed by a number of techniques. UV-visiblc, fluorescence 
spectroscopy, circular dichroism and dynamic light scattering aie 
used to investigate the structural changes in protein associated 
with ligand binding. Here, our study offers not only direct proof 
for ligand-indured conformational alterations in protein, but also 
a clear understanding of die nature and after eflfects of these 
changes. 
Materials and Methods 
Materials 
Fatly acid li-ec human scrum albumin (A1887), IN (N2780) and 
2N (185507) were from Sigma-.'Xldrich, USA, 8-quinolinol (8H), 
tris and hydi-ochloric acid were from Qiialigens, India, whereas 
nilTocefin (484400) was a product of Calbiochem. 
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